User Image Cart Icon 0 Search Image

Insulin & Obesity

  1. A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase
  2. A case of familial Bardet-Biedl syndrome (obesity, slight mental retardation, polydactyly, retinitis pigmentosum and renal failure) with insulin-resistant diabetes mellitus
  3. A case of insulin autoimmune syndrome that developed after topiramate anti-obesity medication
  4. A central role for JNK in obesity and insulin resistance
  5. A clinically confirmed family history for early myocardial infarction is associated with increased risk of obesity, insulin resistance and metabolic syndrome
  6. A combination of circulating chemokines as biomarkers of obesity‐induced insulin resistance at puberty
  7. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization
  8. A CONNECTION BETWEEN insulin RESISTANCE AND ANDROGENS, INDEPENDENT OF obesity?
  9. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome.
  10. A Distinct Population of Lipid Sensing iNKT Cells are Enriched in Fat and Protect Against Diet-Induced obesity and insulin Resistance (176.26)
  11. A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity
  12. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome
  13. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
  14. A high alanine aminotransferase/aspartate aminotransferase ratio determines insulin resistance and metabolically healthy/unhealthy obesity in a general adult …
  15. A high omega-6 PUFA diet impairs hepatocyte insulin signalling during diet-induced obesity
  16. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD …
  17. A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila
  18. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer
  19. A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity
  20. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in …
  21. A major role of insulin in promoting obesity-associated adipose tissue inflammation
  22. A major role of insulin in promoting obesity-associated adipose tissue inflammation
  23. A Meta-analysis of Effects of Aerobic Exercise on Glucose and insulin in Overweight/obesity Children and Adolescent [J]
  24. A Meta-Analysis of the Impact of obesity, Metabolic Syndrome, insulin Resistance, and Microbiome on the Diagnosis of Barrett’s Esophagus
  25. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
  26. A mitochondrially encoded hormone ameliorates obesity and insulin resistance
  27. A mouse model of diet-induced obesity and insulin resistance
  28. A multidisciplinary intervention in childhood obesity acutely improves insulin resistance and inflammatory markers independent from body composition
  29. A Multiplatform Non-targeted Metabolomics Approach to Investigate insulin Resistance Associated to obesity in Childhood
  30. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity
  31. A new endoscopically implantable device (SatiSphere) for treatment of obesity—efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
  32. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight …
  33. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis
  34. A new tumor necrosis factor (TNF)-α regulator, lipopolysaccharides-induced TNF-α factor, is associated with obesity and insulin resistance
  35. A non-invasive marker of insulin resistance in patients with obesity
  36. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance
  37. A novel GPCR messenger mediating cholinergic stimulation of synaptotagmin-dependent insulin exocytosis and obesity
  38. A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
  39. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer
  40. A pharmacologic sympathectomy prevents the development of obesity and insulin resistance in the high fat fed rat
  41. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma
  42. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp …
  43. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
  44. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
  45. A Potential New Treatment Option for Asthma in the Setting of obesity or insulin Resistance?
  46. A potential role for insulin treatment during pregnancy in reducing postpartum psychological distress in maternal obesity: An administrative population health …
  47. A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly
  48. A preliminary study of mechanism of periodontitis and periodontal therapy influence in insulin resistance for obesity rats
  49. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects
  50. A randomized control trial of the impact of LCPUFA‐ω3 supplementation on body weight and insulin resistance in pubertal children with obesity
  51. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients
  52. A review of the carbohydrate–insulin model of obesity
  53. A role for 5-lipoxygenase products in obesity-associated inflammation and insulin resistance
  54. A role for EP3 and its associated G protein, Gz, in negatively regulating beta-cell function and mass in the context of insulin resistance and obesity
  55. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression
  56. A simple and effective model to study insulin resistance in obesity and diabetes and the processes and mechanisms of in vitro aging using lymphocyte culture
  57. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity
  58. A study of association of sex hormones with insulin resistance and obesity for diabetes mellitus risk in adult women
  59. A Study on insulin Resistance and obesity Among Women at High Risk for Breast Cancer Using Cluster Analysis.
  60. A study on relation of obesity to serum lipid, leptin and insulin concentration in elementary schoolchildren
  61. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip …
  62. A study on the relationship between neck circumference and obesity related indexes and metabolic disorders associated with insulin resistance
  63. A Submaximal Exercise Patterns Intervention on the Plasmatic Leptin Level and insulin Resistance for Overweight/obesity Boys Adolescences
  64. A three-year follow-up study on risk factors for obesity and non-insulin dependent diabetes mellitus in aging populations in China
  65. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
  66. A Uniform. Approach in the Use of U-500 Regular insulin in the Management Of Paiients with obesity and Insu] in Resistance: The Clinicia’s View.
  67. A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance
  68. AB0025 Is Abatacept Successful in Improving insulin Resistance in A High Fat Diet Model of obesity?
  69. AB0092 Effect of methotrexate, leflunomide and hydroxychloroquine on the insulin resistance and obesity associated with rheumatoid arthritis: obese mouse models …
  70. AB1098 obesity and insulin resistance in fibromyalgia patients
  71. ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production, insulin-glucose homeostasis, inflammation and obesity
  72. Abdominal obesity and insulin resistance after an episode of acute pancreatitis
  73. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project
  74. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
  75. Abdominal obesity and insulin resistance in people exposed to moderate-to-high levels of dioxin
  76. Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study
  77. Abdominal obesity as a mediator of the influence of physical activity on insulin resistance in Spanish adults
  78. Abdominal obesity as important component of insulin-resistance syndrome.
  79. Abdominal obesity associated with elevated serum Butyrylcholinesterase activity, insulin resistance and reduced high density lipoprotein-cholesterol levels
  80. Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
  81. Abdominal obesity in older women: potential role for disrupted fatty acid reesterification in insulin resistance
  82. Abdominal obesity is associated with insulin resistance and reduced glycogen synthase activity in skeletal muscle
  83. Abdominal obesity is associated with insulin resistance.
  84. Abdominal obesity Predicts Declining insulin Sensitivity in Non-Obese Normoglycemics
  85. Abdominal obesity predicts declining insulin sensitivity in non‐obese normoglycaemics: the insulin Resistance Atherosclerosis Study (IRAS)
  86. ABDOMINAL obesity, DYSLIPIDEMIA, insulin RESISTANCE, TYPE 2 DIABETES AND ATHEROSCLEROSIS: WHO IS THE RIGHT PATIENT TO BE …
  87. Abdominal obesity, fatty acids and insulin resistance
  88. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature …
  89. Abdominal obesity, insulin resistance and hypertension: impact on left ventricular mass and function in women
  90. Abdominal obesity, insulin resistance, and alterations in hemostasis
  91. Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
  92. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression
  93. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population
  94. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise
  95. Abdominal obesity, insulin resistance, and the risk of colonic adenoma
  96. Abdominal obesity, insulin resistance, metabolic syndrome and cholesterol homeostasis
  97. ABDOMINAL obesity, METABOLIC SYNDROME AND insulin RESISTANCE: PP. 26.340
  98. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
  99. Abdominal subcutaneous adipose tissue gene expression in relation to tissue-specific insulin resistance in human obesity
  100. Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic
  101. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
  102. Ablation of insulin-producing cells prevents obesity but not premature mortality caused by a high-sugar diet in Drosophila
  103. Ablation of MARK4, an AMPK-related Kinase, Leads to insulin Hypersensitivity and Resistance to Diet-induced obesity
  104. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
  105. Abnormal liver function and insulin resistance in obesity
  106. Abnormal mitochondrial metabolism in obesity and insulin resistance
  107. Abnormalities of Glucose and insulin Metabolism in Exogenous obesity.
  108. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity
  109. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central …
  110. Abrogation of toll-like receptor 4 mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria …
  111. Absence of GIP secretion alleviates age-related obesity and insulin resistance
  112. ABSENCE OF GUT MICROBIOTA PROTECTS AGAINST DIET-INDUCED obesity AND insulin-RESISTANCE BUT PREDISPOSES TO LIVER DAMAGE
  113. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity
  114. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice
  115. Absence of the ROS Scavenger DJ-1 Paradoxically Protects Mice from obesity and insulin Resistance
  116. Absence of toll‐like receptor‐2 (Tlr2) attenuates diet induced obesity and adipose tissue inflammation and insulin resistance
  117. Abstract CN13-04: obesity, insulin resistance, hyperglycemia, and cancer: A novel role for metformin as an anticancer drug
  118. Abstract KN01: Keynote Lecture: PI 3-kinase links obesity, insulin resistance, and cancer
  119. Abstract MP55: DNA methylation mediates the effects of obesity on insulin resistance in african american youth and young adults
  120. Abstract P034: Association between obesity Indices and insulin Resistance among Healthy Korean Adolescents
  121. Abstract P088: obesity, Hypertension and insulin Resistance in a Primary Pediatric Setting in Southern Italy
  122. Abstract P438: Staying Active improves insulin Resistance independent of the Metabolic Syndrome and obesity
  123. Abstract P636: insulin Resistance in obesity Results in Postprandial Salt and Water Loss
  124. Abstract WP132: Relationship Of Neck Circumference And insulin Resistance On The Cerebrovascular Reactivity In Subjects With obesity.
  125. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action
  126. Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American …
  127. Acanthosis nigricans in obese children and adolescents in relation to severity of obesity and insulin resistance.
  128. Acanthosis nigricans with severe obesity, insulin resistance and hypothyroidism: improvement by diet control
  129. ACANTHOSIS NIGRICANS, obesity, insulin RESISTANCE AND HYPERANDROGENEMIA: NATURAL HISTORY AND PEDIATRIC PERSPECTIVE
  130. Acanthosis nigricans: A valid clinical marker of insulin resistance in obesity
  131. Acetylsalicylic acid modulates inflammation and insulin resistance in a mouse model of diet-induced obesity
  132. Acquired obesity Changes Adipose Tissue MRNA Expression, Increases Abdominal and Liver Fat, and Causes insulin Resistance in Monozygotic Twins
  133. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins
  134. ACSL1 multi‐tissue knockout mice are resistant to diet‐and age‐induced obesity and insulin resistance
  135. Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats
  136. Activating transcriptional factor 4 correlated with obesity and insulin resistance in polycystic ovary syndrome
  137. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance
  138. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling
  139. Activation of malonyl‐CoA/fatty acid synthase axis is an early event in the effects of insulin in human skeletal muscle myotubes: Implication for obesity linked insulin …
  140. Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth
  141. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes
  142. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance
  143. Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
  144. Activation of α7nAChR via vagus nerve prevents obesity-induced insulin resistance via suppressing endoplasmic reticulum stress-induced inflammation in Kupffer …
  145. Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment for obesity and insulin resistance
  146. Acupuncture for Treatment of obesity and insulin Resistance
  147. Acupuncture targeting SIRT1 in the hypothalamic arcuate nucleus can improve obesity in high-fat-diet-induced rats with insulin resistance via an anorectic effect
  148. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity
  149. Acute regulation of insulin release by the pituitary gland in relation to hyperinsulinaemia and obesity
  150. Acylcarnitine kinetics in a fasting-and obesity-induced insulin resistant mouse model
  151. Adapter proteins regulate insulin resistance and lipid metabolism in obesity
  152. Adapting to insulin resistance in obesity: role of insulin secretion and clearance
  153. Adaptive immunity and antigen-specific activation in obesity-associated insulin resistance
  154. Adaptive immunity in obesity and insulin resistance
  155. ADAR1 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice
  156. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents
  157. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
  158. Adenosine Triphosphate-Sensitive Potassium (KATp) Channel Activity Is Coupled with insulin Resistance in obesity and
  159. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance
  160. Adenylyl cyclase 3 haploinsufficiency confers susceptibility to diet-induced obesity and insulin resistance in mice
  161. Adenylyl cyclase type 5 deficiency protects against diet-induced obesity and insulin resistance
  162. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis
  163. Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity
  164. Adipocyte CREB promotes insulin resistance in obesity
  165. Adipocyte DIO2 expression increases in human obesity but is not related to systemic insulin sensitivity
  166. Adipocyte dysfunction, inflammation, and insulin resistance in obesity
  167. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  168. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in …
  169. Adipocyte insulin resistance: effects of aging, obesity, exercise, and food restriction
  170. Adipocyte protein carbonylation and oxidative stress in obesity-linked mitochondrial dysfunction and insulin resistance.
  171. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity
  172. Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice
  173. Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset of insulin resistance and attenuates adipose tissue inflammation in obesity
  174. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance
  175. Adipocyte‐specific enhancement of angiotensin II type 1 receptor‐associated protein ameliorates diet‐induced visceral obesity and insulin resistance
  176. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice
  177. Adipocytokine profile and insulin resistance in childhood obesity
  178. Adipocytokines and insulin levels in young obese subjects at risk for type II diabetes–the STYrian Juvenile obesity Study (STYJOBS)
  179. Adipocytokines, insulin resistance and obesity coherence in women with previously diagnosed gestational diabetes
  180. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer
  181. Adipocytokines: a bridge connecting obesity and insulin resistance
  182. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid‐related orphan receptor gamma
  183. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity
  184. ADIPOKINE PROFILES OFinsulin SENSITIVE obesityAND insulin RESISTANCE obesity AMONG CHINESE CHILDREN: THE BCAMS STUDY
  185. Adipokines as Novel Links between obesity and insulin Resistance
  186. Adipokines, Ghrelin and obesity‐Associated insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome
  187. Adipokines, inflammation, and insulin resistance in obesity
  188. Adipokines, systemic inflammation and inflamed adipose tissue in obesity and insulin resistance
  189. Adipokines: the missing link between insulin resistance and obesity
  190. Adiponectin and adiponectin receptors in obesity-linked insulin resistance
  191. Adiponectin and insulin resistance in childhood obesity
  192. Adiponectin and insulin resistance in obesity-related diseases
  193. Adiponectin and insulin resistance responses to aerobic training in males with abdominal obesity
  194. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
  195. Adiponectin and its role in the obesity-induced insulin resistance and related complications
  196. Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance
  197. Adiponectin as novel biomarker of endothelial dysfunction in insulin resistance and obesity–a narrative review
  198. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression
  199. Adiponectin expression in visceral adiposity is an important determinant of insulin resistance in morbid obesity
  200. Adiponectin Gene Variation-4522C/T Is Associated with Type 2 Diabetic obesity and insulin Resistance in Chinese
  201. Adiponectin gene variation− 4522C/T is associated with type 2 diabetic obesity and insulin resistance in Chinese
  202. Adiponectin, anthropometric measurements and insulin resistance in adolescence with obesity.
  203. Adiponectin, the missing link in insulin resistance and obesity
  204. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
  205. Adiponectin: A Mediator of obesity, insulin Resistance, Diabetes, and the Metabolic Syndrome
  206. Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease
  207. ADIPOSE AND INTESTINAL IMMUNOPATHOLOGY IN obesity RELATED insulin RESISTANCE.
  208. Adipose cell and lipid turnovers in obesity and insulin resistance
  209. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
  210. Adipose DPP4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
  211. Adipose Estrogen and Increased Breast Cancer Risk in obesity: Regulation by Leptin and insulin
  212. Adipose Expression and Regulation of Selenoprotein P in obesity and insulin Resistance
  213. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance
  214. Adipose extracellular matrix remodelling in obesity and insulin resistance
  215. Adipose HuR protects against diet-induced obesity and insulin resistance
  216. Adipose HuR protects against diet-induced obesity and insulin resistance in mice
  217. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat
  218. Adipose inflammation: cause or consequence of obesity-related insulin resistance
  219. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity
  220. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity
  221. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance
  222. Adipose tissue and insulin secretion in the pathophysiology of obesity and its complications
  223. Adipose tissue as a source of proinflammatory factors in obesity: The importance in the development of insulin resistance and diabetes
  224. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance
  225. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance
  226. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance
  227. Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance
  228. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines
  229. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells
  230. Adipose tissue inflammation is directly linked to obesity-induced insulin resistance, while gut dysbiosis and mitochondrial dysfunction are not required
  231. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
  232. Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity
  233. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?
  234. Adipose tissue macrophage phenotypes and characteristics: the key to insulin resistance in obesity and metabolic disorders
  235. Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
  236. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes
  237. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity
  238. Adipose tissue monomethyl branched‐chain fatty acids and insulin sensitivity: Effects of obesity and weight loss
  239. Adipose tissue mRNA expression of HDAC1, HDAC3 and HDAC9 in obese women in relation to obesity indices and insulin resistance
  240. Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy
  241. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes
  242. Adipose Tissue Overexpression of a Constitutively Active Isoform of Chrebp Protects Against obesity and insulin Resistance in Mice
  243. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance
  244. Adipose Tissue Secretory Changes and Low-Grade Inflammation Combine With insulin Resistance and Vascular Dysfunction in Human obesity
  245. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
  246. Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility
  247. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
  248. Adipose Tissue VEGF‐D Overexpression Increases Lymphatic Vessel Density and Protects Against Inflammation and insulin Resistance in obesity
  249. Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity
  250. Adipose TNF and IL-6 expression in human obesity-associated insulin resistance
  251. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance
  252. Adipose-specific deficiency of fumarate hydratase in mice protects against obesity, hepatic steatosis, and insulin resistance
  253. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance
  254. Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release
  255. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosis
  256. Adipose‐specific deletion of Kif5b exacerbates obesity and insulin resistance in a mouse model of diet‐induced obesity
  257. Adiposity in childhood predicts obesity and insulin resistance in young adulthood
  258. Adolescent Metabolic/Bariatric Surgery: Effects on obesity, Comorbidities, and insulin Resistance
  259. Adolescent obesity and insulin resistance: roles of ectopic fat accumulation and adipose inflammation
  260. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
  261. Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II MHC in adipocytes
  262. Adult-onset obesity reveals prenatal programming of glucose-insulin sensitivity in male sheep nutrient restricted during late gestation
  263. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes
  264. Adverse effects of obesity on lipid and lipoprotein levels in the patients with non-insulin dependent diabetes in the young
  265. Adverse Effects of obesity, Hyperglycemia, and insulin Resistance on Cardiac Mechanics
  266. Aerobic Exercise Training Prevents obesity and insulin Resistance Independent of Changes in the Skeletal Muscle ACE2/Ang 1‐7/Mas Axis.
  267. Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose …
  268. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular …
  269. Aging enhances the insulin resistance in obesity through both receptor and postreceptor alterations
  270. AKAP1 Deficiency Attenuates Diet‐Induced obesity and insulin Resistance by Promoting Fatty Acid Oxidation and Thermogenesis in Brown Adipocytes
  271. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian …
  272. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients
  273. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat
  274. Alcohol intake, insulin resistance, and abdominal obesity in elderly men
  275. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor β/δ and retinoic acid receptor
  276. Allelic Variant Gly1057 Asp of IRS-2 Gene Has Distinctive Effects on insulin Secretion and Sensitivity in obesity and Type 2 Diabetes
  277. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX …
  278. Allograft Inflammatory Factor-1 Deficiency Prevents obesity and insulin Resistance by Promoting Brown and Beige Adipocyte Thermogenic Programs
  279. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance
  280. ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-induced obesity and insulin resistance
  281. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity
  282. Alström syndrome: renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH …
  283. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon‐like peptide 1 in diet‐induced obesity
  284. Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice
  285. Alteration of lipid metabolism and insulin secretion in ventromedial hypothalamic obesity rats
  286. Alteration of local adipose tissue trace element homeostasis as a possible mechanism of obesity-related insulin resistance
  287. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance
  288. Alterations in Novel Signals in the Gut–Adipose Axis–A Pilot Study in insulin-Resistant Children with obesity and Biopsy-Proven Nonalcoholic Steatohepatitis
  289. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
  290. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats
  291. Alterations in the liver of intrauterine growth retarded piglets may predispose to development of insulin resistance and obesity in later life
  292. Alterations in vitamin A/retinoic acid homeostasis in diet-induced obesity and insulin resistance
  293. Alterations of carbohydrate and lipoprotein metabolism in childhood obesity–impact of insulin resistance and acanthosis nigricans.
  294. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus
  295. Alterations of Serum True insulin in Patients with Simple obesity and Analyses of Factors Affecting insulin Resistance [J]
  296. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance
  297. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome
  298. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance
  299. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
  300. Altered circulating levels of retinol binding protein 4 and transthyretin in relation to insulin resistance, obesity, and glucose intolerance in Asian Indians
  301. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
  302. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
  303. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity
  304. Altered insulin response to an acute bout of exercise in pediatric obesity
  305. Altered insulin-Dependent Brain Glucose Metabolism During obesity Depends On Specific Brain Areas
  306. Altered interleukin-10 signaling in skeletal muscle regulates obesity-mediated inflammation and insulin resistance
  307. Altered lipid metabolism associated with insulin resistance and obesity is a major contributor to the onset and progression of type 2 diabetes
  308. Altered plasma insulin and glucose after obesity-producing bipiperidyl brain lesions
  309. Altered temporal changes in Ser312-phosphofetuin-A concentrations in response to a glucose challenge in a mouse model of diet-induced obesity and insulin …
  310. Altering adipocyte metabolism as a way to counteract obesity and insulin Resistance
  311. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
  312. Alzheimer’s disease risk, obesity and tau: is insulin resistance guilty?
  313. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity
  314. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II …
  315. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation
  316. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats
  317. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin
  318. Aminotransferase and gamma-glutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
  319. Amniotic fluid insulin concentration as a predictor of obesity.
  320. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity?
  321. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity
  322. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012; 61: 3114–3125
  323. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity
  324. AMPK β1 deletion reduces appetite, preventing obesity and hepatic insulin resistance
  325. An 8-week high-fat diet induces obesity and insulin resistance with small changes in the muscle transcriptome of C57BL/6J mice
  326. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity
  327. An Analysis of the Relationships Among obesity, Plasma insulin, and Hepatic Lipogenic Enzymes in
  328. An animal model of gestational obesity and prediabetes: HISS-dependent insulin resistance induced by a high sucrose diet in Sprague Dawley rats.
  329. An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation
  330. An evaluation of acylated ghrelin and obestatin levels in childhood obesity and their association with insulin resistance, metabolic syndrome, and oxidative stress
  331. An Exploration of relationships between three main characteristics of Equine Metabolic Syndrome, obesity, insulin resistance, and laminitis
  332. An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2A (PP2A)
  333. An In Vivo Screen for Genes Involved in Central Nervous System Control of obesity Identifies Diacylglycerol Kinase as a Regulator of insulin Secretion
  334. An in vivo screen for neuronal genes involved in obesity identifies Diacylglycerol kinase as a regulator of insulin secretion
  335. An individual participant data meta-analysis on metabolomics profiles for obesity and insulin resistance in European children
  336. An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity
  337. An investigation into the effects of aspalathin on myocardial glucose transport using cardiomyocytes from control and obesity-induced insulin resistant rats, and …
  338. An investigation of the association between obesity, acanthosis nigricans, and fasting serum insulin level in 6-9 year old children living on the El Paso-Juarez United …
  339. An obesity genetic risk score predicts risk of insulin resistance among Chinese children
  340. An obesity risk SNP (rs17782313) near the MC4R gene is associated with cerebrocortical insulin resistance in humans
  341. An update on immune dysregulation in obesity‐related insulin resistance
  342. An Update to the WISP-1/CCN4 Role in obesity, insulin Resistance and Diabetes
  343. Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension
  344. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic insulin Resistance Atherosclerosis Study cohort
  345. Analysis of metabolic profiles underlying surrogates for obesity and insulin resistance in young adults from the Western Australian Pregnancy Cohort (Raine) Study
  346. Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity
  347. ANALYSIS OF THE IMPACT OF obesity ON insulin-SENSITIVITY AND METABOLIC ABNOMALITY IN TYPE 2 DIABETES MELLITUS [J]
  348. Analysis of three glucose transporter genes in a Caucasian population: no associations with non‐insulin‐dependent diabetes and obesity
  349. Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome
  350. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women
  351. ANDROLOGY: obesity, insulin RESISTANCE AND THEIR CORRELATION WITH TESTOSTERONE LEVELS IN MALE PATIENTS
  352. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity
  353. Angiogenesis modulates obesity and insulin sensitivity
  354. Angiogenic Potential, Circulating Angiogenic Factors and insulin Resistance in Subjects with obesity
  355. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance
  356. Angiopoietin-related growth factor antagonizes obesity and insulin resistance
  357. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
  358. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice
  359. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women
  360. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation
  361. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity
  362. Anthocyanin‐rich Black Elderberry Extract improves Inflammatory Markers and insulin Resistance in a High‐Fat Diet‐Induced obesity Model of Mice
  363. Anthropometric measures of obesity and insulin resistance in Turkish patients with type 2 diabetes
  364. Anti-diabetic and anti-obesity effects of the allosteric PTP1B inhibitor KY-226 via insulin and leptin signal enhancement
  365. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity
  366. Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice
  367. Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
  368. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice
  369. Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice
  370. Anti‐obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high‐fat diet
  371. Anti‐obesity and anti‐diabetic effects of carteolol in non‐insulin‐dependent diabetic mice
  372. Antihypertensive drugs and insulin resistance in obesity
  373. Antioxidant supplementation and obesity have independent effects on hepatic oxylipin profiles in insulin-resistant, obesity-prone rats
  374. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity
  375. Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment
  376. Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway
  377. Apelin, a newly identified adipokine up-regulated by insulin and obesity
  378. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice
  379. Apolipoprotein C3-deficiency results in diet-induced obesity and insulin resistance in mice
  380. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the …
  381. Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway
  382. Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of obesity, insulin Resistance, and Sex
  383. Appetite, hunger and obesity as a function of dietary sugar intake: Can these effects be mediated by insulin-induced hypoglycemia? A reply to commentaries
  384. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 …
  385. Application of nuclear techniques in the prevention of degenerative diseases (obesity and non-insulin dependent diseases) in ageing
  386. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity.
  387. Are insulin Hypersecretion and Food Additives a Cause of obesity and Diabetes?
  388. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?
  389. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?
  390. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
  391. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
  392. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
  393. Arsenic methylation capacity and obesity are associated with insulin resistance in obese children and adolescents
  394. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of …
  395. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome
  396. Arterial stiffening, insulin resistance and acanthosis nigricans in a community sample of adolescents with obesity
  397. Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
  398. Assess the relationship between insulin fasting levels and healthy obesity in adults in the province of Babylon, Iraq
  399. Assessing associations of cardiorespiratory fitness (CRF) and degree of obesity with insulin-resistance.
  400. ASSESSING obesity AND insulin MOLECULAR PATHWAYS INVOLVED IN WEIGHT LOSS INDUCED BY ROUX-EN-Y GASTRIC BYPASS
  401. Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin
  402. Assessing risk factors for obesity between childhood and adolescence. I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin.
  403. Assessing the Mediating Effect of obesity-Linked SNPs in Nuclear Mitochondrial Genes on Exercise-Enhanced insulin Sensitivity
  404. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
  405. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
  406. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice.
  407. Assessment of obesity, dyslipidemia, and insulin resistance in idiopathic hirsutism: a case–control study
  408. Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in Saudi Arabia
  409. Assisted reproductive technologies predispose to insulin resistance and obesity in male mice challenged with a high-fat diet
  410. Association between 14 bp insertion/deletion HLA‐G functional polymorphism and insulin resistance in a cohort of Italian children with obesity
  411. Association Between Anthropometric Measures of obesity and insulin Resistance in a Self-Selected Group of Indigenous Australians
  412. Association between caries, obesity and insulin resistance in Mexican adolescents
  413. Association between Caries, obesity and insulin Resistance in Mexican Adolescents.
  414. Association between complement component C3 and body composition: a possible obesity inflammatory biomarker for insulin resistance
  415. Association between cortisol, insulin resistance and zinc in obesity: A mini-review
  416. Association between dietary insulin index and load with obesity in adults
  417. Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus: the Sotetsu Study
  418. Association Between Expanded Normal Weight obesity and insulin Resistance Among US Adults in the National Health and Nutrition Examination Survey
  419. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population
  420. Association between G-protein beta3 subunit (GNB (3)) gene C825T polymorphism, hypertension, insulin resistance and obesity
  421. Association between muscle mass and insulin sensitivity independent of detrimental adipose depots in young adults with overweight/obesity
  422. Association between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescents
  423. Association between obesity history and hand grip strength in older adults—exploring the roles of inflammation and insulin resistance as mediating factors
  424. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS high school study
  425. Association between obesity phenotypes of insulin resistance and risk of type 2 diabetes in African Americans: The Jackson Heart Study
  426. Association between polymorphisms of insulin and insulin receptor gene with childhood obesity in Malay population
  427. Association between Serum Lipid Profile and insulin Resistance in Type 2 Diabetic Patients with obesity [J]
  428. Association between Transcription Factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study
  429. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome
  430. #VALUE!
  431. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
  432. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
  433. Association of adipokines and insulin, which have a role in obesity, with colorectal cancer
  434. Association of Adipokines and insulin, Which Have a Role in obesity, with Colorectal Cancer
  435. Association of ADRB1 and UCP3 gene polymorphisms with insulin sensitivity but not obesity
  436. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer
  437. Association of central obesity and insulin resistance with high prevalence of diabetes and cardiovascular disease in an elderly population with low fat intake and lower …
  438. Association of extracellular heat shock protein 70 and insulin resistance in type 2 diabetes; independent of obesity and C-reactive protein
  439. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study
  440. Association of free fatty acids with the insulin-resistant state but not with central obesity in individuals from Venezuela.
  441. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
  442. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
  443. Association of gut microbiome with fasting triglycerides, fasting insulin and obesity status in Mexican children
  444. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
  445. Association of insulin Actions with Blood Pressure in Rodent Models of obesity and Diabetes
  446. Association of insulin actions with blood pressure in rodent models of obesity and diabetes.
  447. Association of insulin resistance and GLP-2 secretion in obesity: a pilot study
  448. Association of insulin resistance and obesity with impaired immune response to нepatitis B vaccination in health care workers
  449. ASSOCIATION OF insulin RESISTANCE AND obesity WITH IMPAIRED IMMUNE RESPONSE TO НЕРАTITIS B VACCINATION IN HEALTH CARE WORKERS
  450. Association of insulin resistance with obesity in children
  451. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose …
  452. Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2‐h postchallenge plasma glucose levels
  453. Association of leptin and insulin with childhood obesity and retinal vessel diameters
  454. Association of Leptin Gene G2548A Polymorphism and Leptin Resistance with insulin Resistance and obesity among Egyptians
  455. Association of Leptin With obesity and insulin Resistance
  456. Association of Markers of obesity with insulin Resistance and Type 2 Diabetes Mellitus in a Rural Female Population
  457. Association of miR-34a and mir-149 with obesity and insulin Resistance in Obese Children and Adolescents
  458. Association of MMP‐8 with obesity, smoking and insulin resistance
  459. Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women
  460. Association of nerve conduction impairment and insulin resistance in children with obesity
  461. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
  462. Association of nonalcoholic fatty liver disease with obesity and insulin resistance
  463. Association of obesity and hyperandrogenemia with insulin resistance in women with polycystic ovary syndrome
  464. Association of obesity and insulin resistance with asthma and aeroallergen sensitization
  465. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
  466. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
  467. Association of obesity and insulin resistance with serum testosterone, sex hormone binding globulin and estradiol in older males
  468. #VALUE!
  469. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women …
  470. Association of obesity indexes of waist circumference, body mass index and WHR with insulin resistance in non-diabetic subjects
  471. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
  472. Association of obesity-mediated insulin resistance and hypothalamic volumes: Possible sex differences
  473. Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action
  474. Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults
  475. Association of osteoprotegerin with obesity, insulin resistance and non-alcoholic fatty liver disease in children
  476. Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance
  477. #VALUE!
  478. Association of Peptic Ulcer Disease with obesity, Serum insulin Level and Lipid Profile
  479. Association of perilipin and insulin receptor substrate-1 genes polymorphism with lipid profiles, central obesity, and type 2 diabetes in a sample of an Iranian …
  480. Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare
  481. Association of Polymorphism in the Glucocorticoid Recepter Gene and Plasm Glucose, insulin, Lipids in Abdominal obesity
  482. Association of Resistin Gene 3′-Untranslated Region EX4-44G–> A Polymorphism with obesity-and insulin-Related Phenotypes in Turkish Type 2 Diabetes …
  483. Association of resistin gene 3′-untranslated region EX4-44G–> A polymorphism with obesity-and insulin-related phenotypes in Turkish type 2 diabetes patients.
  484. Association of serum ferritin and abdominal obesity and insulin resistance
  485. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National …
  486. #VALUE!
  487. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population
  488. Association of serum leptin levels with homeostasis model assessment–estimated insulin resistance and metabolic syndrome: the key role of central obesity
  489. Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level and insulin resistance in obesity
  490. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea
  491. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome
  492. Association of SNP45 in adiponectin gene with obesity and insulin resistance
  493. Association of TCF7L2 and GCG gene variants with insulin secretion, insulin resistance, and obesity in new-onset diabetes
  494. Association of the C825T polymorphism of the G-protein β3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic …
  495. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity
  496. Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes
  497. Association of the TNF‐α−308 G/A Promoter Polymorphism with insulin Resistance in obesity
  498. Association of the− 243A> G,+ 61450C> A Polymorphisms of the Glutamate Decarboxylase 2 (GAD2) Gene with obesity and insulin Level in North Indian …
  499. #VALUE!
  500. Association of Trp64Arg polymorphism of beta3-adrenergic receptor with insulin resistance in Polish children with obesity.
  501. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study
  502. Association of β2-adrenergic receptor and insulin receptor substrate-1 polymorphisms with obesity in a Northern Indian population
  503. Associations between Body Fat Measurement by Dual-Energy X-Ray Absorptiometry and Abdominal obesity and insulin Resistance in Korean Populations: Cross …
  504. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance
  505. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity
  506. Associations between long self-reported sleep, obesity and insulin resistance in a cohort of premenopausal Black and White South African women
  507. Associations between sleep duration and insulin resistance in European children and adolescents considering the mediating role of abdominal obesity
  508. Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults
  509. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
  510. Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents
  511. Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease
  512. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults
  513. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
  514. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals
  515. Associations of obesity-metabolic Status With insulin Resistance and Chronic Inflammation Level: Results From the CNTR Study
  516. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity
  517. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project
  518. Associations of Serum Fatty Acid Proportions with obesity, insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study
  519. Associations of the PTEN− 9C> G polymorphism with insulin sensitivity and central obesity in Chinese
  520. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
  521. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
  522. AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity
  523. ATF7 ablation prevents diet-induced obesity and insulin resistance
  524. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate
  525. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
  526. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
  527. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
  528. Attenuated insulin induced dilation in coronary arteries from obesity resistant and obesity prone high fat fed rats (1071.6)
  529. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
  530. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
  531. Attenuation of Diet-Induced obesity, Hypertension and insulin Resistance in Vascular Endothelial Endothelin-1 Knockout Mice
  532. Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
  533. Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2
  534. Attenuation of obesity, insulin resistance, and inflammation in TLR4 deficient 10ScN mice in response to a diet high in saturated fat
  535. Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus
  536. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity
  537. Augmented insulin and leptin resistance of high fat diet-fed APPswe/PS1dE9 transgenic mice exacerbate obesity and glycemic dysregulation
  538. Aurantio‐obtusin improves obesity and insulin resistance induced by high‐fat diet in obese mice
  539. Authors’ response: Associations of obesity and circulating insulin and glucose with breast cancer risk
  540. Autoimmune activation of the GnRH receptor induces insulin resistance independent of obesity in a female rat model
  541. Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet‐induced obesity rats
  542. Autonomic Blockade Improves obesity-Associated insulin Resistance
  543. Autonomic neuropathy in non‐insulin dependent (type II) diabetes mellitus. Possible influence of obesity
  544. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
  545. Autophagy: a potential link between obesity and insulin resistance
  546. AUTOTAXIN IS NUTRITIONALLY REGULATED AND ALTERS MITOCHONDRIAL FUNCTION IN obesity-INDUCED insulin RESISTANCE
  547. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
  548. Avocatin B Protects Against Lipotoxicity and Improves insulin Sensitivity in Diet‐Induced obesity
  549. B Cell Activation in insulin Resistance and obesity
  550. B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance
  551. B lymphocyte stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
  552. B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
  553. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
  554. b3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome
  555. B64 EFFECTS OF obesity ON LUNG FUNCTION: insulin Excess Leads To Lung Remodeling And Features Of Asthma
  556. Baccharis dracunculifolia methanol extract enhances glucose-stimulated insulin secretion in pancreatic islets of monosodium glutamate induced-obesity model rats
  557. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation
  558. Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway
  559. Basal insulin and obesity
  560. Basis of Impaired Coronary Metabolic Dilation in obesity and insulin Resistance
  561. Bax inhibitor-1 deficiency leads to obesity by increasing Ca2+-dependent insulin secretion
  562. Behavior of C-peptide and immunoreactive insulin in essential obesity
  563. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet‐induced obesity mice
  564. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a …
  565. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
  566. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
  567. Beneficial effects of IKKε-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice
  568. Beneficial effects of murtilla extract and madecassic acid on insulin sensitivity and endothelial function in a model of diet-induced obesity
  569. Beneficial Effects of vitamin D on insulin sensitivity, blood pressure, abdominal subcutaneous fat thickness, and weight loss in refractory obesity
  570. Beneficial Effects of Vitamin D on insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory obesity
  571. Beneficial metabolic effects of selected probiotics on diet‐induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota
  572. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss
  573. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature
  574. Bif-1 deficiency impairs lipid homeostasis and causes obesity accompanied by insulin resistance
  575. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
  576. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
  577. Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity
  578. Bioactive insulin-like growth factor-I in obesity
  579. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance
  580. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: relationships with obesity and insulin resistance
  581. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women
  582. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity
  583. Biochemical Effects of Anti-Diabetic Therapies on obesity and insulin Resistance Induced by Monosodium Glutamate in Male Rats
  584. Biochemical studies of cutaneous damage in mouse models of insulin resistance and obesity
  585. #VALUE!
  586. Biocompounds attenuating the development of obesity and insulin resistance produced by a high-fat sucrose diet
  587. Biomarkers of Alzheimer disease, insulin resistance, and obesity in childhood
  588. Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup?
  589. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population
  590. BITC and S-carvone restrain high-fat diet-induced obesity and ameliorate hepatic steatosis and insulin resistance
  591. Black yeast beta glucan for insulin Resistance Prevention through IL-33, ST2 and Leptin Level: An In vivo Study of an obesity model using Sprague dawley Rats
  592. Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance
  593. Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes
  594. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-α signaling protected Wistar rats from diet-induced obesity and insulin resistance
  595. Blocking CD40-TRAF6 Signaling is a Novel Therapeutic Target in obesity-Associated insulin Resistance
  596. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
  597. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States …
  598. Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity
  599. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity
  600. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
  601. Blood coagulation and aortic wall integrity in rats with obesity-induced insulin resistance
  602. Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity
  603. Blood insulin levels during oral glucose tolerance tests in the obese child. Influence of age, sex, degree and duration of obesity
  604. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ× C3H/HeJ intercross
  605. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men
  606. Blood sugar and immunoreactive insulin in women with hypothalamic, maternal and simple obesity. Part I.
  607. Blood viscosity in human obesity: relation to glucose tolerance and insulin status.
  608. Blueberries Improve Whole‐Body insulin Action and Alter the Development of obesity in High‐Fat Fed Mice
  609. Body Composition and its Association with insulin Resistance in Korea Older Population: A Focus on Sarcopenic obesity
  610. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men
  611. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity
  612. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in irs2–/–mice
  613. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats
  614. Brain and behavioral correlates of insulin resistance in youth with depression and obesity
  615. Brain insulin and obesity: From Man to C. elegans
  616. #VALUE!
  617. Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones
  618. Brain-Specific Disruption of the Maternal (but not Paternal) Allele of the Imprinted G [sub s] α Gene Leads to obesity and insulin Resistance.
  619. Breastmilk with a high omega‐6 to omega‐3 fatty acid ratio induced cellular events similar to insulin resistance and obesity in 3T3‐L1 adipocytes
  620. Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus …
  621. Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
  622. Brown adipose tissue triglyceride content is associated with decreased insulin sensitivity, independently of age and obesity
  623. Bypassing the duodenum does not improve insulin resistance associated with diet‐induced obesity in rodents
  624. c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice
  625. C-peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity
  626. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose …
  627. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
  628. C-reactive protein, obesity, and insulin resistance in postmenopausal women in urban slums of North India
  629. C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance
  630. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes
  631. C825T Polymorphism of the G Protein β3 Subunit Is Associated with obesity but Not with insulin Sensitivity
  632. Ca2+ mishandling and cardiac dysfunction in obesity and insulin resistance: Role of oxidative stress
  633. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon …
  634. Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations
  635. Calanus oil in the treatment of obesity-related low-grade inflammation, insulin resistance, and atherosclerosis
  636. Caloric restriction in pregnant diabetic women: a review of maternal obesity, glucose and insulin relationships as investigated at the University of California, San Diego …
  637. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity
  638. Can obesity Alone Increase Fasting Serum insulin, Fasting Serum C-Peptide and insulin Resistance?
  639. Can prokineticin prevent obesity and insulin resistance?
  640. Canagliflozin improves obesity and insulin resistance in a diabetic patient with Cushing’s disease undergoing postoperative steroid therapy: A case report
  641. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis
  642. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity
  643. Cannabis use in relation to obesity and insulin resistance in the inuit population
  644. Carbohydrate intake affects insulin binding to human erythrocytes in normal weight subjects but not in subjects with family obesity
  645. Carbohydrates, insulin, and obesity
  646. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4 …
  647. CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice
  648. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
  649. Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
  650. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies
  651. #VALUE!
  652. Cardiomyopathy in obesity, insulin resistance and diabetes
  653. Cardiorespiratory fitness, insulin sensitivity, and perceptions of obesity treatment in obese children and adolescents
  654. Cardiovascular and renal complications in obesity and obesity-related medical conditions: role of sympathetic nervous activity and insulin resistance
  655. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance
  656. Cardiovascular and Renal Integration: Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs
  657. Cardiovascular Consequences of obesity and Type 2 Diabetes: Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the …
  658. Cardiovascular risk factors in adolescents: Role of insulin resistance and obesity
  659. Carotid Intima-media thickness in childhood and adolescent obesity relations to abdominal obesity, high triglyceride level and insulin resistance
  660. Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice
  661. Case problem: Dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome/Response
  662. Cashew apple extract inhibition of fat storage and insulin resistance in the diet-induced obesity mouse model
  663. Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Induced obesity and insulin Resistance
  664. Casitas b-lineage lymphoma–deficient mice are protected against high-fat diet–induced obesity and insulin resistance
  665. Caspase-12, but not caspase-11, inhibits obesity and insulin resistance
  666. CATECHOL-O-METHYLTRANFERASE GENOTYPE MODULATION OF insulin RESISTANCE IN obesity, IS INDEPENDENT OF BLOOD PRESSURE LEVEL: 9B …
  667. CATECHOLAMINES, obesity AND insulin—RESISTANT DIABETES: EXPERIMENTAL INSIGHTS
  668. Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin …
  669. Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes insulin resistance during obesity
  670. Causal Effects of Overall and Abdominal obesity on insulin Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization …
  671. Causal Relationship of Non-alcoholic Fatty Liver Disease with obesity and insulin Resistance.
  672. Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice
  673. CC motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice
  674. CCL2 and CCL3 chemokine gene expression and their receptors in human visceral and subcutaneous adipose tissue is associated with obesity and insulin …
  675. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status
  676. Ccrl2 deficiency deteriorates obesity and insulin resistance through increasing adipose tissue macrophages infiltration
  677. CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages
  678. CD40 deficiency aggravates diet-induced obesity, adipose tissue inflammation, and insulin resistance in mice
  679. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance
  680. CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity
  681. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
  682. Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus
  683. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
  684. Cellular inflammatory responses: novel insights for obesity and insulin resistance
  685. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme.
  686. Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure
  687. Central and peripheral insulin resistance in a large animal model of obesity
  688. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does …
  689. Central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS but are associated with insulin resistance and abdominal obesity
  690. Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge
  691. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5 ‘flanking region of the human insulin gene
  692. Central obesity and hypertension: relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects
  693. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function
  694. Central obesity and the insulin resistance syndrome: new elements in the etiology of non-communicable diseases
  695. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?
  696. Central obesity increases the risk of gestational diabetes partially through increasing insulin resistance
  697. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort …
  698. Central obesity with insulin Resistance and Type 2 Diabetes
  699. Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
  700. Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns
  701. Central serotonin and dopamine transporters in overeating, obesity and insulin resistance
  702. Cephalic phase insulin response as a predictor of body weight gain and obesity induced by a palatable cafeteria diet.
  703. Ceramide kinase deficiency improves diet-induced obesity and insulin resistance
  704. Ceramides, mitochondrial fission, and reactive oxygen species a novel mechanism of obesity‐induced insulin resistance (LB167)
  705. CerS1-derived C18: 0 ceramide in skeletal muscle promotes obesity-induced insulin resistance
  706. Changes in DNA Methylation and Gene Expression of insulin and obesity-Related Gene PIK3R1 after Roux-en-Y Gastric Bypass
  707. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes.
  708. Changes in insulin sensitivity after weight loss in hypertensive patients with obesity
  709. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats
  710. Changes in plasma immunoreactive insulin during thyroid treatment of obesity.
  711. Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity
  712. Changes of insulin Resistance and β-Cell Secrete Function in Children with Simple obesity [J]
  713. Changes of serum leptin, adiponection and insulin levels in females with simple obesity
  714. chapter 6–metabolic and vascular insulin sensitivity in obesity and hypertension
  715. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance
  716. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity
  717. Characterization of gut microbiota and adipose tissues in the regulation of obesity-induced insulin resistance
  718. Characterization of inflammation and insulin resistance in high‐fat diet‐induced male C57BL/6J mouse model of obesity
  719. CHARACTERIZATION OF SERUM insulin IN STUDIES OF obesity OF CUINO PIGS
  720. Characterization of the insulin-like growth factor axis in term pregnancies complicated by maternal obesity
  721. Characterizing the Effects of Diabetes and obesity on insulin and Leptin Levels amongst Pregnant Women
  722. CHDH-PNPLA3 Gene–Gene Interactions Predict insulin Resistance in Children with obesity
  723. Chemerin Serum Level and insulin Resistancein Hypertensive Patients with obesity
  724. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in …
  725. Chemical inducers of obesity-associated metabolic stress activate inflammation and reduce insulin sensitivity in 3T3-L1 adipocytes
  726. Chemokine systems link obesity to insulin resistance
  727. Childhhood obesity, insulin resistance and increased cardiovascular risk
  728. Childhood obesity and insulin resistance
  729. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
  730. Childhood obesity and insulin resistance: how should it be managed?
  731. Childhood obesity and insulin-resistant syndrome
  732. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation.
  733. Childhood obesity, insulin Resistance, and Magnesium Metabolism
  734. Childhood obesity, thyroid function, and insulin resistance–is there a link? A longitudinal study
  735. Childhood obesity: serum lipoproteins, glucose and insulin concentrations after an oral glucose load.
  736. Childhood social preference and adolescent insulin resistance: Accounting for the indirect effects of obesity
  737. Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
  738. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition …
  739. Chromogranin A regulation of obesity and peripheral insulin sensitivity
  740. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes
  741. Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice
  742. Chronic Exposure to Environmental Level Phenanthrene Induces Non-obesity-Dependent insulin Resistance in Male Mice
  743. Chronic exposure to PCBs (Aroclor 1254) exacerbates obesity-induced insulin resistance and hyperinsulinemia in mice
  744. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
  745. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet‐induced obesity rats
  746. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp
  747. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions
  748. Chronic stress, glucocorticoids, insulin and obesity
  749. Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse
  750. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation
  751. Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity
  752. Circadian disruption leads to insulin resistance and obesity
  753. Circadian rhythms of cortisol and insulin in nutritional obesity in children
  754. Circulating adhesion molecule serum concentrations in individuals with insulin sensitive obesity
  755. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity
  756. Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents
  757. Circulating follistatin and activin A and their regulation by insulin in obesity and type 2 diabetes
  758. Circulating High Molecular Weight Adiponectin Levels Are Related to obesity hut not to insulin Sensitivity in Healthy and Glucose Tolerant Caucasians.
  759. Circulating immune complexes and insulin antibodies in obesity in children
  760. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
  761. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance
  762. Circulating microRNA profile in insulin Resistant Childhood obesity
  763. Circulating miRNA Signatures Associated with insulin Resistance in Adolescents with obesity
  764. Circulating mitochondrial DNA is decreased in children and adolescents with obesity and/or insulin resistance
  765. Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation
  766. Circulating soluble IL-6 receptor concentration and visceral adipocyte size are related to insulin resistance in Taiwanese adults with morbid obesity
  767. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance
  768. CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity
  769. Clinacal Application of Determination of insulin Receptor in NIDDM Patients with obesity
  770. Clinical application of relative insulin sensitivity index in children with obesity and diabetes mellitus
  771. Clinical assessment of obesity and insulin resistance in type 1 diabetes subjects seen at a center in Kolkata
  772. Clinical case of the month. Natural history of morbid obesity: towards insulin-requiring type 2 diabetes and reversal after bariatric surgery
  773. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree of obesity at diagnosis of diabetes
  774. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree of obesity at diagnosis of diabetes
  775. Clinical Research of Integrated Chinese and Western Medicine Therapy for Patients with obesity Hypertension Related insulin Resistance
  776. Clinical significance of changes of plasma leptin and serum insulin/testosterone levels before and after treatment in patients with woman obesity of infertile
  777. Clinical use of continuous subcutaneous insulin infusion for type 2 diabetic patients with obesity [J]
  778. Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer
  779. Clinico pathological study of Acanthosis Nigricans and its correlation with obesity and insulin resistance
  780. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population
  781. Cme instructions: Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance
  782. CNS Vitamin D Improves Glucose Tolerance, Hepatic insulin Sensitivity, and Reverses Diet-Induced obesity
  783. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
  784. Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor
  785. Coconut oil aggravates pressure overload-induced cardiomyopathy without inducing obesity, systemic insulin resistance, or cardiac steatosis
  786. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.
  787. Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice
  788. Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
  789. Combination therapy with metformin and fenofibrate for insulin resistance in obesity
  790. Combined effect of abdominal obesity and both hepatic lipase gene polymorphism and angiotensin genepolymorphism on lipid and lipoprotein levels and insulin …
  791. #VALUE!
  792. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity
  793. Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis
  794. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
  795. Combined Influence of insulin Resistance, Overweight/obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes
  796. #VALUE!
  797. Combining metabolic profiling of plasma and faeces as a fingerprint of insulin resistance in obesity
  798. Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, obesity, and insulin Resistance. Diabetes 2015; 64: 1522 …
  799. Comment on: Cani et al.(2007) Metabolic Endotoxemia Initiates obesity and insulin Resistance: Diabetes
  800. Comment on: Cani et al.(2007) Metabolic endotoxemia initiates obesity and insulin resistance: Diabetes 56: 1761–1772
  801. Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, insulin Resistance, obesity, and Chronic Inflammation …
  802. Commentary on the Impact of obesity and Puberty on insulin Sensitivity
  803. Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis
  804. Comments on: Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.
  805. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study
  806. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity
  807. Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels
  808. Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity, obesity-Related insulin Resistance, and Circulating Leptin Levels
  809. Common STAT3 Variants Are Not Associated With obesity or insulin Resistance in Female Twins
  810. Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistance
  811. Common variants in the regulatory region of the insulin gene are associated with fasting plasma insulin levels in juvenile obesity
  812. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 …
  813. Comparing Different Markers of insulin Resistance in Pediatric obesity
  814. Comparison of Abdominal obesity and Fatty Liver and Their Association with insulin Resistance and Metabolic Syndrome in Chinese Adults
  815. Comparison of Cardiometabolic Syndrome Parameters, obesity, insulin Resistance, and Elevated Alanine Aminotransferase in Current Professional Baseball and …
  816. Comparison of Lipoprotein Based insulin Resistance Score and Traditional Risk Factors in Adolescents with obesity
  817. Comparison of Predictive Value of obesity and Lipid Related Variables for Metabolic Syndrome and insulin Resistance in Obese Adults
  818. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity
  819. Comparison of the association with sleep apnoea of obesity versus insulin resistance
  820. Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity
  821. Comparison of therapeutic effects of electroacupuncture and acupoint catgut embedding in redu-cing serum leptin and insulin levels in simple obesity patients
  822. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: a cross-sectional study
  823. Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis
  824. Complement 3 serum levels as a pro-inflammatory biomarker for insulin resistance in obesity
  825. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
  826. Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity
  827. Complement component C3: relationship with obesity, insulin resistance and cardiovascular risk markers.
  828. Complement factor C3 methylation and mRNA expression is associated to BMI and insulin resistance in obesity
  829. Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle
  830. Complex Interactions Between Diet, Exercise, and the HPA Axis on the Development of obesity, insulin Resistance, and Type 2 Diabetes
  831. Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog
  832. CONCISE REVIEW biological: Periodontal inflammation and insulin resistance—lessons from obesity
  833. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance
  834. Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance
  835. Conjugated linoleic acid, obesity, and insulin resistance: waiting for the day of liberation from chronic disease
  836. Constitutive insulin sensitivity and obesity my be caused by PTEN mutations
  837. Consumption of added sugars from liquid but not solid sources predicts impaired glucose homeostasis and insulin resistance among youth at risk of obesity
  838. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity
  839. Continuous glucose monitoring, oral glucose tolerance, and insulin-glucose parameters in adolescents with simple obesity.
  840. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population
  841. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women
  842. Contribution of B cells to obesity and insulin resistance
  843. Contribution of genetic, biochemical and environmental factors on insulin resistance and obesity in Mexican young adults
  844. Contribution of insulin resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesity & obesity
  845. Contribution of leptin in the development of insulin resistance in pregnant women with obesity
  846. Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance
  847. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus
  848. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study
  849. Contribution of TNF-α to obesity-Associated insulin Resistance
  850. Contribution of visceral obesity to the insulin resistance syndrome
  851. Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium‐dependent vasodilation in humans
  852. Convergence of leptin and insulin signaling networks in obesity
  853. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus
  854. Copeptin and Nesfatin-1 Are Interrelated Biomarkers with Roles in the Pathogenesis of insulin Resistance in Chinese Children with obesity
  855. Copeptin and Obestatin Levels in Polycystic Ovary women and their Relation to obesity, insulin metabolism and Cardiovascular diseases
  856. Copeptin as a Novel Biomarker of obesity-Induced insulin Resistance and Metabolic Syndrome
  857. Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance
  858. Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection?
  859. Correction: Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
  860. Correction: insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in obesity
  861. Correction: Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Induced obesity and insulin Resistance but Have Low Bone Density
  862. Correction: obesity Resistance and Enhanced insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy …
  863. Correction: Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls
  864. Correlation analysis of serum obestatin expression with insulin resistance in childhood obesity
  865. Correlation Analysis on obesity Complicated with Hyperlipidemia And Lipid, Fatty-insulin Axis, Autonomic Nerve Function
  866. Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity
  867. Correlation Between insulin Resistance and obesity in Normoglycemic Obese Syrian Subjects
  868. Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study
  869. Correlation between insulin-like growth factor-I and obesity index during inpatient treatment in anorexia nervosa in childhood and adolescence
  870. Correlation between Mid-thigh Low Density Muscle and insulin Resistance in obesity
  871. Correlation between myostatin and obesity or insulin resistance of patients with polycystic ovary syndrome
  872. Correlation Between obesity, BMI and insulin Resistance in Bulgarian Children
  873. Correlation Between obesity, Body Mass Index and insulin Resistance in Bulgarian Children
  874. Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients [J]
  875. Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
  876. Correlation between the various measurements of obesity and the degree of resistance to insulin
  877. Correlation of body mass index with serum leptin, insulin and sex hormones level in preschool obesity children
  878. Correlation of childhood obesity and related insulin resistance with leptin and retinol binding protein 4
  879. Correlation of Childhood obesity and Related insulin Resistance with Leptin and Retinol Binding Protein 4: Correspondence
  880. Correlation of obesity and the novel adipocytokines, leptin and adiponectin with insulin resistance in type 2 diabetes
  881. Correlation of obesity Status with Zinc Serum Levels and insulin Resistance in Perimenopause Obese Women
  882. Correlation of obesity with C-reactive protein, leptin and insulin sensitive index in children
  883. Correlation of obesity, insulin resistance and lipid profile in women with PCOS in Kims Hospital Bangalore
  884. Correlation of Plasma Angiopoietin-2 and Inflammation Marker with insulin Resistence in Patients with Central obesity
  885. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients
  886. Correlation of serum cytokines with insulin sensitivity and RAS system activity in patients with obesity-related hypertension
  887. Correlation of serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 level with other hormones in preschool obesity children
  888. Correlation of serum leptin and insulin levels of pregnant protein-restricted rats with predictive obesity variables
  889. CORRELATION OF TUMOUR NECROSIS FACTOR-αWITH obesity INDUCED insulin RESISTANCE IN TYPE 2 DIABETES MELLITUS
  890. Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus
  891. Correlations of Xinjiang Kazak obesity and insulin resistance to cardiovascular risk factors
  892. Corrigendum to ‘Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities’
  893. Corrigendum: IL-37 protects against obesity-induced inflammation and insulin resistance
  894. Corticostriatal dopamine networks mediate impulsivity in obesity and insulin resistance
  895. Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and β3-AR activation
  896. Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus
  897. Could SCGF-Beta Levels Be Associated with Inflammation Markers and insulin Resistance in Male Patients Suffering from obesity-Related NAFLD?
  898. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice
  899. COX‐2‐mediated inflammation in fat is crucial for obesity‐linked insulin resistance and fatty liver
  900. CREBH improves diet-induced obesity, insulin resistance, and metabolic disturbances by FGF21-dependent and FGF21-independent mechanisms
  901. CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance
  902. Cross-sectional and longitudinal relationship of sodium-lithium countertransport to insulin, obesity and blood pressure in healthy perimenopausal women.
  903. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance
  904. Crucial roles of N ox2‐derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle‐aged mice
  905. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues
  906. Cudrania tricuspidata water extract improved obesity-induced hepatic insulin resistance in db/db mice by suppressing ER stress and inflammation
  907. Cudrania tricuspidata water extract improves obesity-induced hepatic insulin resistance through suppression of ER stress and inflammation in db/db mice
  908. Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study
  909. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes
  910. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway
  911. Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
  912. Cx30. 2 deletion causes imbalances in testicular Cx43, Cx46, and Cx50 and insulin receptors. Reciprocally, diabetes/obesity alters Cx30. 2 in mouse testis
  913. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance
  914. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance
  915. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity
  916. CXCL5 is an adipose tissue derived factor that links obesity to insulin resistance
  917. CXCR3 modulates obesity‐induced visceral adipose inflammation and systemic insulin resistance
  918. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1
  919. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance
  920. Cyclocarya paliurus (Batal.) Ijinskaja aqueous extract (CPAE) ameliorates obesity by improving insulin signaling in the hypothalamus of a metabolic syndrome …
  921. Cystathionine beta synthase-hydrogen sulfide system in paraventricular nucleus reduced high fatty diet induced obesity and insulin resistance by brain …
  922. Cystathionine γ‐lyase deficiency aggravates obesity‐related insulin resistance via FoxO1‐dependent hepatic gluconeogenesis
  923. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
  924. d-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
  925. Daily branched‐chain amino acid intake and risks of obesity and insulin resistance in children: A cross‐sectional study
  926. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study
  927. Daniel Porte Jr.: a leader in our understanding of the role of defective insulin secretion and action in obesity and type 2 diabetes
  928. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
  929. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
  930. De novo 19p13. 2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability
  931. Debating the relevance of resistin: hormone links obesity and insulin resistance in mice, but doubts persist about impact on type 2 diabetes research.(Hot Papers)
  932. Decaffeinated green coffee bean extract attenuates diet-induced obesity and insulin resistance in mice
  933. Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults
  934. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin
  935. #VALUE!
  936. Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity
  937. Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity
  938. Decreased basal insulin secretion from pancreatic islets of pups in a rat model of maternal obesity
  939. Decreased hepatic insulin extraction in upper body obesity: relationship to unbound androgens and sex hormone binding globulin
  940. Decreased insulin removal contributes to hyperinsulinemia in obesity
  941. Decreased jaw bone density and osteoblastic insulin signaling in a model of obesity
  942. Decreased number of insulin receptors in obesity: studies in the obese hyperglycemic mouse (author’s transl)
  943. Decreased serum CA 19‐9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux‐en‐Y …
  944. Decreased sex hormone binding globulin (SHBG) and insulin‐like growth factor binding protein (IGFBP‐1) in extreme obesity
  945. Decrement in resting and insulin‐stimulated soleus muscle mitochondrial respiration is an early event in diet‐induced obesity in mice
  946. Dectin-1 activation exacerbates obesity and insulin resistance in the absence of MyD88
  947. Defective Activation of Protein Kinase Cz in Muscle by insulin and Phosphatidylinositol-3,4,5,-(PO4)3 in obesity and Polycystic Ovary Syndrome
  948. Defective autophagy causes a maladaptive cardiac phenotype to exercise that leads to premature death and FGF21‐mediated protection against obesity and insulin …
  949. Defective FXR-SHP regulation in obesity aberrantly increases miR-802 expression, promoting insulin resistance and fatty liver
  950. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance
  951. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus
  952. Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
  953. Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance
  954. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice
  955. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity
  956. Deficiency in the short‐chain acyl‐CoA dehydrogenase protects mice against diet‐induced obesity and insulin resistance
  957. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
  958. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
  959. Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance
  960. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity
  961. Deficiency of Tyk2 kinase in mice leads to obesity and insulin resistance
  962. Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity-and age-induced peripheral insulin resistance: a study in …
  963. Dehydroepiandrosterone in relation to obesity, insulin resistance and lipid spectra in Czech non-diabetic population
  964. Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet‐induced obesity
  965. Deletion of ALMS1 (Alstrom Syndrome 1) enhances salt‐sensitive hypertension, and induces insulin resistance and obesity in rats.
  966. Deletion of Apolipoprotein D Prevents Diet-Induced obesity and insulin Resistance.
  967. Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance
  968. Deletion of CD1d in adipocytes aggravates adipose tissue inflammation and insulin resistance in obesity
  969. Deletion of class A scavenger receptor deteriorates obesity-induced insulin resistance in adipose tissue
  970. Deletion of EHD2 Attenuated Adipocyte Hypertrophic Expansion and Ameliorated Diet-Induced obesity and insulin Resistance
  971. Deletion of G0/G1 Switch Gene 2 prevents obesity and insulin resistance and promotes browning of white adipose tissue
  972. Deletion of Gpr21 protects against obesity-associated inflammation and insulin resistance
  973. Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
  974. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity
  975. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
  976. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
  977. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
  978. Dependence of Hypothalamic obesity on insulin, the Pituitary and the Adrenal Gland1
  979. Depot-specific expression of caveolin-1 in human adipose tissue and their relationship with obesity and insulin resistance
  980. Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance
  981. Depressed levels in plasma insulin-growth factor-1 (IGF-1) and binding protein-1 (IGFBP-1) in adolescence obesity. 372
  982. Detection and Analysis of Leptin, insulin and Sexual Hormone in Serum of Simple obesity Boys
  983. Detection of insulin sensitivity and antibody against insulin in obesity induced by antipsychotics
  984. Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity
  985. Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention
  986. Determination of Optimal Cut-off Points for obesity-related Measures of Metabolic Syndrome Based on insulin Resistance
  987. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice
  988. Development and validation of a cell based model of insulin resistance and investigation into the intracellular molecular defects induced by diabetes and obesity
  989. Development of a new modified western diet to induce NASH with obesity and insulin resistance in mice
  990. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase
  991. Development of obesity and insulin resistance in the Israeli sand rat (Psammomys obesus). Does leptin play a role?
  992. Development of obesity in Zucker rats: early insulin resistance in muscles but normal sensitivity in white adipose tissue
  993. Development of obesity-induced inflammation and insulin resistance: The role of adipose tissue, fatty acids, and toll-like receptors
  994. Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity
  995. Development of Yak-Sun for Excess Syndrome obesity (1) Effects of Weight, Serum Glucose, insulin and Lipid Profiles of Oriental Medicinal Herbs with Removal of …
  996. Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role?
  997. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
  998. Diabetes and insulin resistance in pediatric obesity
  999. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose …
  1000. Diabetes and obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and insulin Resistance
  1001. Diabetes in pregnancy: insulin resistance, obesity and placental dysfunction
  1002. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response.
  1003. Diabetes-related risk factors and cognitive aging: focus on obesity, insulin resistance, and the metabolic syndrome
  1004. Diabetes, obesity and hypertension: role of insulin and the sympathetic nervous system
  1005. Diabetes, obesity, insulin resistance: different pathways to cancer?
  1006. Diabetes: Have We Got It All Wrong?: insulin hypersecretion and food additives: cause of obesity and diabetes?
  1007. Diagnosing obesity, diabetes mellitus, and insulin resistance syndrome
  1008. Diagnostic accuracy of triglyceride/glucose and triglyceride/HDL index as predictors for insulin resistance in children with and without obesity
  1009. Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance
  1010. Diet in the Prevention and Control of obesity, insulin Resistance, and Type II Diabetes
  1011. Diet-and obesity-independent improvements in insulin sensitivity in mice genetically deficient in tumor necrosis factor-α (TNF-α KO).
  1012. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor–α
  1013. Diet-induced maternal obesity alters insulin signalling in male mice offspring rechallenged with a high-fat diet in adulthood
  1014. Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the yoshida sarcoma
  1015. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid–sensitive gene expression in insulin target tissues of C57BL/6J mice
  1016. Diet-induced obesity impairs insulin-induced vasodilation in mouse mesenteric arteries via a mechanism involving ET-1
  1017. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental …
  1018. Diet-induced obesity in young mice interferes with the pancreatic intrinsic nervous system maturation and alters its control of insulin secretion
  1019. Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats
  1020. Diet-induced obesity obstructs insulin signaling in the heart
  1021. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle
  1022. Diet‐induced central obesity and insulin resistance in rabbits
  1023. Diet‐induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin and insulin signaling in the pathophysiology of obesity
  1024. Diet‐induced obesity and impaired insulin and glucose tolerance in sterol regulatory element binding protein‐1a knock‐out mice
  1025. Diet‐induced obesity and insulin resistance are associated with brown fat degeneration in SIRT 1‐deficient mice
  1026. Diet‐induced obesity causes insulin resistance in mouse brown adipose tissue
  1027. Diet‐Induced obesity Causes Selective insulin Resistance
  1028. Diet‐induced obesity in rats decreases insulin sensitivity and baroreflex gain
  1029. Diet‐induced obesity in young mice: Consequences on the pancreatic intrinsic nervous system control of insulin secretion
  1030. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach
  1031. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis
  1032. Diet, obesity, and metabolic control in girls with insulin dependent diabetes mellitus.
  1033. Dietary 1, 3-diacylglycerol protects against diet-induced obesity and insulin resistance
  1034. Dietary aloe improves insulin sensitivity via the suppression of obesity-induced inflammation in obese mice
  1035. Dietary aloe QDM complex reduces obesity-induced insulin resistance and adipogenesis in obese mice fed a high-fat diet
  1036. Dietary anthocyanin-rich extract of açai protects from diet-induced obesity, liver steatosis and insulin resistance with modulation of gut microbiota in mice
  1037. Dietary blueberry attenuates obesity‐associated insulin resistance by reducing adipocyte death and macrophage pro‐inflammatory activation in adipose tissue of high …
  1038. Dietary capsaicin reduces obesity‐induced insulin resistance and hepatic steatosis in obese mice fed a high‐fat diet
  1039. Dietary effects on A2AR expression in liver and adipose tissues: A role for A2AR in protecting against inflammation and insulin resistance in obesity
  1040. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The insulin Resistance Atherosclerosis Study (IRAS)
  1041. Dietary fat versus carbohydrate in obesity and insulin resistance
  1042. Dietary fiber, plasma insulin, and obesity
  1043. Dietary guar gum supplementation does not modify insulin resistance in gross obesity
  1044. Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin …
  1045. Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity in inducing systemic insulin …
  1046. DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE insulin RESISTANCE: SYNERGY WITH obesity IN INDUCING SYSTEMIC insulin …
  1047. Dietary isoliquiritigenin at a low dose ameliorates insulin resistance and NAFLD in diet-induced obesity in C57BL/6J mice
  1048. Dietary management of obesity and insulin resistance: countering risk for laminitis
  1049. Dietary n-6/n-3 FA Ratio, but Not Total Content of n-3 PUFA, Regulates Diet-induced obesity, insulin Resistance, and Metabolic Dysfunction (OR19-01-19)
  1050. Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols
  1051. Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice
  1052. Dietary regulation of insulin receptors in obesity
  1053. Dietary supplementation with Agaricus blazei murill extract prevents diet‐induced obesity and insulin resistance in rats
  1054. Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice
  1055. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut …
  1056. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation
  1057. Dietary-induced obesity in Mice results in Metabolic and Vascular insulin-like Growth Factor 1 Resistance
  1058. Differences in gene expression between young and adult mice may play a protective role against insulin resistance in the setting of high fat diet-induced obesity.
  1059. DIFFERENCES OF HOMEOSTASIS MODEL ASSESMENT-insulin RESISTANCE (HOMA-IR) LEVELS BETWEEN obesity PREGNANT WOMEN WITH THE …
  1060. Different Expression of Duodenal Genes Related to insulin Resistance Between Nonobese Women and Those with Severe obesity
  1061. Different genes for obesity are associated with insulin loss of regulation of the membrane (Ca2++ Mg2+)-ATPase in the obesity syndrome. Lessons from animal …
  1062. Differential association between S100A4 levels and insulin resistance in prepubertal children and adult subjects with clinically severe obesity
  1063. Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in …
  1064. Differential effects of insulin resistance on leucine and glucose kinetics in obesity
  1065. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin‐signaling pathways in the offspring
  1066. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity
  1067. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
  1068. Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
  1069. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis
  1070. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
  1071. Differentiation between obesity and insulin resistance in the association with C-reactive protein
  1072. Difficult Intubation Rates in Relation to Diabetes, insulin Dependency, and obesity
  1073. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity
  1074. Diminished hepatic insulin removal in obesity
  1075. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low‐dose metformin and thiazolidinedione combination therapy in …
  1076. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway
  1077. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore insulin Sensitivity in the Diet-Induced obesity in Vivo Mouse Model
  1078. Discrimination between obesity and insulin resistance in the relationship with adiponectin
  1079. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance
  1080. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance
  1081. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity
  1082. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet–induced obesity and insulin resistance in mice
  1083. Dissecting the relationship between obesity and hyperinsulinemia: role of insulin secretion and insulin clearance
  1084. Dissociation between high fat diet-induced obesity (DIO) and insulin resistance: lessons from AHNAK knockout mice
  1085. Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1
  1086. Distinct gene signatures predict insulin resistance in young mice with high fat diet-induced obesity
  1087. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance
  1088. Distribution of subcutaneous fat predicts insulin action in obesity in sex‐specific manner
  1089. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
  1090. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
  1091. Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm
  1092. DNA methylation of FKBP5 in South African women: associations with obesity and insulin resistance
  1093. DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance
  1094. DNA methylation of the LY86 gene is associated with obesity, insulin resistance, and inflammation
  1095. DNA polymorphism of the insulin gene, diabetes, and severe obesity
  1096. Do Cardiorespiratory Fitness and Abdominal obesity Mediate the Exercise-Induced Change in insulin Sensitivity in Older Adults?
  1097. Do flavanols-rich natural products relieve obesity-related insulin resistance?
  1098. Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
  1099. Do obesity and non-insulin dependent diabetes mellitus aggravate exercise-induced microproteinuria?
  1100. Do obesity and physical inactivity underlie the insulin resistance of aging?
  1101. Does aging intensify the insulin resistance of human obesity?
  1102. Does cardiorespiratory fitness attenuate the adverse effects of severe/morbid obesity on cardiometabolic risk and insulin resistance in children? A pooled analysis
  1103. Does inflammation mediate the association between obesity and insulin resistance?
  1104. Does insulin concentration modify the outcome of dietary intervention in young adults with obesity?
  1105. Does insulin explain the relation between maternal obesity and poor lactation outcomes? An overview of the literature
  1106. Does Leptin Affect Directly Blood Pressure in Obese Hypertensive Women-Influence of insulin and Different Methods of obesity Assessment
  1107. Does microvascular dysfunction link obesity with insulin resistance and hypertension?
  1108. Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients?
  1109. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
  1110. Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity
  1111. Double Incretin Receptor Knockout Mice Are Protected from Diet-Induced obesity and insulin Resistance.
  1112. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice
  1113. Down-regulation of adipose 11 [beta] HSD1 mediates the insulin sensitising effects of salicylate in obesity
  1114. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance
  1115. DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization
  1116. DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization
  1117. DPP-4 inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes
  1118. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
  1119. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway
  1120. Dual CCR2/5 antagonist attenuates obesity‐induced insulin resistance by regulating macrophage recruitment and M1/M2 status
  1121. Duration of obesity and risk of non-insulin-dependent diabetes mellitus
  1122. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia
  1123. Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity‐related type 2 diabetes mellitus
  1124. Dynamics of insulin secretion and the clinical implications for obesity and diabetes
  1125. Dynamics of insulin secretion in obesity and diabetes
  1126. Dyslipidemia, obesity, insulin Resistance and Atherosclerosis in LDL-Receptor Deficient Rats
  1127. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity
  1128. Dysregulation of Glycogen Synthase COOH- and NH2-Terminal Phosphorylation by insulin in obesity and Type 2 Diabetes Mellitus
  1129. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes
  1130. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice
  1131. E. The Influence of obesity on insulin Signaling at
  1132. E028: Leptin, obesity, insulin resistance and intraerythrocyte sodium content in hypertensive syndrome
  1133. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity
  1134. Early Clinical Indicators of Metabolic Syndrome and insulin Resistance in A Cohort of Greek Children with obesity
  1135. Early diet, insulin-like growth factor-1, growth and later obesity
  1136. Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss–results of an …
  1137. Early intervention of N-acetylcysteine better improves insulin resistance in diet-induced obesity mice
  1138. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity
  1139. Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin …
  1140. Early response of plasma insulin to small doses of intravenous glucose: Effect of obesity
  1141. Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques
  1142. Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice
  1143. Eating competence is associated with lower prevalence of obesity and better insulin sensitivity in finnish adults with increased risk for type 2 diabetes: The stopdia …
  1144. Eating habits of preschool children and the risk of obesity, insulin resistance and metabolic syndrome in adults
  1145. Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions
  1146. Ectopic UCP1 overexpression in white adipose tissue improves insulin sensitivity in Lou/C rats, a model of obesity resistance
  1147. Editorial (Thematic Issue: Vascular Dysfunction in obesity and insulin Resistance)
  1148. Editorial [Hot Topic: New Insight in obesity and insulin Resistance (Guest Editor: Geltrude Mingrone)]
  1149. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity
  1150. Effect of 7 days of exercise on exogenous carbohydrate oxidation and insulin resistance in children with obesity
  1151. EFFECT OF 8 WEEKS OF AEROBIC INTERVAL TRAINING ON LEVELS OF LIPOCALIN-2, GLUCOSE, insulin AND insulin RESISTANCE IN obesity WOMEN
  1152. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity
  1153. Effect of a high protein/low glycaemic index diet on insulin resistance in adolescents with overweight/obesity—A PREVIEW randomized clinical trial
  1154. Effect of a long term very low calorie diet on glucose/insulin metabolism in obesity. Influence of fat distribution on hepatic insulin extraction.
  1155. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature
  1156. Effect of acetylsalicylic acid on inflamed adipose tissue. insulin resistance and hepatic steatosis in a mouse model of diet-induced obesity
  1157. Effect of acupoint catgut embedding on TNF-alpha and insulin resistance in simple obesity patients
  1158. Effect of Acupoint Catgut Embedding on TNF-α and insulin Resistance in Simple obesity Patients [J]
  1159. Effect of acupoint thread embedding on blood lipids and insulin in simple obesity
  1160. Effect of acupoint thread embedding on the peripheral serum leptin and insulin levels in simple obesity patients
  1161. Effect of acupuncture on blood serum leptin and insulin in a rat model of obesity [J]
  1162. Effect of acupuncture on serum insulin level in the patient of simple obesity
  1163. EFFECT OF AEROBIC TRAINING PROGRAM ON obesity AND insulin RESISTANCE IN YOUNG WOMEN WITH POLYCYSTIC OVERY SYDROME
  1164. Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man
  1165. Effect of aging and obesity on insulin responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344× Brown Norway rats
  1166. Effect of an alcohol-free beer enriched with isomaltulose and a resistant dextrin on insulin resistance in diabetic patients with overweight or obesity
  1167. Effect of antioxidant treatment on some indicators of obesity-induced changes in insulin sensitivity and beta-cell function in New Zealand white rabbits.
  1168. Effect of ARHGAP21 reduction upon glucose-insulin homeostasis and body composition of diet-induced obesity in C57BL/6 mice
  1169. Effect of avocado soybean unsaponifiables on insulin secretion and insulin sensitivity in patients with obesity
  1170. Effect of Bloodletting Cupping on the Serum insulin Level in Simple obesity
  1171. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity
  1172. Effect of Cabergoline on Body Weight, Glycemic Control and insulin Resistance in Patient with obesity and Prediabetes
  1173. Effect of combination of irbesartan with amlodipine on serum leptin level and insulin sensitivity in young obesity-associated hypertensive patients [J]
  1174. Effect of common genetic variants of growth arrest-specific 6 gene on insulin resistance, obesity and type 2 diabetes in an Asian population
  1175. Effect of Comprehensive Intervention Therapy of Losing Weight on Blood Leptin, Blood Lipid, Blood Glucose, insulin in Adolescent Girl Students with Simple obesity
  1176. Effect of Curcuma longa L. on the obesity and insulin resistance in Sprague-Dawley rats and db/db mice
  1177. #VALUE!
  1178. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat
  1179. Effect of diet-induced obesity on glucose and insulin tolerance of a rodent with a low insulin response (Acomys cahirinus)
  1180. Effect of doxazosin on insulin resistance in hypertensive patients with obesity
  1181. Effect of electroacupuncture and diet adjusting on insulin resistance in rats with nutrition obesity
  1182. Effect of Endogenous insulin Levels on Serum Testosterone, Glycemic, and obesity Parameters in Premenopausal Women with Type 2 Diabetes Mellitus
  1183. Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril
  1184. Effect of experimental reducing fat on leptin resistance and insulin resistance in adolecent girl students with simple obesity
  1185. Effect of high-fat-diet on serum glucose, triglyceride, leptin and insulin sensitivity in obesity-susceptible and obesity-resistant rats.[J]
  1186. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity
  1187. Effect of insulin on postradiation obesity of bone marrow
  1188. Effect of insulin on stimulated lipolysis in obesity with normal carbohydrate tolerance and unimpaired thyroid function.
  1189. Effect of insulin therapy and obesity on colon adenoma and advanced adenoma among type II diabetes mellitus population
  1190. Effect of insulin–glucose metabolism compared with obesity on adipose omentin gene expression in different models of diabetic C57BL/6 mice
  1191. Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis
  1192. Effect of irbesartan and hydrochlorothiazide on insulin resistance and lipid in hypertensive patients with obesity
  1193. Effect of long term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity
  1194. Effect of maternal obesity on insulin action in male adult offspring rats
  1195. Effect of meridian tuina on serum insulin and triglyceride of 50 simple obesity patients
  1196. Effect of naloxone on beta-endorphin and insulin concentrations during glucose tolerance testing in patients with simple obesity
  1197. Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity
  1198. Effect of obesity and body fat distribution on sex hormones and insulin in men
  1199. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients
  1200. Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus
  1201. Effect of obesity and insulin Resistance Factor on Lipid Metabolism in Women with Polycystic Ovary Syndrome
  1202. Effect of obesity and insulin resistance on diabetic control
  1203. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women
  1204. Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man
  1205. Effect of obesity and insulin sensitivity on adiponectin isoform distribution
  1206. Effect of obesity and insulin Sensitivity on Adiponectin Isoform Distribution.
  1207. Effect of obesity and of starvation on insulin activity
  1208. Effect of obesity and type 2 diabetes on protein anabolic response to insulin in elderly women
  1209. Effect of obesity and weight loss on the arginine vasopressin response to insulin‐induced hypoglycaemia
  1210. Effect of obesity Intervention Programs on Adipokines, insulin Resistance, Lipid Profile and Low Grade Inflammation in 3-to 5-Year-Old Children
  1211. Effect of obesity intervention programs on adipokines, insulin resistance, lipid profile, and low-grade inflammation in 3-to 5-y-old children
  1212. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations
  1213. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM
  1214. Effect of obesity on insulin Secretion in Response to a 48-Hour Physiological Increase in Plasma FFA in Mexican-American Subjects Genetically Predisposed Type 2 …
  1215. Effect of obesity on insulin sensitivity of human adipose tissue
  1216. Effect of obesity on insulin signaling through JAK2 in rat aorta
  1217. Effect of obesity on Left Ventricular Functions in Patients With Non insulin Dependent Diabetes Mellitus
  1218. Effect of obesity on plasma insulin-like growth factor-I in cancer patients.
  1219. Effect of obesity on susceptibility to fatty acid–induced peripheral tissue insulin resistance
  1220. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus
  1221. Effect of obesity on Tissue Expression of Growth Hormone (GH) Receptor and insulin-like Growth Factor-I RNA
  1222. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
  1223. #VALUE!
  1224. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia
  1225. Effect of pharmacological suppression of insulin secretion on tissue sensitivity to insulin in subjects with moderate obesity.
  1226. Effect of physical training on insulin action in obesity
  1227. Effect of piperine in obesity induced insulin resistance and type-II diabetes mellitus in rats.
  1228. Effect of pomegranate juice on insulin secretion and sensitivity in patients with obesity
  1229. Effect of prolonged fasting glucose and insulin metabolism in exogenous obesity
  1230. Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice
  1231. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes
  1232. Effect of seyoeum on obesity, insulin resistance, and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice
  1233. Effect of tea polyphones on serum leptin, insulin and blood lipids in rats with obesity [J]
  1234. Effect of the intake of dietary protein on insulin resistance in subjects with obesity: a randomized controlled clinical trial
  1235. Effect of ursolic acid on insulin resistance and hyperinsulinemia in rats with diet-induced obesity: role of adipokines expression
  1236. Effect of ursolic acid on obesity-induced insulin resistance in rat liver
  1237. Effect of Vitamin D Supplementation on obesity‐Induced insulin Resistance: A Double‐Blind, Randomized, Placebo‐Controlled Trial
  1238. Effect of Weight Loss and Triiodothyronine on Plasma Growth Hormone and insulin in obesity.
  1239. Effect of weight reduction on metabolic products of carbohydrate and fat metabolism and on the behaviour of serum insulin in obesity.
  1240. Effects of 12-week circuit exercise program on obesity index, appetite regulating hormones, and insulin resistance in middle-aged obese females
  1241. Effects of 12-week circuit exercise program on obesity index, appetite regulating hormones, and insulin resistance in middle-aged obese females
  1242. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats
  1243. Effects of a Eucaloric Low Glycemic Index Diet on insulin Sensitivity and Intramyocellular Lipid Content in Adults with Abdominal obesity
  1244. Effects of acute exercise on insulin binding to monocytes in obesity
  1245. Effects of Age and obesity on insulin Binding to Isolated Adipocytes12
  1246. Effects of age, diet and obesity on insulin secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)
  1247. Effects of aging and obesity on insulin secretion and sensitivity
  1248. Effects of astragalus polysaccharides on insulin sensitivity in obesity rats fed with high-fat diet
  1249. Effects of bariatric surgery on preclinical myocardial alterations in severe obesity and the related role of insulin resistance
  1250. Effects of caloric restriction and exercise of insulin receptors in obesity: Association with changes in membrane lipids
  1251. Effects of castration-induced visceral obesity and antioxidant treatment on lipid profile and insulin sensitivity in New Zealand white rabbits
  1252. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery
  1253. Effects of childhood malnutrition on the increase of risk factors for obesity, non-insulin dependent diabetes mellitus and coronary heart disease
  1254. Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity
  1255. Effects of Curcumin on insulin Resistance in Simple obesity Rats
  1256. Effects of diet-induced obesity on protein expression in insulin signaling pathways of skeletal muscle in male Wistar rats
  1257. Effects of Diet‐induced obesity on Protein Expressions of insulin Signalling Pathways in the Skeletal Muscle of Male Wistar Rats
  1258. Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities and insulin resistance in KK mice with high-fat diet-induced obesity
  1259. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity
  1260. Effects of Difference Chinese Medicinal Herbs for Tonifying Spleen on obesity Degree and insulin Resistance in Diet-induced obesity Rats
  1261. Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice
  1262. Effects of different intensity exercise on blood glucose, adolescent obesity rats insulin sensitivity and RBP4
  1263. Effects of electroacupuncture on insulin resistance and hypothalamic insulin signal molecule in rats with diet-induced obesity
  1264. Effects of electroacupuncture on insulin resistance and hypothalamic insulin signal molecule in rats with diet-induced obesity
  1265. Effects of estrogen on high-fat diet-induced obesity and insulin resistance in ovariectomized rats
  1266. Effects of exercise modality on insulin resistance and ectopic fat in adolescents with overweight and obesity: a randomized clinical trial
  1267. Effects of fasting on insulin secretion and glucose tolerance in obesity.
  1268. Effects of free fatty acids on insulin secretion in obesity
  1269. Effects of FTOSNPrs9939609 on Body Composition and insulin Resistance in Overweight and obesity Male College students
  1270. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity
  1271. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes
  1272. Effects of insulin gene dosage on murine obesity and lifespan
  1273. Effects of insulin Level on Dyslipidemia in Children with Simple obesity
  1274. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding
  1275. Effects of Inula helenium on Inflammation and insulin Resistance in obesity-induced insulin Resistance Mouse by High Fat Diet
  1276. Effects of Long‐Term Soy vs Casein Protein Intake and obesity on Serum insulin‐Like Growth Factor 1 (IGF‐1) and IGFBP‐3 Levels using Obese Female Zucker Rat …
  1277. Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension
  1278. Effects of maresin 1 on adipose tissue inflammation and insulin resistance on obesity: characterization of mechanisms involved
  1279. Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique
  1280. Effects of mazindol on carbohydrate and insulin metabolism in obesity
  1281. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: A double-blind, randomized, controlled study
  1282. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in patients with simple obesity [J]
  1283. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
  1284. Effects of monosodium glutamate‐induced obesity in mice on carbohydrate metabolism in insulin secretion
  1285. Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion
  1286. Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance
  1287. Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity–insulin resistance …
  1288. Effects of naloxone-induced opiate receptors blockade on insulin secretion in obesity
  1289. Effects of obesity and exercise training on mitochondrial function and insulin resistance in aging skeletal muscle
  1290. Effects of obesity and exercise training on mitochondrial function and insulin resistance in aging skeletal muscle
  1291. Effects of obesity and Gender on insulin Receptor Expression in Liver of SHHF/Mcc‐FACP Rats
  1292. Effects of obesity and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats
  1293. Effects of obesity And insulin on Tissue-Specific Recycling Between Cortisol And Cortisone in Men
  1294. Effects of obesity and ovarian steroids on insulin secretion and removal in sheep
  1295. Effects of obesity and short‐term dietary manipulations on serum insulin and leptin levels in female Zucker rats following DMBA treatment
  1296. Effects of obesity and weight reduction on serum insulin levels
  1297. Effects of obesity on insulin and glucose metabolism in cyclic heifers
  1298. Effects of obesity on insulin resistance in patients with hypertension
  1299. Effects of obesity on insulin resistance, β-cell function and serum high-sensitivity C-reactive protein level in first-degree relatives of type 2 diabetic patients
  1300. Effects of obesity on insulin sensitivity and responsiveness in sheep
  1301. Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
  1302. Effects of obesity on metabolic and cardiovascular outcomes following insulin initiation in patients with type 2 diabetes
  1303. Effects of obesity on pancreatic β cell function and insulin function
  1304. Effects of obesity on Serum insulin‐Like Growth Factor 1 (IGF‐1) Levels Using DMBA‐Induced Ovariectomized Zucker Rat Model.
  1305. Effects of obesity surgery on non–insulin-dependent diabetes mellitus
  1306. Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone …
  1307. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men
  1308. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey …
  1309. Effects of Omega-3 Fatty Acids on insulin Resistance in an Ovariectomized Mouse Model of Diet-Induced obesity Treated with Chemotherapy
  1310. Effects of physical activity on insulin action and glucose tolerance in obesity.
  1311. Effects of Physical Activity on The Inflammatory Process Related to insulin Resistance and obesity
  1312. Effects of physical exercise in molecular parameters of the route of obesity and insulin signaling
  1313. Effects of pioglitazone and metformin on body weight and the insulin resistance parameters in young patients with obesity
  1314. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
  1315. Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein‐modified fast and refeeding
  1316. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials
  1317. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity
  1318. Effects of starvation and obesity on somatostatin, insulin, and glucagon release from an isolated perfused organ system
  1319. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats
  1320. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats14
  1321. Effects of Tea Pigments on Rat Models with obesity-induced insulin Resistance [J]
  1322. Effects of telmisartan on body fat, serum lipids and insulin resistance in patients with obesity hypertension [J]
  1323. Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity
  1324. Effects of the 11beta hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in human obesity
  1325. Effects of the Magenstrasse and Mill operation for obesity on plasma leptin and insulin resistance
  1326. Effects of the Magenstrasse and Mill operation for obesity on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen and insulin
  1327. Effects of various natural sweeteners on insulin resistance, inflammation and liver steatosis in a rat model of diet‐induced obesity
  1328. Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women
  1329. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin
  1330. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity
  1331. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
  1332. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial
  1333. Efficacy of exenatide combined with insulin glargine in newly diagnosed type 2 diabetes patients with obesity
  1334. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance
  1335. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance
  1336. Elevated alanine aminotransferase in current national football league players: correlation with cardiometabolic syndrome markers, obesity, and insulin resistance.
  1337. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children
  1338. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults
  1339. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity
  1340. Elevated fasting insulin levels increase the risk of abdominal obesity in Korean men
  1341. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
  1342. ELEVATED INTERLUKIN-6 LEVELS AS A CONSEQUENCE, NOT THE CAUSE OF obesity AND insulin RESISTANCE
  1343. Elevated LDL-Cholesterol Level Predicts Diabetes in Centrally Obese Women but Not Men Relative Roles of insulin Resistance and Central obesity
  1344. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
  1345. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2
  1346. Elevated serum TNF-α is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance
  1347. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-[alpha] system activity
  1348. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover
  1349. Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
  1350. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state
  1351. Emerging role of adipose tissue hypoxia in obesity and insulin resistance
  1352. Emerging role of aldosterone in mediating the vicious cycle of obesity, insulin resistance and metabolic syndrome
  1353. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes
  1354. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization
  1355. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
  1356. Endocrine disturbances in childhood obesity: growth-hormone and cortisol response to insulin induced hypoglycemia
  1357. Endogenous epinephrine protects against obesity induced insulin resistance
  1358. Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet‐induced obesity
  1359. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
  1360. Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation?
  1361. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
  1362. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease
  1363. Endothelial dysfunction, obesity and insulin resistance
  1364. Endothelial nuclear factor κB in obesity and aging: is endothelial nuclear factor κB a master regulator of inflammation and insulin resistance?
  1365. Endothelin‐1 in the pathophysiology of obesity and insulin resistance
  1366. Endothelium-derived hyperpolarizing factors: a potential therapeutic target for vascular dysfunction in obesity and insulin resistance
  1367. Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity
  1368. Endurance training and obesity: effect on substrate metabolism and insulin sensitivity.
  1369. Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and Type II …
  1370. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity
  1371. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and …
  1372. Enhanced hepatic A-ring reduction of glucocorticoids in obesity: Regulation by glucocorticoids and insulin
  1373. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model
  1374. Enhanced Lymphangiogenesis and Lymphatic Function Protects Diet‐induced obesity and insulin Resistance
  1375. Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance
  1376. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance
  1377. ENPP1 Variants and Haplotypes Predispose to Early Onset obesity and Impaired Glucose and insulin Metabolism in German Obese Children
  1378. ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity
  1379. Environmental determinants of obesity and insulin-resistance
  1380. EP3 signaling is decoupled from regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance
  1381. Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-induced obesity and insulin resistance
  1382. Epidemiologic study of central obesity, insulin resistance and associated disturbances in the urban population of North India.
  1383. Epidemiologic study of diet and coronary risk factors in relation to central obesity and insulin levels in rural and urban populations of north India
  1384. Epidemiological Study of obesity and Metabolic Syndrome in Chinese Schoolchildren: Relationship with insulin Resistance and Adipocytokins.
  1385. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus
  1386. Epigenetic germline inheritance of diet-induced obesity and insulin resistance
  1387. Epigenetics: How does obesity lead to insulin resistance?
  1388. Equine obesity and its role in insulin resistance, inflammation and risk for laminitis
  1389. #VALUE!
  1390. #VALUE!
  1391. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting
  1392. #VALUE!
  1393. Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance
  1394. Erratum: Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
  1395. Erratum: Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic …
  1396. Erratum: Obstructive Sleep Apnea, insulin Resistance, and Steatohepatitis in Severe obesity
  1397. Erratum. APPL1 Counteracts obesity-Induced Vascular insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and …
  1398. Erratum. Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced obesity and insulin Resistance by Regulating the Homeostasis of Energy Storage and …
  1399. Esculentin-2CHa-related peptides modulate islet cell function and improve glucose tolerance in mice with diet-induced obesity and insulin resistance
  1400. Essential role of protein tyrosine phosphatase 1B in obesity‐induced inflammation and peripheral insulin resistance during aging
  1401. Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance
  1402. Establishment of obesity Rat Animal Model with Leptin Resistance and insulin Resistance
  1403. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
  1404. Estimation of the correlation of insulin resistance and selected adipocytokines in children with simple obesity–preliminary study
  1405. Estradiol: THE EMERGING EVIDENCE FOR A PROTECTIVE ROLE AGAINST insulin RESISTANCE AND obesity.
  1406. Estrogen modulates adiposity and protects against obesity-associated inflammation, oxidative stress, and insulin resistance
  1407. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity
  1408. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice
  1409. Ethnic differences in inflammation: Association with obesity and insulin resistance
  1410. Ethnic differences in insulin resistance, adiponectin levels and abdominal obesity: Haitian Americans and African Americans, with and without type 2 diabetes …
  1411. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort
  1412. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women
  1413. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population
  1414. Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity
  1415. Evaluating a pragmatic estimate of insulin sensitivity in Latino youth with obesity
  1416. Evaluation of B-cell secretion and peripheral insulin resistance during pregnancy and after delivery in gestational diabetes mellitus with obesity
  1417. Evaluation of existing and candidate measures of obesity for detection of insulin resistance and cardiometabolic risk among Asian Indians: Development of two …
  1418. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity
  1419. Evaluation of Ghrelin Levels in Polycystic Ovary Syndrome and the Correlation with obesity, insulin Resistance and Other Biochemical Features
  1420. #VALUE!
  1421. Evaluation of insulin resistance in children and adolescent with moderate and severe obesity.
  1422. Evaluation of Mn-superoxide dismutase and catalase gene expression in childhood obesity: its association with insulin resistance
  1423. Evaluation of neck circumference as a predictor of central obesity and insulin resistance in Chinese adults
  1424. Evaluation of ovulation regularity in relation to insulin hematic levels, androgens and obesity in polycistic ovary syndrome
  1425. Evaluation of TG-HDL Ratio Instead of HOMA Ratio as insulin Resistance Marker in Overweight and Children with obesity.
  1426. EVALUATION OF THE OF insulin RESISTANCE EFFECTS ON obesity AND RELATED PARAMETERS
  1427. Evaluation of the Relationship between insulin, Vitamin D Levels and Dietary Habits in Adults with Normal Weight and obesity
  1428. Evaluation of visfatin in patients with obesity, metabolic syndrome, insulin resistance and impaired glucose tolerance; case-control study
  1429. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity
  1430. Evidence for recent increases in obesity and non‐insulin‐dependent diabetes mellitus in a Navajo community
  1431. Evidence for two types of juvenile obesity on the basis of body composition and insulin release following small doses of glucose
  1432. Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity
  1433. Evidence in obese children: contribution of tri-ponderal mass index or body mass index to dyslipidemia, obesity-inflammation, and insulin sensitivity
  1434. Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children
  1435. Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients
  1436. Evidence that insulin resistance is responsible for the decreased thermic effect of glucose in human obesity.
  1437. Evolution of obesity and insulin resistance: relevance to PCOS
  1438. Evolutionary Aspects of obesity, insulin Resistance, and Cardiovascular Risk
  1439. Exaggerated insulin response to glucagon in simple obesity
  1440. Excessive gestational weight gain and obesity contribute to altered expression of maternal insulin-like growth factor binding protein-3
  1441. Excessive serum insulin response to oral glucose in obesity and mild diabetes study of 501 patients
  1442. Exenatide therapy in insulin-treated type 2 diabetes and obesity
  1443. Exercise alleviates cognitive functions by enhancing hippocampal insulin signaling and neuroplasticity in high-fat diet-induced obesity
  1444. Exercise and dietary change ameliorate high fat diet induced obesity and insulin resistance via mTOR signaling pathway
  1445. Exercise and obesity-induced insulin resistance in skeletal muscle
  1446. Exercise and obesity-Induced insulin Resistance in Skeletal Muscle
  1447. Exercise in aging: its important role in mortality, obesity and insulin resistance
  1448. Exercise modifies microvascular reactivity to insulin in the OLETF rat, a rodent model of hyperphagia‐induced obesity and type II diabetes
  1449. Exercise Program Improves insulin Resistance and Functional Limitation in Sedentary Elderly Patients with obesity
  1450. Exercise Reverses Diet-Induced obesity and obesity-Associated insulin Resistance through the IKKβ/NF-KB Pathway
  1451. Exercise Training Attenuates Sarcopenic obesity‐Induced insulin Resistance and Mitochondrial Dysfunction in the Rat Skeletal Muscle
  1452. Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet‐induced obesity rats
  1453. Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus
  1454. Exercise‐induced reduction in obesity and insulin resistance in women: a randomized controlled trial
  1455. Exosomal transfer of obesity adipose tissue for decreased miR-141-3p mediate insulin resistance of hepatocytes
  1456. Expanded normal weight obesity and insulin resistance in US adults of the National Health and Nutrition Examination Survey
  1457. Expansive vascular remodeling and increased vascular calcification response to cholecalciferol in a murine model of obesity and insulin resistance
  1458. Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat
  1459. Experimental obesity in Man: Hyperaminoacidemia and Diminished Effectiveness of insulin in Regulating Peripheral Amino Acid Release.
  1460. Experimental study on the mechanism of raspberry ketone on simple obesity and insulin resistance relevant to obesity
  1461. Exploring Phytotherapeutic Alternatives for obesity, insulin Resistance and Diabetes Mellitus
  1462. Exploring the use of adjusted body mass index thresholds based on equivalent insulin resistance for defining overweight and obesity in UK South Asian …
  1463. Exposure to maternal obesity during suckling outweighs in utero exposure in programming for post-weaning adiposity and insulin resistance in rats
  1464. Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner
  1465. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes
  1466. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance
  1467. Expression of FOXC2 in adipose tissues and its correlation with obesity and insulin resistance
  1468. Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation
  1469. Expression of Sirtuin 1 in visceral adipose tissue in Tibetan mini-pigs with obesity and insulin resistance induced by high fat/cholesterol diet
  1470. Expression of the central obesity and type 2 diabetes mellitus genes is associated with insulin resistance in young obese children
  1471. Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin …
  1472. F-DIO obesity-prone rat is insulin resistant before obesity onset
  1473. FABP4-Cre mediated expression of constitutively active ChREBP protects against obesity, fatty liver, and insulin resistance
  1474. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality
  1475. Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes
  1476. Factors associated with insulin resistance in patients with chronic HCV genotype 1 infection without obesity or type 2 diabetes
  1477. Factors Associated with insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without obesity or Type 2 Diabetes
  1478. Factors Governing Development of Non-Alcoholic Fatty Liver Disease and insulin Resistance in obesity
  1479. Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity
  1480. Familial and individual predictors of obesity and insulin resistance in urban H ispanic children
  1481. Familial Diabetes Mellitus in Mice, Associated with insulin Resistance obesity, and Hyperplasia of the Islands of Langerhans
  1482. Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance
  1483. Family with Sequence Similarity 13, Member A Protects Against obesity-Related Metabolic Disorder by Modulating the Adipocyte insulin Signaling
  1484. Family with Sequence Similarity 13, Member A Protects Against obesity-Related Metabolic Disorder by Modulating the Adipocyte insulin Signaling
  1485. Fanconi anemia links reactive oxygen species to insulin resistance and obesity
  1486. Fas (CD 95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance
  1487. Fas and FasL Expression in Human Adipose Tissue Is Related to obesity, insulin Resistance, and Type 2 Diabetes
  1488. Fast food, central nervous system insulin resistance, and obesity
  1489. Fasting insulin and obesity-related phenotypes are linked to chromosome 2p: the Strong Heart Family Study
  1490. Fasting insulin level in obese children: relationship to comorbidities of childhood obesity
  1491. Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents
  1492. Fasting insulin, Glucose, and HbA1c Among Young Adults with Overweight and obesity
  1493. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men
  1494. Fasting‐based estimates of insulin sensitivity in overweight and obesity: a critical appraisal
  1495. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
  1496. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats
  1497. Fat metabolism in obesity, with special emphasis on the insulin resistance and elevated lipid mobilization in visceral obesity
  1498. Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease
  1499. Fat-depot specific differences in adipose tissue inflammation in the setting of obesity and insulin resistance
  1500. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance
  1501. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet–induced obesity and insulin resistance by inhibiting lipolysis
  1502. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity
  1503. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance
  1504. Fatty acid composition of skeletal muscle membrane phospholipids, insulin resistance and obesity
  1505. Fatty acids, obesity and insulin resistance
  1506. Fatty acids, obesity, and insulin resistance: time for a reevaluation
  1507. Fatty liver, insulin resistance, and obesity: relationships with increase in coronary artery calcium over time
  1508. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity
  1509. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels
  1510. FDP-E induces adipocyte inflammation and suppresses insulin-stimulated glucose disposal: effect of inflammation and obesity on fibrinogen Bβ mRNA
  1511. Features of some anthropometric indices and indices of insulin resistance in patients with non-alcoholic steatohepatitis on the background of obesity and …
  1512. Febrile neutropenia induces changes in insulin sensitivity similar to obesity
  1513. Fecal microbiota signatures of insulin resistance, inflammation and metabolic syndrome in youth with obesity. A pilot study.
  1514. Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance
  1515. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity.
  1516. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity
  1517. Feeding high oleic acid Canola oil or olive oil alters inflammation, insulin resistance and lipid metabolism in a rodent model of diet induced obesity
  1518. Female 5 [beta]-reductase knockout mice are protected from diet induced obesity, insulin resistance, and glucose intolerance
  1519. Female obesity: testosteronemia is positively correlated with peripheral insulin resistance
  1520. Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development
  1521. Fenfluramine in chilhood obesity: clinical experience and effects of fenfluramine and weight loss on blood glucose, plasma insulin and plasma growth hormone …
  1522. Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2/TACE
  1523. Ferriman-Gallwey Score correlates with obesity and insulin level in Polycystic Ovary Syndrome–an observational study
  1524. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity
  1525. Fetal origins of insulin resistance and obesity
  1526. Fetuin-null mice are protected against obesity and insulin resistance associated with aging
  1527. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: the BCAMS Study
  1528. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
  1529. FGF21 gene therapy as treatment for obesity and insulin resistance
  1530. Fiber intake and insulin resistance in 6374 adults: The role of abdominal obesity
  1531. Fibre, satiety and insulin-a new approach to overnutrition and obesity
  1532. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance
  1533. Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions
  1534. Finding Links between obesity and Diabetes: Using Diacylglycerol Kinase to Regulate insulin Signaling
  1535. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity
  1536. Fish oil in a high lard diet prevents obesity, hyperlipemia, and adipocyte insulin resistance in rats
  1537. Fitness, insulin sensitivity, and frontal lobe integrity in adults with overweight and obesity
  1538. Five genes influenced by obesity may contribute to the development of thyroid cancer through the regulation of insulin levels
  1539. FKBP5 polymorphism is associated with insulin resistance in children and adolescents with obesity
  1540. Flavonoid-rich extract of Paulownia fortunei flowers attenuates diet-induced hyperlipidemia, hepatic steatosis and insulin resistance in obesity mice by AMPK pathway
  1541. Flow motion dynamics of microvascular blood flow and oxygenation: Evidence of adaptive changes in obesity and type 2 diabetes mellitus/insulin resistance
  1542. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity
  1543. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity
  1544. Food-related sensory stimuli are able to promote pancreatic polypeptide elevation without evident cephalic phase insulin secretion in human obesity
  1545. Food, obesity and non-insulin-dependent diabetes: are there molecular links?
  1546. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism
  1547. Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity
  1548. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary‐induced obesity and insulin …
  1549. FOXC2 and CAPN10 as candidate genes for obesity, insulin resistance and type 2 diabetes
  1550. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance
  1551. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy
  1552. Free fatty acid oxidation in insulin resistance and obesity
  1553. Free fatty acids (FFA), a link between obesity and insulin resistance
  1554. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients
  1555. Free fatty acids in insulin‐resistant individuals are associated with the insulin‐resistant state but not with central obesity
  1556. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction
  1557. Free fatty acids—the link between obesity and insulin resistance
  1558. Free Fatty Acids, A Major Link Between obesity, insulin Resistance, Inflammation, and Atherosclerotic Vascular Disease
  1559. Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions
  1560. Free insulin-like growth factors in human obesity
  1561. Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin, and metabolic parameters
  1562. Freeze-dried strawberry and blueberry attenuates diet-induced obesity and insulin resistance in rats by inhibiting adipogenesis and lipogenesis
  1563. Frequency of insulin resistance in nondiabetic adult Bangladeshi individuals of different obesity phenotypes
  1564. Frequency of obesity, insulin resistance, cardio-metabolic risk factors and genetic variation in the genes encoding ADIPOQ and PPAR-[gamma] in urban adults
  1565. From immune senescence and insulin resistance to obesity and sarcopenia: iNKT cell as bridge?
  1566. From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance
  1567. From obesity to type 2 diabetes: the interplay between insulin resistance and impaired insulin secretion
  1568. From Starvation to obesity: How insulin Resistance Affects Global Health
  1569. Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance
  1570. FT–IR Saliva Profiling in Patients with obesity and obesity–Related insulin Resistance
  1571. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity
  1572. Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment
  1573. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
  1574. Further evidence for insulin hypersecretion not as an initial event but as a consequence of body growth and maturation in juvenile-onset obesity
  1575. G protein–coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity
  1576. G protein–coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus
  1577. G Proteins Regulating insulin Action and obesity
  1578. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat …
  1579. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
  1580. Galacto-oligosaccharides supplementation decreases obesity and improves insulin sensitivity in mice fed a Western-type diet
  1581. Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome
  1582. Gamma tocotrienol improves high fat diet‐induced obesity and insulin resistance by inhibiting adipose inflammation and macrophage recruitment (383.4)
  1583. Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment
  1584. Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms
  1585. Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway
  1586. Gastric Bypass in an Adolescent with obesity, insulin Resistance, and Type 1 Diabetes
  1587. Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation or food restriction
  1588. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels
  1589. Gastric sleeve surgery alleviates obesity-associated insulin resistance and suppresses endoplasmic reticulum stress in adipose tissue of db/db mice
  1590. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non‐diabetic Japanese patients with schizophrenia
  1591. GENDER DIFFERENCES OF VITAMIN D LEVELS AND ITS ASSOCIATION WITH SELECTED obesity MARKERS, insulin RESISTANCE IN YOUNG …
  1592. Gender-specific effect of-102G> a polymorphism in insulin induced gene 2 on obesity in Chinese children
  1593. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM
  1594. Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats
  1595. Genetic ablation of calcium-independent phospholipase A2γ prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and …
  1596. Genetic Ablation of GIP Producing K Cells Reduces Diet Induced obesity (OB) and insulin Resistance (IR) in Mice.
  1597. Genetic Ablation of Liver CPT-1A Gene Protects Mice against High-Fat Diet–Induced obesity and insulin Resistance
  1598. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet‐induced obesity and insulin resistance
  1599. Genetic ablation of miR-33 increases food intake, enhances adipose tissue expansion, and promotes obesity and insulin resistance
  1600. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evicence for polygenic control
  1601. Genetic analysis of the IRS: pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
  1602. Genetic deconstruction of complex traits related to the cardiovascular complications of insulin resistance in multigenic obesity mouse models
  1603. Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance
  1604. Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance
  1605. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice
  1606. Genetic engineering of the skeletal muscle to counteract insulin resistance and obesity
  1607. Genetic evidence that carbohydrate-stimulated insulin secretion leads to obesity
  1608. Genetic models of human obesity and non-insulin dependent diabetes in animals: problem of adequacy.
  1609. Genetic Nicotinamide N-Methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance
  1610. Genetic obesity and dietary sucrose decrease hepatic glucagon and insulin receptors in LA/N-corpulent rats
  1611. Genetic predisposition to obesity is associated with insulin secretion in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study
  1612. Genetic reduction of circulating insulin-like growth factor (IGF)-1 inhibits obesity-promoted colon tumorigenesis in mice
  1613. Genetic reduction of circulating insulin-like growth factor (IGF)-1 inhibits obesity-promoted colon tumorigenesis in mice and alters microRNA expression
  1614. Genetic Variants Associated With obesity and insulin
  1615. Genetic variants associated with obesity and insulin resistance in Hispanic boys with nonalcoholic fatty liver disease
  1616. Genetic variants of retinol-binding protein 4 in adolescents are associated with liver function and inflammatory markers but not with obesity and insulin resistance
  1617. Genetic Variation in β3-Adrenergic Receptor and obesity, Type 2 Diabetes, insulin Resistance in Chinese Pedigrees
  1618. Genetics of gene expression of the insulin signaling pathway in polygenic obesity
  1619. Genetics of Paediatric Type 2 Diabetes: ABCC8 Mutation in obesity-Associated insulin Secretion Defects
  1620. Genotype C/C 13910 of the Lactase Gene as a Risk Factor for the Formation of insulin-Resistant obesity in Children
  1621. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance
  1622. Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic insulin Insensitivity, obesity, and Metabolic Syndrome in Adult Female Offspring
  1623. Gestational oxidative stress protects against adult obesity and insulin resistance
  1624. #VALUE!
  1625. GH receptor deficiency in Ecuadorian adults is associated with obesity and enhanced insulin sensitivity
  1626. Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice
  1627. #VALUE!
  1628. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
  1629. Global Tudor‐SN transgenic mice are protected from obesity‐induced hepatic steatosis and insulin resistance
  1630. Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity
  1631. GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance
  1632. Glucocorticoid metabolism in human obesity; increased 5 [alpha]-reductase activity is associated with insulin resistance in both men and women
  1633. Glucocorticoid Receptor Is Instrumental for the Mechanism of Beta-Cell Compensation for insulin Resistance in Dietary obesity
  1634. Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice
  1635. Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice
  1636. Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
  1637. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance …
  1638. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity
  1639. Glucose and insulin values in an adolescent outpatient population with a high prevalence of obesity and risk factors for diabetes mellitus type 2
  1640. Glucose impairments and insulin resistance in prostate cancer: The role of obesity, nutrition and exercise
  1641. Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells
  1642. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. obesity predicts coronary atherosclerosis and …
  1643. Glucose Intolerance, insulin Resistance and obesity Risk in Children with Family History of Type II Diabetes
  1644. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity …
  1645. Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity: effects of dietary composition and adipose cell …
  1646. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus
  1647. Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity
  1648. Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs.
  1649. Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride
  1650. Glucose tolerance, plasma insulin, and plasma glucagon in relation to obesity in chickens
  1651. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men
  1652. Glucose Tolerance, Plasma insulin, HDL Cholesterol and obesity: 12-year Follow-Up and Development of Coronary Heart Disease in Edinburgh Men
  1653. Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by 18 F …
  1654. Glucose-6-phosphate dehydrogenase deficiency improves insulin resistance with reduced adipose tissue inflammation in obesity
  1655. Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity
  1656. Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM
  1657. GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1 GT/GT, a mouse model for obesity and insulin resistance
  1658. Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition
  1659. Glutathione depletion prevents diet‐induced obesity and enhances insulin sensitivity
  1660. Glycaemic control, insulin resistance and obesity
  1661. Glycated hemoglobin, but not insulin sensitivity, is associated with memory in subjects with obesity
  1662. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity
  1663. Glycerol-3-phosphate dehydrogenase activity in human lymphocytes: effects of insulin, obesity and weight loss
  1664. Glycogen Synthase Kinase-3a Contributes to the Development of Cardiac Dysfunction During obesity and insulin Resistance Through Regulation of Peroxisome …
  1665. Goat’s milk intake prevents obesity, hepatic steatosis and insulin resistance in mice fed A high-fat diet by reducing inflammatory markers and increasing energy …
  1666. Gonadal white adipose tissue-derived exosomal MiR-222 promotes obesity-associated insulin resistance
  1667. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens
  1668. Good fats versus bad fats: a comparison of fatty acids in the promotion of insulin resistance, inflammation, and obesity
  1669. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance
  1670. GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity
  1671. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
  1672. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity
  1673. Gravidity, obesity, and non-insulin-dependent diabetes among Pima Indian women
  1674. Green tea prevents obesity by increasing expression of insulin-like growth factor binding protein-1 in adipose tissue of high-fat diet-fed mice
  1675. Growth and obesity and its association with plasma level of steroid hormones and insulin-like growth factor-I (IGF-I) in Slovak female students.
  1676. Growth hormone is necessary for the p53-mediated, obesity-induced insulin resistance in male C57BL/6J× CBA mice
  1677. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
  1678. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity
  1679. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition
  1680. Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
  1681. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance
  1682. Guarana supplementation attenuated obesity, insulin resistance, and adipokines dysregulation induced by a standardized human Western diet via brown adipose …
  1683. Guenther Boden, MD (1935–2015): A Pioneer in Human Studies of Nutrition and obesity—And the Mystery of insulin Resistance for Handling Glucose
  1684. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice
  1685. Gut inflammation as a contributing factor for the development of insulin resistance in obesity
  1686. Gut microbiome and its role in obesity and insulin resistance
  1687. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance
  1688. Gut microbiota composition and its effects on obesity and insulin resistance
  1689. Gut microbiota impairs insulin clearance during obesity
  1690. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
  1691. Gut microbiota interacts with markers of adipose tissue browning, insulin action and plasma acetate in morbid obesity
  1692. Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
  1693. Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice
  1694. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice
  1695. Haptoglobin Phenotypes Are Associated with the Postload Glucose and insulin Levels in Pediatric obesity
  1696. Heart Rate, insulin resistance, obesity and blood Pressure in Croatian Rural Population
  1697. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
  1698. Hematopoietic kit deficiency, rather than lack of mast cells, protects mice from obesity and insulin resistance
  1699. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats
  1700. Hemodynamic factors in the insulin resistance of obesity and hyperlipidemia
  1701. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
  1702. Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity
  1703. Hepatic Apolipoprotein M Overexpression Increased Total Sphingosine 1-phosphate Mass and Ameliorate insulin Resistance in Diet Induced obesity Mice
  1704. Hepatic atypical protein kinase C: an inherited survival-longevity gene that now fuels insulin-resistant syndromes of obesity, the metabolic syndrome and type …
  1705. Hepatic Bax inhibitor-1 inhibits IRE1α and protects from obesity-associated insulin resistance and glucose intolerance
  1706. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance
  1707. Hepatic insulin dynamics. Effects of male gender and obesity: Role of free fatty acids.
  1708. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression
  1709. Hepatic mTORC1 opposes impaired insulin action to control mitochondrial metabolism in obesity
  1710. Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis
  1711. Hepatic oncostatin M receptor β regulates obesity-induced steatosis and insulin resistance
  1712. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2
  1713. Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance
  1714. Hepatic Stearoyl-CoA Desaturase-1 Deficiency does not Protect Mice from Diet-Induced obesity and insulin Resistance
  1715. Hepatic Steatosis is Common in Adolescents with obesity and PCOS and Relates to De Novo Lipogenesis but not insulin Resistance
  1716. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity
  1717. Hepatocyte DACH1 is increased in obesity via nuclear exclusion of HDAC4 and promotes hepatic insulin resistance
  1718. Hepatocyte growth factor prevented high-fat diet-induced obesity and improved insulin resistance in mice
  1719. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
  1720. Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
  1721. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
  1722. Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance
  1723. Herbal formula HT048 attenuates diet-induced obesity by improving hepatic lipid metabolism and insulin resistance in obese rats
  1724. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome
  1725. Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene–obesity interaction
  1726. Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity
  1727. Heterogeneity of plasma insulin and triglyceride levels in obesity demonstrated by family study
  1728. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes
  1729. Heterozygous p53 knockout affects development of obesity, insulin resistance and non-alcoholic steatohepatitis in mice fed with a Western type diet
  1730. Hexosamines as mediators of nutrient sensing: relevance to obesity, insulin resistance, and diabetes
  1731. High density lipoprotein cholesterol, insulin and obesity in Samoans
  1732. High Early Childhood insulin Increases Asthma Risk Independent of obesity
  1733. High Expression Level of PPARγ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model of insulin-Sensitive obesity
  1734. High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters
  1735. High fat-induced obesity associated with insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate
  1736. High incidence of obesity and elevated serum immunoreactive insulin level in patients with paravertebral ligamentous ossification: a relationship to the development of …
  1737. High incidence of obesity and insulin resistance in prepubertal children, born too small for their gestational age
  1738. High prevalence of overweight, obesity, insulin resistance and metabolic syndrome in rural children and adolescents
  1739. High serum fasting peptide YY (3–36) is associated with obesity-associated insulin resistance and type 2 diabetes
  1740. High serum selenium levels are associated with increased risk for diabetes mellitus independent of central obesity and insulin resistance
  1741. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels
  1742. High-density lipoprotein composition in obesity: interrelationships with plasma insulin levels and body weight.
  1743. High-fat diet is associated with obesity-mediated insulin resistance and β-cell dysfunction in Mexican Americans
  1744. High-fat diet-induced obesity and insulin resistance are characterized by differential beta oscillatory signaling of the limbic cortico-basal ganglia loop
  1745. High-fat diet-induced obesity and insulin resistance in CYP4a14 Ϫ/Ϫ mice is mediated by 20-HETE
  1746. High-fat diet-induced obesity and insulin resistance in CYP4a14−/− mice is mediated by 20-HETE
  1747. High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol
  1748. High-fat diet–induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice
  1749. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse
  1750. High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons
  1751. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring
  1752. High-intensity interval training improves markers of oxidative metabolism in skeletal muscle of individuals with obesity and insulin resistance
  1753. High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance
  1754. High‐fat diet obesity associated with insulin resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate
  1755. High‐fat Diet‐induced Ultradian Leptin and insulin Hypersecretion are Absent in obesity‐resistant Rats
  1756. High‐normal tsh values in obesity: Is it insulin resistance or adipose tissue’s guilt?
  1757. Higher Concentrations of Glucose or insulin Increase the Risk of Various Types of Cancer in obesity or Type 2 Diabetes by Decreasing the Expression of …
  1758. Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
  1759. Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance
  1760. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
  1761. Hippocampal insulin resistance and altered food decision-making as players on obesity risk
  1762. Hippocampal insulin resistance links maternal obesity with impaired neuronal plasticity in adult offspring
  1763. HIS-388, a novel orally active and long-acting 11β-HSD1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and non-genetic type …
  1764. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance
  1765. HOMA, QUICKI and MF fm to Measure insulin Resistance in Morbid obesity
  1766. Homeostasis model assessment of insulin resistance in a general adult population in Korea: additive association of sarcopenia and obesity with insulin resistance
  1767. Homeostatic model assessment of insulin resistance as a predictor of metabolic syndrome: consequences of obesity in children and adolescents
  1768. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women
  1769. Hormone resistance in diabetes and obesity: insulin, leptin, and FGF21
  1770. Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss
  1771. How much variance in insulin resistance is explained by obesity?
  1772. How much variance in insulin resistance is explained by obesity?
  1773. How the association between obesity and inflammation may lead to insulin resistance and cancer
  1774. HSP72 protects against obesity-induced insulin resistance
  1775. Huangjinya Black Tea Alleviates obesity and insulin Resistance via Modulating Fecal Metabolome in High‐Fat Diet‐Fed Mice
  1776. Human growth gene family chromosomal architecture is affected by maternal obesity, gestational diabetes and insulin treatment
  1777. Human muscle fiber type–specific insulin signaling: Impact of obesity and type 2 diabetes
  1778. Human obesity and insulin Resistance
  1779. Human obesity and insulin resistance: lessons from experiments of nature
  1780. Human obesity and thinness, hyperlipidemia, hyperglycemia, and insulin resistance associated with HIV1 protease inhibitors Prevention by alternating several …
  1781. Human obesity relationship with Ad36 adenovirus and insulin resistance
  1782. Human plasma resistin level relate to insulin resistance and obesity
  1783. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro
  1784. Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice
  1785. Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-induced obesity and insulin resistance
  1786. Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance
  1787. Hydroxychloroquine improves obesity-associated insulin resistance and hepatic steatosis by regulating lipid metabolism
  1788. Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice
  1789. Hydroxytyrosol improves obesity and insulin resistance by modulating gut microbiota in high-fat diet-induced obese mice
  1790. Hyperactivity of the hypothalamo‐pituitary‐adrenal axis in obesity: a study of ACTH, AVP, β‐lipotrophin and Cortisol responses to insulin‐induced hypoglycaemia
  1791. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired …
  1792. Hyperglycemia and obesity as Determinants of Glucose, insulin, and Glucagon Responses to β-Endorphin in Human Diabetes Mellitus
  1793. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes
  1794. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance
  1795. Hyperinsulinemia and its impact on obesity and insulin resistance.
  1796. Hyperinsulinemia does not compensate for peripheral insulin resistance in obesity
  1797. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production
  1798. Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity
  1799. Hyperinsulinemia in individuals with obesity: role of insulin clearance
  1800. Hyperinsulinemia Leads the Elevation of Plasma Aldosterone Concentration Independently with obesity, Dyslipidemia, and insulin Resistance in Patients with Type 2 …
  1801. Hyperinsulinemia of obesity is due to decreased clearance of insulin
  1802. Hyperinsulinemia, insulin resistance and free fatty acids. The dog model in diabetes and obesity research
  1803. Hyperleptinemia and insulin resistance in obesity-associated sleep apnoea: Sex-dependent effects of CPAP application
  1804. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations
  1805. Hypertension and coronary heart disease in patients with type 2 (non insulin dependent) diabetes: influence of overweight and obesity.
  1806. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy
  1807. Hypertension and Dyslipidemia, but Not Fasting Blood Glucose, Dissociate From Central obesity and insulin Resistance With Advancing Age
  1808. Hypertension and Metabolic Disarray: Diabetes Mellitus, insulin Resistance, and obesity Hypertension: Kidney, Sodium, and the Renin-Angiotensin System
  1809. Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system
  1810. Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus
  1811. Hypertension, serum insulin, obesity and the metabolic syndrome
  1812. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
  1813. Hypoadiponectinemia in obesity: association with insulin resistance
  1814. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
  1815. Hypomagnesemia and obesity in Relation to insulin Resistance and Glycemic Control in Type 2 Diabetic Patients
  1816. Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance
  1817. Hypothalamic insulin resistance in obesity: effects on glucose homeostasis
  1818. Hypothalamic insulin-sensitizing effect of exenatide in dietary induced rat model of obesity
  1819. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist
  1820. Hypothalamic obesity is due to insulin Hypersecretion: Reversal With Octreotide• 455
  1821. Hypothalamic or central obesity is associated with an early rise in plasma insulin concentration
  1822. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled ‘hypertensive …
  1823. Hypothesis: postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity
  1824. Identification and functional characterization of a missense mutation in resistin in 2 patients with severe obesity and insulin resistance Running Title: A missense …
  1825. Identification and functional characterization of a missense mutation in resistin in two patients with severe obesity and insulin resistance
  1826. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients
  1827. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q.
  1828. Identification of early transcriptome signatures in placenta exposed to insulin and obesity
  1829. Identification of early transcriptome signatures in placenta exposed to insulin and obesity
  1830. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity
  1831. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance
  1832. Identification of novel alleles associated with insulin resistance in childhood obesity using pooled-DNA genome-wide association study approach
  1833. Identification of Susceptibility Loci for obesity, insulin Resistance, and Hyperglycemia in a Backcross Model of New Zealand Obese (NZO) and Lean SJL Mice
  1834. Identifying genetic modifiers of obesity and insulin sensitivity
  1835. Identifying the links between obesity, insulin resistance and β‐cell function: potential role of adipocyte‐derived cytokines in the pathogenesis of type 2 diabetes
  1836. IF1 connects obesity and insulin resistance through mitochondrial reprogramming in association with ANT2
  1837. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant …
  1838. IGF-binding protein-2 protects against the development of obesity and insulin resistance
  1839. IGF-Binding Protein-2 Protects Against the Development of obesity and insulin Resistance
  1840. IGFBP-1: A vasculoprotective peptide in obesity and insulin resistance
  1841. IGFBP-3 interacts with the vitamin D receptor in insulin signaling associated with obesity in visceral adipose tissue
  1842. IKK-β links inflammation to obesity-induced insulin resistance
  1843. IKKε is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity
  1844. IL-14. Small Molecule insulin Mimetics with Potential Utilities as Anti-diabetic and Anti-obesity Therapies
  1845. IL-29 promoted obesity-induced inflammation and insulin resistance
  1846. IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance
  1847. IL-34 is associated with obesity, chronic inflammation, and insulin resistance
  1848. IL-37 protects against obesity-induced inflammation and insulin resistance
  1849. IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice
  1850. Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure
  1851. Imbalanced insulin actions in obesity and type 2 diabetes: key mouse models of insulin signaling pathway
  1852. Immune and inflammatory processes in obesity, insulin resistance, diabetes, and related cardiometabolic complications
  1853. Immunity as a link between obesity and insulin resistance
  1854. Immunologic shifts in inhabitants of the Tian’-Shan’lowlands and highlands, suffering from obesity and non-insulin-dependent diabetes mellitus
  1855. Immunoreactive insulin and obesity in women.
  1856. Immunoreative insulin in obesity of adult women.
  1857. Impact of Aldose Reductase on Endothelial Function and Vascular insulin Resistance in Diet-Induced obesity
  1858. Impact of alpha-lipoic acid on insulin sensitivity in individuals with obesity and impaired glucose tolerance [J]
  1859. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities
  1860. Impact of bariatric surgery on heme oxygenase-1, inflammation, and insulin resistance in morbid obesity with obstructive sleep apnea
  1861. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT
  1862. Impact of changes in obesity parameters on glucose metabolism and insulin resistance over a one-year period
  1863. Impact of Chromosome 2 obesity Loci on Cardiovascular Complications of insulin Resistance in LDL Receptor–Deficient C57BL/6 Mice
  1864. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable …
  1865. Impact of degree of obesity on surrogate estimates of insulin resistance
  1866. Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1
  1867. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity
  1868. Impact of insulin resistance and obesity on elevated blood pressure in Chinese children and adolescents: The BCAMS study
  1869. Impact of insulin resistance and obesity on intracytoplasmic sperm injection outcomes in young women with polycystıc ovary syndrome
  1870. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond
  1871. Impact of obesity and insulin-resistance on bone mineral density in Tunisian postmenopausal women
  1872. Impact of obesity and insulin-resistance on cirrhosis and portal hypertension
  1873. Impact of obesity on IL-12 family gene expression in insulin responsive tissues
  1874. Impact of obesity on insulin action in NIDDM
  1875. Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity
  1876. Impact of obesity on maternal and neonatal outcomes in insulin-resistant pregnancy
  1877. Impact of obesity on MMTV-Wnt-1 Mammary Cancer: Role of The insulin-Like Growth Factor-1 (IGF-1)/Akt/mTOR Pathway
  1878. Impact of obesity on MMTV-Wnt-1 mammary cancer: role of the insulin-like growth factor-1 (IGF-1)/Akt/mTOR pathway
  1879. Impact of obesity on Plasma C1q/TNF-Related Protein 3 and insulin Resistance in Newly Diagnosed T_2DM Patients
  1880. Impact of obesity on resting metabolic rate and glucose-induced thermogenesis in non-insulin dependent diabetes mellitus.
  1881. Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes
  1882. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C
  1883. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study
  1884. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and …
  1885. Impact of proteinase 3 and insulin growth factor BP-3 proteolysis in obesity-induced cardiometabolic risk
  1886. Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice
  1887. Impact of sex on microvascular reactivity in a murine model of diet-induced obesity and insulin resistance
  1888. Impact of Uncoupling Protein 3 Deficiency on High-Fat Diet-Induced obesity and insulin Resistance
  1889. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity
  1890. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity
  1891. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance
  1892. Impaired fat tolerance as a risk factor of insulin resistance in young patients with obesity
  1893. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance
  1894. IMPAIRED GHRELIN SECRETION IN obesity: THE KEY ROLE OF insulin RESISTANCE
  1895. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin …
  1896. Impaired growth hormone response to growth hormone releasing factor and insulin‐hypoglycaemia in obesity
  1897. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity
  1898. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients
  1899. Impaired macrophage autophagy induces systemic insulin resistance in obesity
  1900. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance
  1901. Impaired phagocytosis as a key mechanism underlying obesity‐induced inflammation and insulin resistance
  1902. Impaired platelet sensitivity to the anti-aggregating effects of adenosine in obesity and obese non-insulin-dependent diabetes mellitus
  1903. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation
  1904. Impaired Transient Receptor Potential Vanilloid Type-1 Signaling Promotes obesity and Leptin/insulin Resistance In Mice
  1905. Implication of inflammatory signaling pathways in obesity-induced insulin resistance
  1906. Implication of MAP kinases in obesity-induced inflammation and insulin resistance
  1907. Implication of obesity-induced miR-96 in hepatic insulin resistance
  1908. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity
  1909. Importance of lean muscle maintenance to improve insulin resistance by body weight reduction in female patients with obesity
  1910. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet‐induced obesity
  1911. IMPORTANCE OF SHIP2 GENE IN obesity INDUCED MUSCLE insulin RESISTANCE: FOCUS ON PALMITATE
  1912. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise.
  1913. Imprinted insulin predisposes children to obesity
  1914. Improved insulin sensitivity after exercise training is linked to reduced plasma C 14: 0 ceramide in obesity and type 2 diabetes
  1915. Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension
  1916. Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action
  1917. Improvement of heart rate variability after decreased insulin resistance after sleeve gastrectomy for morbidly obesity patients
  1918. Improvement of hyperandrogenism and insulin resistance in females with severe obesity after weight loss through bariatric surgery
  1919. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures
  1920. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity
  1921. Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance
  1922. Improvement of obesity-linked skeletal muscle insulin resistance by strength and endurance training
  1923. Improving obesity and insulin Resistance by Targeting Skeletal Muscle MKP-1
  1924. In addition to insulin resistance and obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese-a population-based study …
  1925. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a …
  1926. In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling …
  1927. IN FOCUS: Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance
  1928. In normoglycaemic siblings of type 2 diabetic patients, obesity accounts for decreased insulin sensitivity but not for hypertension.
  1929. In patients with coronary artery disease the NCEP-defined metabolic syndrome, insulin resistance and obesity are all associated with decreased adiponectin …
  1930. In the article entitled “Increased Susceptibility to insulin Re-sistance Associated with Abdominal obesity in Aging Rats,”
  1931. in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With insulin Release, insulin Sensitivity, and obesity in a Population-Based Sample …
  1932. In Vivo Changes in Central and Peripheral insulin Sensitivity in a Large Animal Model of obesity
  1933. In vivo kinetics of islet compensation and dysfunction in a mouse model of diet-induced obesity and insulin resistance
  1934. In-silico study of the immune systems associated genes in case of type-2 diabetes with insulin action and resistance and in obesity
  1935. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice
  1936. Inactivation of insulin in Livers from Mice with Goldthioglueose obesity.
  1937. Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity
  1938. Inactivation of PKCθ leads to increased susceptibility to obesity and dietary insulin resistance in mice
  1939. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity
  1940. Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthy obesity Phenotype: The Relevance of insulin Resistance
  1941. Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin, insulin, and IGF-1
  1942. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution
  1943. Increase in insulin secretion with age: its clinical importance in evaluating abnormal secretions focused on diabetes type II and obesity
  1944. Increase insulin sensitivity by PTP1B deletion abolished obesity‐induced hypertension in mice
  1945. Increased 4E-BP1 expression protects against diet-induced obesity and insulin resistance in male mice
  1946. Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-β1 gene
  1947. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus
  1948. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance
  1949. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity
  1950. Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity
  1951. Increased adipose tissue expression of IL‐18R and its ligand IL‐18 associates with inflammation and insulin resistance in obesity
  1952. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
  1953. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity
  1954. Increased binding of insulin to mononuclear blood cells following gastric bypass for morbid obesity
  1955. Increased body mass index increase and insulin resistance parameters in dyslipidemia. Risk and positive correlation in essential obesity
  1956. Increased C-jun N terminal kinase (JNK) activity may link insulin resistance and inflammation in human central obesity
  1957. INCREASED EXPRESSION OF IL-18R AND IL-18 IN THE ADIPOSE TISSUE IS ASSOCIATED WITH insulin RESISTANCE (HOMA-IR) IN obesity
  1958. Increased expression of triggering receptor expressed on myeloid cells‐1 in the population with obesity and insulin resistance
  1959. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study
  1960. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
  1961. Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer’s disease mouse model
  1962. Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes
  1963. Increased insulin requirement may contribute to risk of obesity in children and young people with Type 1 Diabetes Mellitus
  1964. Increased insulin resistance compounded by reduced insulin sensitivity drives the” Fat Aussie”(Alms1foz/foz) model of Alström syndrome towards obesity and type 2 …
  1965. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity
  1966. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
  1967. Increased insulin Sensitivity by High-Altitude Hypoxia in Mice with High-Fat Diet-Induced obesity Is Associated with Activated AMPK Signaling and Subsequently …
  1968. Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance
  1969. Increased maternal insulin resistance promotes placental growth and decreases placental efficiency in pregnancies with obesity and gestational diabetes mellitus
  1970. Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance
  1971. Increased muscle blood supply and transendothelial nutrient and insulin transport induced by food intake and exercise: effect of obesity and ageing
  1972. Increased obesity resistance and insulin sensitivity in mice lacking the isocitrate dehydrogenase 2 gene
  1973. Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity
  1974. Increased serum dihomo-γ-linolenic acid levels are associated with obesity, body fat accumulation, and insulin resistance in Japanese patients with type 2 diabetes
  1975. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance
  1976. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance
  1977. Increased Susceptibility to insulin Resistance Associated with Abdominal obesity in Aging Rats**
  1978. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity
  1979. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin
  1980. Independent effects of obesity and insulin resistance on postprandial thermogenesis in men.
  1981. Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance
  1982. Independent tissue contributors to obesity-associated insulin resistance
  1983. Indices of insulin Resistance in Children with Simple obesity.
  1984. Indices of insulin resistance in paediatric obesity
  1985. Indices of obesity, dyslipidemia, and insulin resistance in apparently healthy Caribbean subjects
  1986. Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice
  1987. Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity
  1988. Induction of obesity and insulin Resistance in Mice using a Modified Diet
  1989. Inflamed Host: Serine/Threonine Phosphorylation Signaling Pathway that Links obesity and insulin Resistance and Worse Prognosis for COVID-19
  1990. Inflammasome is a central player in the induction of obesity and insulin resistance
  1991. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
  1992. Inflammation and obesity: STAMPing out insulin resistance?
  1993. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease
  1994. Inflammation and the IKK β/I κ B/NF-κ B axis in obesity-and diet-induced insulin resistance
  1995. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
  1996. Inflammation in obesity is a common link between defects in fatty acid metabolism and insulin resistance
  1997. Inflammation is not a contributing factor in the development of insulin resistance in diet induced obesity in rats
  1998. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
  1999. Inflammation‐mediated obesity and insulin resistance as targets for nutraceuticals
  2000. Inflammation, insulin resistance, and obesity
  2001. Inflammation: the link between insulin resistance, obesity and diabetes
  2002. Inflammatory and metabolic role of Kupffer cells in diet-induced obesity and insulin resistance
  2003. Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein
  2004. Inflammatory Cross-Talk Between Short Sleep Duration and obesity in Development of insulin Resistance: Narrative Review
  2005. Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages
  2006. Inflammatory Responses to obesity and insulin Resistance
  2007. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance
  2008. Influence of a mini-trampoline rebound exercise program on insulin resistance, lipid profile and central obesity in individuals with type 2 diabetes.
  2009. Influence of acupuncture on insulin resistance in simple obesity patients
  2010. Influence of Acupuncture on Leptin, insulin-resistance and Adiponectin of Type 2 Diabetic obesity Rats [J]
  2011. Influence of catgut implantation at acupoints on leptin and insulin resistance in simple obesity rats
  2012. Influence of Diet and Exercise Comprehensive Correction on Plasma insulin in obesity Complicated with Menopausal Syndrome Patients
  2013. Influence of dietary protein upon the development of obesity, insulin resistance (IR) and energy metabolism (EM) in malnourished mice fed a high fat diet (HFD)
  2014. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients
  2015. Influence of electronic acupuncture on serum leptin and insulin of rats with simple obesity
  2016. Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity
  2017. Influence of insulin resistance on renal function in patients with abdominal obesity.
  2018. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study.
  2019. Influence of maternal obesity on insulin sensitivity and secretion in offspring
  2020. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver
  2021. Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution
  2022. Influence of nutritional state and obesity on pituitary control of insulin secretion
  2023. Influence of obesity and family history of type 2 diabetes mellitus on serum ferritin and insulin levels in young adults
  2024. Influence of obesity and insulin resistance on left atrial size in children
  2025. Influence of obesity and insulin resistance on scavenger receptor CD36 expression on monocytes in young women
  2026. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue
  2027. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity
  2028. Influence of obesity in the miRNome landscape: miR-4454, a-tissue-specific regulator of insulin response
  2029. Influence of obesity in the miRNome: miR-4454, a key regulator of insulin response via splicing modulation in prostate
  2030. Influence of obesity on first-phase insulin secretion in individuals with different glucose tolerance
  2031. Influence of obesity on insulin and C-peptide levels in elderly diabetic patients [J]
  2032. Influence of obesity on insulin‐mediated dilation in the human microcirculation
  2033. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.
  2034. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia
  2035. Influence of obesity to glucose tolerance, insulin, blood lipid and fribrinogen level in middle-aged and elderly men
  2036. Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat
  2037. Influence of risk factors on insulin resistance in patients with overweight and obesity.
  2038. Influence of Various Diets on Diurnal Levels of Plasma Glucose, insulin, and Lipids in obesity and insulin-Independent Diabetics
  2039. Influence of weight reduction on plasma high-density-lipoprotein cholesterol concentrations in severe obesity: interrelationships with plasma insulin levels
  2040. Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity
  2041. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance
  2042. Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improves insulin signal transduction in diet-induced obesity
  2043. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
  2044. Inhibition of cyclooxygenases attenuates diet-induced obesity and compensatory increased glucose-stimulated insulin secretion in C57BL/6J mice
  2045. Inhibition of Hepatic Glucocorticoid Availability in Response to the Development of Diet Induced obesity and insulin Resistance in Mice.
  2046. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus
  2047. Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats
  2048. Inhibition of P2Y6 signaling in AgRP neurons reduces food intake and improves systemic insulin sensitivity in obesity
  2049. Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity
  2050. Inhibition of Stearoyl-CoA Desaturase 1 (SCD1) dissociates insulin resistance and obesity from atherosclerosis
  2051. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus
  2052. Innate immune pathway links obesity to insulin resistance
  2053. Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model of obesity and insulin resistance
  2054. iNOS promotes hypothalamic insulin resistance associated with deregulation of energy balance and obesity in rodents
  2055. Insights into obesity and insulin resistance from the study of extreme human phenotypes
  2056. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance
  2057. Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance
  2058. insulin access to skeletal muscle is impaired during the early stages of diet‐induced obesity
  2059. insulin access to skeletal muscle is preserved in obesity induced by polyunsaturated diet
  2060. insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus
  2061. insulin action and resistance in obesity and type 2 diabetes
  2062. insulin action in brown adipose tissue is compromised during diet-induced obesity
  2063. insulin action in morbid obesity: a focus on muscle and adipose tissue
  2064. insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity
  2065. insulin action in the brain and how this may cause/exacerbate obesity or diabetes
  2066. insulin Action on Endothelial Cells Limits Leukocyte-Endothelial Interaction through CXCR4 and Counteracts Intestinal Tumor Formation in obesity
  2067. insulin and blood pressure in obesity.
  2068. insulin AND CYCLICAL obesity IN THE DORMOUSE, GLIS GLIS.
  2069. insulin and glucose transporter gene expression in obesity and diabetes
  2070. insulin and growth hormone balance: implications for obesity
  2071. insulin and human obesity.
  2072. insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity
  2073. insulin and hypertension: lessons from obesity
  2074. insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians
  2075. insulin and IGFs in obesity-related breast cancer
  2076. insulin and leptin action: roles in diabetes and obesity.
  2077. insulin and leptin relations in obesity: a multimedia approach
  2078. insulin and obesity in the Zucker genetically obese rat “fatty”
  2079. insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state
  2080. insulin as a factor of increased androgen production in women with obesity and polycystic ovaries
  2081. insulin attenuates cardiac dysfunction in a rodent model of diet induced obesity and insulin resistance
  2082. insulin based combination treatments of patients with obesity and type 2 diabetes
  2083. insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting
  2084. insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding
  2085. insulin clearance in obesity
  2086. insulin deficiency: a possible link between obesity and cognitive function
  2087. insulin Degradation by Adipose Human obesity
  2088. insulin degradation by adipose tissue is increased in human obesity
  2089. insulin degradation by adipose tissue is increased in human obesity
  2090. insulin dependent diabetes mellitus: the affect of obesity on blood glucose control
  2091. insulin downregulates M 2-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications
  2092. insulin dysregulation in a population of Finnhorses and associated phenotypic markers of obesity
  2093. insulin dysregulation in horses with induced obesity
  2094. insulin gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhood obesity
  2095. insulin hypoglycemia, a functional test of the state of the hypothalamo-hypophyseo-adrenal system in obesity
  2096. insulin impairs regulatory T cell function: implications for obesity (P1020)
  2097. insulin inhibits IL-10–mediated regulatory T cell function: implications for obesity
  2098. insulin levels during pregnancy or obesity in normoglycemic women with a positive history of diabetes mellitus
  2099. insulin measurement is also inappropriate in paediatric obesity
  2100. insulin metabolism in hypothalamic obesity
  2101. insulin normalization as an approach to the pharmacological treatment of obesity
  2102. insulin production and resistance in different models of diet-induced obesity and metabolic syndrome
  2103. insulin receptor binding and insulin action in human fat cells: effects of obesity and fasting
  2104. insulin receptor binding in obesity: a reassessment
  2105. insulin receptor deficiency in genetic and acquired obesity
  2106. insulin receptor kinase activity in muscles and white adipose tissue during course of VMH obesity
  2107. insulin receptor substrate‐1 inhibits high‐fat diet‐induced obesity by browning of white adipose tissue through miR‐503
  2108. insulin receptor variants and obesity-related cancers in the Framingham Heart Study
  2109. insulin receptor: role in the resistance of human obesity to insulin
  2110. insulin receptors in adipose tissue of rats with monosodium glutamate-induced obesity
  2111. insulin reduces reaction of follicular granulosa cell to FSH stimulation in obesity-related infertility women during IVF
  2112. insulin reduces reaction of follicular granulosa cells to FSH stimulation in women with obesity-related infertility during IVF
  2113. insulin regulation of glucose and lipid metabolism in massive obesity
  2114. insulin regulation of monoamine signaling: pathway to obesity
  2115. insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response‐dependent insulin resistance as a cause of obesity‐associated …
  2116. insulin release in response to oral glucose in obesity: The effect of reduction of body weight
  2117. insulin Resistance & Inflammatory Markers in obesity.
  2118. insulin Resistance Affects both insulin and Exercise Stimulated Glucose Uptake in obesity Independent of Glucose Delivery. In vivo Studies Using [[sup. 15] O]-[H. sub …
  2119. insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls
  2120. insulin resistance and changes in plasma concentration of TNFα, IGF1, and NEFA in dogs during weight gain and obesity
  2121. insulin RESISTANCE AND COMPENSATORY HYPERinsulinEMIA: THE LINCHPIN BETWEEN obesity AND CARDIOVASCULAR
  2122. insulin Resistance and Glucose Metabolism in Childhood obesity
  2123. insulin Resistance and High TNF [Alpha] Concentrations Precede obesity in Rats Fed High Carbohydrate Diet during Suckling Period
  2124. insulin resistance and hunger in childhood obesity: a patient and physician’s perspective
  2125. insulin resistance and hypersecretion in obesity. European Group for the Study of insulin Resistance (EGIR).
  2126. insulin resistance and impaired glucose tolerance in overweight/obese adolescents attending an obesity clinic in Belgium
  2127. insulin Resistance and Inflammation: Links Between obesity and Cardiovascular Disease
  2128. insulin Resistance and its Relevance with Age, Sex, Season and obesity in Darehshori Horse Breed
  2129. insulin resistance and low metabolic rate: do they cause obesity?
  2130. insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity
  2131. insulin resistance and metabolic disorders in women with morbid obesity
  2132. insulin resistance and metabolic syndrome in children with obesity
  2133. insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
  2134. insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity
  2135. insulin resistance and obesity
  2136. insulin resistance and obesity
  2137. insulin resistance and obesity affect lipid profile in the salivary glands
  2138. insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function
  2139. insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
  2140. insulin resistance and obesity in a mouse model of systemic lupus erythematosus
  2141. insulin resistance and obesity in childhood
  2142. insulin Resistance and obesity in Lupus
  2143. insulin Resistance and obesity in Mexican Youth
  2144. insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjects
  2145. insulin resistance and obesity, and their association with depression in relatively young people
  2146. insulin resistance and obesity, and their association with depression in relatively young people: findings from a large UK birth cohort
  2147. insulin resistance and obesity: how do they affect tau pathology?
  2148. insulin resistance and obesity: resistin, a hormone secreted by adipose tissue
  2149. insulin resistance and parental obesity as predictors to response to therapeutic life style change in obese children and adolescents 10–18 years old
  2150. insulin Resistance and Systemic Inflammation in Patients with Osteoarthrosis Associated with obesity: The Effectiveness of Symptomatic Slow-Acting Drugs
  2151. insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
  2152. insulin resistance and the metabolic syndrome in obese children referred to an obesity center
  2153. insulin resistance and the persistence of obesity from childhood into adulthood
  2154. insulin resistance and the renin-angiotensin-aldosterone system in metabolic syndrome and obesity-related hypertension
  2155. insulin resistance and the severity of coronary artery disease based on obesity status in stable-angina patients: A cross-sectional analysis
  2156. insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with …
  2157. insulin resistance and upper-body obesity in polycystic ovary syndrome
  2158. insulin resistance and visceral fat obesity in hyperlipidemia
  2159. insulin resistance as a characteristic of hypertension with overweight/obesity in Shanghai Chinese
  2160. insulin resistance as common molecular denominator linking obesity to Alzheimer’s disease
  2161. insulin resistance as key factor for linking modulation of gut microbiome to health claims and dietary recommendations to tackle obesity
  2162. insulin resistance associated to obesity: the link TNF-alpha
  2163. insulin resistance associates with hepatic lobular inflammation in subjects with obesity
  2164. insulin resistance contributes to obesity-related proteinuria
  2165. insulin resistance contribution to pathogenesis of cardiac remodeling in patients with hypertension in combination with obesity and type 2 diabetes
  2166. insulin resistance due to obesity
  2167. insulin Resistance for Adolescents with obesity in Latvia
  2168. insulin resistance in aging is related to abdominal obesity
  2169. insulin Resistance in Aging ls Related to Abdominal obesity
  2170. insulin resistance in childhood obesity
  2171. insulin resistance in childhood obesity.
  2172. insulin Resistance in Children and Adolescents with Exogen-Constitutional obesity
  2173. insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity
  2174. insulin resistance in children and teenagers with exogenous constitutive obesity
  2175. insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity
  2176. insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity
  2177. insulin resistance in Mexican Americans—A precursor to obesity and diabetes?
  2178. insulin resistance in morbid obesity: reversal with intramyocellular fat depletion
  2179. insulin resistance in obesity
  2180. insulin resistance in obesity and hypertension: an important link with cardiovascular disease
  2181. insulin resistance in obesity and its molecular control
  2182. insulin resistance in obesity and metabolic syndrome: is there a connection with platelet l-arginine transport?
  2183. insulin resistance in obesity and noninsulin dependent diabetes mellitus.
  2184. insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies
  2185. insulin resistance in obesity as analyzed by the response of glucose kinetics to glucagon infusion
  2186. insulin resistance in obesity as the underlying cause for the metabolic syndrome
  2187. insulin resistance in obesity can be reliably identified from fasting plasma insulin
  2188. insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin
  2189. insulin resistance in obesity, type II diabetes and stress
  2190. insulin resistance in obesity: a critical analysis at enzyme level. A review.
  2191. insulin resistance in obesity: an overview of fundamental alterations
  2192. insulin resistance in obesity: body-weight or energy balance?
  2193. insulin resistance in obesity: metabolic mechanisms and measurement methods
  2194. insulin resistance in obesity: pathogenesis and effects
  2195. insulin resistance in obesity: Targeting the Molecular Mechanisms of Metabolic Disease
  2196. insulin resistance in patients with stroke is related to visceral fat obesity and adipocytokines
  2197. insulin Resistance in Pima Indians: A Combined Effect of Genetic Predisposition and obesity‐related Skeletal Muscle Cell Hypertrophy
  2198. insulin Resistance In Semi-Urban South Western Nigeria And It’s Relationship With Indices Of obesity
  2199. insulin resistance in the defense against obesity
  2200. #VALUE!
  2201. insulin resistance in type 2 diabetes and obesity: implications for endothelial function
  2202. insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation
  2203. insulin resistance in very low birth weight infants progresses during childhood without aggravation of obesity or dyslipidaemia
  2204. insulin resistance in visceral obesity
  2205. insulin resistance in women with polycystic ovary syndrome contributed to cardiovascular disease risk factors independent of obesity.
  2206. insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
  2207. insulin resistance is a characteristic feature of primary hypertension independent of obesity
  2208. insulin Resistance Is a Late Manifestation of Ovariectomy in Mice That Occurs in the Absence of obesity but Is Associated With Adipose Tissue Inflammation
  2209. insulin resistance is associated with arterial stiffness independent of obesity in male adolescents
  2210. insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese
  2211. insulin resistance is associated with gut permeability without the direct influence of obesity in young adults
  2212. insulin resistance measured by QUICKI and obesity in type 2 diabetic patients
  2213. insulin resistance measured by the triglyceride-glucose index and risk of obesity-related cancers: An epidemiological investigation in more than 500,000 individuals.
  2214. insulin resistance might link obesity and congestive heart failure
  2215. insulin resistance modifies the association between obesity and current asthma in adults
  2216. insulin Resistance Modifies the Association Between obesity and Current Asthma in Adults
  2217. insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
  2218. insulin resistance of human adipose tissue in obesity measured with [18F] FDG and PET
  2219. insulin resistance pathogenesis in metabolic obesity
  2220. insulin resistance study in diabetes mellitus type II and its correlation with obesity
  2221. insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications
  2222. insulin resistance syndrome and Alzheimer’s disease: age-and obesity-related effects on memory, amyloid, and inflammation
  2223. insulin resistance syndrome and obesity
  2224. insulin RESISTANCE SYNDROME IN PAEDIATRIC obesity.
  2225. insulin resistance syndrome including obesity, premature pubarche and polycystic ovary syndrome
  2226. insulin resistance versus insulin secretion in the hypertension of obesity.
  2227. insulin resistance via modification of PGC1α function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state of obesity. A double …
  2228. insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess
  2229. insulin resistance without obesity induced by cotton pellet granuloma in mice
  2230. insulin resistance–a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential …
  2231. insulin Resistance-associated Impairment Of Preadipocyte Differentiation In Human Abdominal obesity
  2232. insulin resistance, atherogenic dyslipidemia and other atherogenic factors in simple obesity and obesity with Acanthosis nigricans (an) in childhood
  2233. insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus
  2234. insulin resistance, central obesity, and risk of colorectal adenomas
  2235. insulin resistance, endothelial function, fibrinolytic activity, and markers of obesity in children
  2236. insulin resistance, glucose regulation, obesity and mood: A review of the literature.
  2237. insulin resistance, glucose regulation, obesity, and mood.
  2238. insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity
  2239. insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity
  2240. insulin resistance, hyperinsulinemia, and LH: relative roles in peripubertal obesity-associated hyperandrogenemia
  2241. insulin Resistance, Hyperinsulinemia, and LH: Relative Roles in Peripubertal obesity-Associated Hyperandrogenemia
  2242. insulin resistance, hyperinsulinemia, and obesity-associated hypertension.
  2243. insulin resistance, impaired postprandial lipid metabolism and abdominal obesity
  2244. insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism
  2245. insulin resistance, insulin response, and obesity as indicators of metabolic risk
  2246. insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity
  2247. insulin resistance, obesity and breast cancer risk
  2248. insulin resistance, obesity and diabetes: the connection
  2249. insulin resistance, obesity and hypertension
  2250. insulin resistance, obesity and hypertension: an overview
  2251. insulin resistance, obesity and hypertension: is the link waist circumference?
  2252. insulin resistance, obesity and hypovitaminosis D adversely affect pregnancy utcome: Can Supplemental vitamin D cut this risk?
  2253. insulin resistance, obesity and lipotoxicity
  2254. insulin resistance, obesity and the metabolic syndrome.
  2255. insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?
  2256. insulin resistance, obesity indices and lipid profile in Nigerian patients with type 2 diabetes mellitus
  2257. insulin resistance, obesity, and liver cancer
  2258. insulin resistance, obesity, and metabolic syndrome among non-diabetic pre-and post-menopausal women in North Taiwan
  2259. insulin Resistance, obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
  2260. insulin resistance, obesity, hypertension, and renal sodium transport
  2261. insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age< or= 14 years, 13 with …
  2262. insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions
  2263. insulin resistance, obesity, metabolic syndrome, and lifestyle modification
  2264. insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity
  2265. insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity
  2266. insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis)
  2267. insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity
  2268. insulin RESISTANCE, TUMOR NECROSIS FACTOR-ALPHA IN obesity-ASSOCIATED HYPERTENSION: PP. 34.367
  2269. insulin resistance, β-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus
  2270. insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis
  2271. insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
  2272. insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1
  2273. insulin resistance: Lessons from animal models of obesity
  2274. insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus
  2275. insulin Resistance: The Linchpin Between obesity and obesity-Related Metabolic Abnormalities
  2276. insulin resistance: the link between obesity and cardiovascular disease
  2277. insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular …
  2278. insulin response to a rapid intravenous injection of dextrose in patients with anorexia nervosa and obesity
  2279. insulin response to a spontaneously ingested standard meal during the development of obesity in GTG-injected mice.
  2280. insulin response to an intravenous glucose load during development of obesity in gold thioglucose-injected mice
  2281. insulin response to glucagon: the opposing effects of diabetes and obesity
  2282. insulin response to high intensity interval training versus resistive training in post menopusal obesity
  2283. insulin responsiveness in vitro of diaphragm and adipose tissue from weanling rats with hypothalamic obesity
  2284. insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity
  2285. insulin secretion and body composition in obesity
  2286. insulin secretion and carbohydrate tolerance in childhood obesity
  2287. insulin secretion in childhood obesity
  2288. insulin secretion in experimental obesity
  2289. insulin secretion in human obesity: effects of prolonged fasting and refeeding.
  2290. insulin secretion in hypothalamic obesity: Diurnal variation and the effect of naloxone
  2291. insulin secretion in obesity
  2292. insulin secretion in obesity after exercise
  2293. insulin secretion in obesity and diabetes: an illustrative case
  2294. insulin secretion, insulin resistance, and obesity
  2295. insulin secretion, obesity, and potential behavioral influences: results from the insulin Resistance Atherosclerosis Study (IRAS)
  2296. insulin secretion, peripheral insulin sensitivity and insulin-receptor binding in subjects with different degrees of obesity
  2297. insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
  2298. insulin sensitivity affects propensity to obesity in an ethnic-specific manner: results from two controlled weight loss intervention studies
  2299. insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the insulin Resistance and Atherosclerosis Study
  2300. insulin sensitivity and carbohydrate metabolism of rats with hypothalamic obesity
  2301. insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma
  2302. insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain
  2303. insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity
  2304. insulin sensitivity from preschool to school age in patients with severe obesity
  2305. insulin sensitivity in anorexia nervosa: a mirror image of obesity?
  2306. insulin sensitivity in Chinese: Inter-relations with obesity and other components of the metabolic syndrome.
  2307. insulin sensitivity M ratio and IRI/G ratio in patients with hypertension and obesity
  2308. insulin sensitivity of adipocytes from inbred mouse strains resistant or sensitive to diet-induced obesity
  2309. insulin sensitivity of the body in experimental hypothalamic obesity
  2310. insulin sensitivity predictions in individuals with obesity and type II diabetes mellitus using mathematical model of the insulin signal transduction pathway
  2311. insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study
  2312. insulin Sensitization and Anti‐obesity Effects of Astragalus Polysaccharide on High Fat Diet‐fed C57BL/6J Mice
  2313. insulin signal transduction and glucose transport in human adipocytes: effects of obesity and low calorie diet
  2314. insulin status and vascular responses to weight loss in obesity
  2315. insulin suppresses TNF-dependent early osteoarthritic changes associated with obesity and type 2 diabetes
  2316. insulin translates unfavourable lifestyle into obesity
  2317. insulin Treatment, Type 2 Diabetes and obesity
  2318. insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
  2319. insulin-and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations
  2320. insulin-dependent activation of MCH neurons impairs locomotor activity and insulin sensitivity in obesity
  2321. insulin-dependent metabolism of branched-chain amino acids in obesity
  2322. insulin-Induced Free IGF-I Suppression is Lost in obesity
  2323. insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
  2324. insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone
  2325. insulin-like growth factor 1 related to chronic low-grade inflammation in patients with obesity and early change of its levels after laparoscopic sleeve gastrectomy
  2326. insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children
  2327. insulin-like growth factor and its dynamics in babies born from mothers with obesity
  2328. insulin-like growth factor binding protein-1, non-alcoholic fatty liver disease, and its relationship with fructose consumption in children with obesity
  2329. insulin-like growth factor binding protein-3 (IGFBP-3) enhances obesity-related breast tumorigenesis
  2330. insulin-like growth factor binding protein-3 links obesity and breast cancer progression
  2331. insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children
  2332. insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity
  2333. insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)
  2334. insulin-mediated sympathoexcitation in obesity and type 2 diabetes
  2335. insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity
  2336. insulin-receptor interaction on liver cell membranes and isolated adipocytes of rats in experimental obesity
  2337. insulin-regulated aminopeptidase in adipocyte is Cys-specific and affected by obesity
  2338. insulin-sensitive obesity
  2339. insulin-Sensitive obesity
  2340. insulin-sensitive obesity in humans–a ‘favorable fat’phenotype?
  2341. insulin-Sensitive obesity: Prospective and Interventional Studies
  2342. insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes
  2343. insulin-stimulated protein kinase C λ/ζ activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction
  2344. insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity
  2345. insulin‐like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma
  2346. insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
  2347. insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in obesity
  2348. insulin, central dopamine D2 receptors, and monetary reward discounting in obesity
  2349. insulin, ghrelin and early return of hunger in women with obesity and polycystic ovary syndrome
  2350. insulin, insulin resistance, obesity, and cancer
  2351. insulin, Leptin and Ghrelin in obesity with and without Hypertension.
  2352. insulin, obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia.
  2353. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity
  2354. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity
  2355. Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores
  2356. Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity
  2357. Interaction connecting Leptin-obesity–insulin dependent diabetes mellitus
  2358. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with obesity and lifestyle factors on postmenopausal breast cancer risk
  2359. Interaction of sex steroid hormones and obesity on insulin resistance and type 2 diabetes in men: the Third National Health and Nutrition Examination Survey
  2360. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 diabetes: studies with …
  2361. Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational …
  2362. Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
  2363. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity
  2364. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia
  2365. Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia
  2366. INTERACTIVE EFFECTS OF obesity AND OVARIAN STEROIDS ON insulin PHYSIOLOGY IN CATTLE AND SHEEP.
  2367. Intercellular adhesion molecule 1, ICAM-1, in polycystic ovary syndrome: relationship to insulin resistance or obesity
  2368. Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans
  2369. Interferon activated gene 202b (Ifi202b) promotes Zfp432 expression and suppresses the thermogenic gene program resulting in obesity and insulin resistance
  2370. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
  2371. Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization
  2372. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents
  2373. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
  2374. Interleukin-6 depletion selectively improves hepatic insulin action in obesity
  2375. Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance
  2376. Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia
  2377. INTERLEUKIN‐10 DEFICIENCY LIMITS THE DEVELOPMENT OF obesity AND insulin RESISTANCE PRODUCED BY A HIGH FAT DIET
  2378. Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice
  2379. Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure
  2380. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance
  2381. Interplay between gut microbiota and p66Shc affects obesity‐associated insulin resistance
  2382. Interplay of an obesity-based genetic risk score with dietary and endocrine factors on insulin resistance
  2383. Intertissue communication in the pathogenesis of insulin resistance in obesity and type 2 diabetes
  2384. Intestinal FABP2 A54T Polymorphism: Association with insulin Resistance and obesity in Women
  2385. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
  2386. Intestinal Microbiota and Bacterial Translocation: Impact of Diet, obesity and insulin Resistance
  2387. Intestinal microbiota contributes to energy balance, metabolic inflammation, and insulin resistance in obesity
  2388. Intestinal Microbiota, obesity and insulin Resistance—What Are the Relationships?
  2389. Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
  2390. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice
  2391. Intra-Placental Gene Transfer of Human insulin-Like Growth Factor-1 Prevents obesity in an Intra-Uterine Growth Restricted Model Exposed to High Fat Diet …
  2392. Intra-Placental Gene Transfer of Human insulin-Like Growth Factor-1 Reprograms Fetal Predisposition to obesity in Intra-uterine Growth Restriction
  2393. Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes
  2394. Intracellular lipid accumulation and insulin sensitivity in muscle and liver: Fighting against “intracellular obesity”
  2395. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic‐mediated obesity and insulin resistance
  2396. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity
  2397. Intramuscular lipid metabolism, insulin action, and obesity
  2398. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity
  2399. Intranasal targeting of hypothalamic PTP1B and TCPTP reinstates leptin and insulin sensitivity and promotes weight loss in obesity
  2400. Intrauterine influences on obesity and insulin resistance in pre-pubertal children.
  2401. Inverse relationship of the CMKLR1 relative expression and chemerin serum levels in obesity with dysmetabolic phenotype and insulin resistance
  2402. Investigating the onset of insulin resistance and non-alcoholic fatty liver disease in obesity-induced cardiac dysfunction
  2403. Investigating the role of Class-1 Phosphoinositide 3 Kinases (PI3Ks) in insulin signaling and obesity
  2404. Investigating the role of insulin-like growth factor binding protein-2 (IGFBP-2) in childhood obesity and Type 2 Diabetes
  2405. Investigating the Wnt/β-catenin Pathway in Conventional Dendritic cells in obesity-Induced Tissue Inflammation and insulin Resistance
  2406. Investigation of DNA Methylation in obesity and its Underlying insulin Resistance
  2407. Investigation of Relationship between Leptin and insulin Resistance in obesity [J]
  2408. Investigation of the association between obesity and insulin-induced gene 1 polymorphism at 7q36. 3 region in Uygur population in Xinjiang, China
  2409. Investigation of the relationship between genetic and environmental risk factors associated with obesity and insulin resistance in South African patients with non …
  2410. Investigation on the relationships among blood zinc, copper, insulin and thyroid hormones in non-insulin dependent diabetes mellitus and obesity
  2411. Involvement of adipocytokines in pathogenesis of insulin resistance, obesity, and metabolic syndrome
  2412. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
  2413. Involvement of protein phosphatase 5 (pp5) in diet-induced obesity and insulin resistance
  2414. Inward Glucose Transfer Accounts for insulin‐Dependent Increase in Brain Glucose Metabolism Associated with Diet‐Induced obesity
  2415. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity
  2416. iRhom2 serves as a facilitator in obesity by enhancing adipose inflammation and insulin resistance
  2417. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
  2418. Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations
  2419. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance
  2420. Is Absence of Carbohydrate Metabolism Disorders in Patients with Prolonged History of obesity due to Low insulin Resistance or Preserved insulin Secretion?
  2421. Is Exposure to Bisphenol‐A and Phthalates Associated with obesity, Metabolic Disturbances and insulin Resistance among US adults?
  2422. Is insulin the link between hypertension and obesity?
  2423. Is insulin-dependent diabetes and obesity a predisposition for endometrial and pancreatic carcinoma?
  2424. Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension?
  2425. #VALUE!
  2426. Is leptin the link between obesity and insulin resistance?
  2427. Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
  2428. Is obesity-related insulin status the cause of blunted growth hormone secretion in turner’s syndrome?
  2429. Is salivary gland function altered in noninsulin-dependent diabetes mellitus and obesity–insulin resistance?
  2430. #VALUE!
  2431. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius
  2432. Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats
  2433. Islet insulin secretion, β-cell mass, and energy balance in a polygenic mouse model of type 2 diabetes with obesity
  2434. Jaboticaba peel powder and jaboticaba peel aqueous extract reduces obesity, insulin resistance and hepatic fat accumulation in rats
  2435. Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling
  2436. JNK activation of BIM promotes hepatic oxidative stress, steatosis, and insulin resistance in obesity
  2437. JNK at the crossroad of obesity, insulin resistance, and cell stress response
  2438. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation
  2439. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity
  2440. Joint Effects of obesity and Vitamin D Deficiency on insulin Resistance and Type 2 Diabetes
  2441. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001–2006
  2442. #VALUE!
  2443. Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation.
  2444. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity
  2445. Kinome profiling reveals abnormal activity of kinases in skeletal muscle from adults with obesity and insulin resistance
  2446. KLF10 Deficiency in CD4+ T Cells Triggers obesity, insulin Resistance, and Fatty Liver
  2447. Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
  2448. Korean diet prevents obesity and ameliorates insulin resistance in mice fed a high-fat diet
  2449. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation
  2450. L-PGDS-produced PGD 2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
  2451. L-pGDs-produced pGD2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
  2452. L-PGDS-produced PGD2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
  2453. Labrador tea (Rhododendron groenlandicum) attenuates insulin resistance in a diet-induced obesity mouse model
  2454. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis
  2455. Lack of association between endothelial nitric oxide synthase glu298Asp variation, visceral obesity and insulin related phenotypes in Turkish type 2 diabetic …
  2456. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile
  2457. Lack of dietary regulation of jejunal glycolytic enzymes and disaccharidases in obesity: the role of insulin
  2458. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance
  2459. Lack of Uncoupling Protein 3 Protects from High‐Fat Diet‐Induced obesity, Systemic Inflammation and insulin Resistance in Rats
  2460. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity.
  2461. Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid …
  2462. Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans
  2463. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome …
  2464. Latent inflammation and defect in adipocyte renewal as a mechanism of obesity-associated insulin resistance
  2465. Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, insulin Resistance, and Non-Alcoholic Fatty Liver Disease in obesity
  2466. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance
  2467. Lecithin cholesterol acyltransferase deficiency protects from diet-induced insulin resistance and obesity—novel insights from mouse models
  2468. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple …
  2469. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance
  2470. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance
  2471. Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg Project in Sweden
  2472. Lemon Balm Extract ALS-L1023 Regulates obesity and Improves insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice
  2473. Leptin and insulin resistance in patients with osteoarthritis combined with obesity and the dynamics of their levels on the background of treatment with symptomatic …
  2474. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus
  2475. Leptin in relation to hypertension: The role of obesity in the insulin resistance atherosclerosis study (IRAS)
  2476. Leptin Indicates obesity and insulin Resistance in Men
  2477. Leptin-to-adiponectin ratio is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese: a cross-sectional …
  2478. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity
  2479. Leptin, insulin, and obesity‐related Phenotypes: Genetic Influences on Levels and Longitudinal Changes
  2480. Letter regarding article,“Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis”
  2481. Leucocyte sodium pump activity after meals or insulin in normal and obese subjects: cause for increased energetic efficiency in obesity?
  2482. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance
  2483. Level of beta endorphins and insulin in blood of obese subjects. Effect of surgical treatment for obesity on higher exchange parameters
  2484. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors
  2485. Lifestyle modification in the management of insulin resistance states in overweight/obesity: the role of exercise training
  2486. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey …
  2487. Lifestyle, obesity, and insulin resistance
  2488. Limited contribution of insulin resistance and metabolic parameters to obesity-associated increases in ambulatory blood pressure in a black African …
  2489. Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity
  2490. Link between omentin‐1, obesity and insulin resistance in children: Findings from a longitudinal intervention study
  2491. Link between the obesity and insulin resistance with lipid profile in women polycystic ovary syndrome
  2492. Linking gut microbiota and inflammation to obesity and insulin resistance
  2493. Linking maternal obesity to early insulin resistance
  2494. Links between body mass index, total body fat, cholesterol, high‐density lipoprotein, and insulin sensitivity in patients with obesity related to depression, anger, and …
  2495. Links between inflammation and insulin resistance in children with morbid obesity and metabolic syndrome
  2496. Links between obesity-induced brain insulin resistance, brain mitochondrial dysfunction, and dementia
  2497. Lipid induced macrophage inflammation: implications for obesity induced insulin resistance
  2498. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and …
  2499. Lipid-adjusting Therapy can Enforce insulin Sensitivity of Type 2 Diabetes Mellitus Patients with obesity [J]
  2500. Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults
  2501. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity
  2502. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
  2503. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
  2504. Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents
  2505. Lipoprotein abnormalities in hirsute women II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity
  2506. Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery
  2507. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity
  2508. Liquid sucrose consumption promotes obesity and impairs glucose tolerance without altering circulating insulin levels
  2509. Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway
  2510. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance
  2511. Liver attenuation, pericardial adipose tissue, obesity, and insulin resistance: the Multi‐Ethnic Study of Atherosclerosis (MESA)
  2512. Liver fibrosis and insulin resistance in patients with hypertension, associated with obesity
  2513. Liver insulin receptor tyrosine kinase activity in a rat model of type II diabetes mellitus and obesity
  2514. Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance
  2515. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity
  2516. Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1
  2517. LncRNA TUG1 reduces inflammation and enhances insulin sensitivity in white adipose tissue by regulating miR-204/SIRT1 axis in obesity mice
  2518. LNK deficiency decreases obesity-induced insulin resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue
  2519. Localization of insulin-2 (Ins-2) and the obesity mutant tubby (tub) to distinct regions of mouse chromosome 7
  2520. Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity
  2521. Long term but not short term exposure to obesity related microbiota promotes host insulin resistance
  2522. Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises
  2523. Long-term consumption of Platycodi radix ameliorates obesity and insulin resistance via the activation of AMPK pathways
  2524. Long-term dysbiosis promotes insulin resistance during obesity despite rapid diet-induced changes in the gut microbiome of mice
  2525. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis
  2526. Long-Term Ingestion of Monosodium L-Glutamate Did Not Induce obesity, Dyslipidemia or insulin Resistance: A Two-Generation Study in Mice
  2527. Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study
  2528. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity
  2529. Long‐Term β‐galacto‐oligosaccharides Supplementation Decreases the Development of obesity and insulin Resistance in Mice Fed a Western‐Type Diet
  2530. Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity
  2531. Loss of Epac2 results in premature obesity and insulin resistance
  2532. Loss of estrogen receptor α signaling leads to insulin resistance and obesity in young and adult female mice
  2533. Loss of FoxOs in muscle reveals sex-based differences in insulin sensitivity but mitigates diet-induced obesity
  2534. Loss of fractalkine-CX3CR1 signaling exacerbates obesity-induced adipose tissue inflammation and insulin resistance through M1 dominant shift in macrophages
  2535. Loss of function mutation in toll-like receptor-4 does not offer protection against obesity and insulin resistance induced by a diet high in trans fat in mice
  2536. Loss of growth hormone–mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity
  2537. Loss of hepatic CEACAM1: a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease
  2538. Loss of insulin response to ingested amino acids after jejunoileal bypass surgery for morbid obesity
  2539. Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice
  2540. Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation
  2541. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling
  2542. Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced obesity and insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure
  2543. Loss of mitochondrial protease ClpP protects mice from diet‐induced obesity and insulin resistance
  2544. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced obesity and insulin Resistance despite Long-Chain Acylcarnitine Accumulation
  2545. Loss of nucleobindin-2 causes insulin resistance in obesity without impacting satiety or adiposity
  2546. Loss of prion protein is associated with the development of insulin resistance and obesity
  2547. Loss of protein kinase Cβ function protects mice against diet‐induced obesity and development of hepatic steatosis and insulin resistance
  2548. Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance
  2549. Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis
  2550. Loss of transcriptional repression by BCL6 confers insulin sensitivity in the setting of obesity
  2551. Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling
  2552. Loss of Uncoupling Protein 3 Attenuates Western Diet–Induced obesity, Systemic Inflammation, and insulin Resistance in Rats
  2553. Loss-of-function mutation in myostatin reduces tumor necrosis factor α production and protects liver against obesity-induced insulin resistance
  2554. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance
  2555. Low 25‐hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery
  2556. Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a …
  2557. #VALUE!
  2558. Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia
  2559. Low concentrations of insulin-like growth factor-I in abdominal obesity.
  2560. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes
  2561. Low doses of cocoa extract supplementation ameliorate diet-induced obesity and insulin resistance in rats
  2562. Low insulin-like growth factor-1 level in obesity nephropathy: a new risk factor?
  2563. Low intrinsic aerobic fitness increases susceptibility to OVX‐induced obesity and insulin resistance in the absence of adipose tissue inflammation (1028.3)
  2564. Low number of insulin receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-induced obesity
  2565. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome
  2566. Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus
  2567. Low-calorie sweeteners augment tissue-specific insulin sensitivity in a large animal model of obesity
  2568. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths
  2569. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity
  2570. Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial
  2571. Low-grade inflammation, obesity, and insulin resistance in adolescents
  2572. Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus
  2573. Low-Molecular-Weight Acid Phosphatase (ACPI), obesity, and Blood Lipid Levels in Subjects with Non-insulin-Dependent Diabetes Mellitus
  2574. Low‐dose diet supplement of a natural flavonoid, luteolin, ameliorates diet‐induced obesity and insulin resistance in mice
  2575. Lower circulating B12 is associated with higher obesity and insulin resistance during pregnancy in a non-diabetic white British population
  2576. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity
  2577. Lower Leg Fat Depots Are Associated with Albuminuria Independently of obesity, insulin Resistance, and Metabolic Syndrome (Korea National Health and …
  2578. Lower NLRP3 inflammasome activity in NAG‐1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity
  2579. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men
  2580. Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox
  2581. Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity.
  2582. Lowering saturated fat and increasing vegetable and fruit intake may increase insulin sensitivity 2 years later in children with a family history of obesity
  2583. LTB4 causes macrophage–mediated inflammation and directly induces insulin resistance in obesity
  2584. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity
  2585. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
  2586. #VALUE!
  2587. Lycopene Alleviates obesity‐Induced Inflammation and insulin Resistance by Regulating M1/M2 Status of Macrophages
  2588. Lysophosphatidic acid inhibits insulin signaling in primary rat hepatocytes via the LPA3 receptor subtype and is increased in obesity
  2589. Lysophosphatidic acid signaling in obesity and insulin resistance
  2590. Lysophosphatidic Acid Signaling in obesity and insulin Resistance
  2591. Lysosomal Nitrosative Stress Contributes to Hepatic insulin Resistance in obesity
  2592. M2 macrophages infusion ameliorates obesity and insulin resistance by remodeling inflammatory/macrophages’ homeostasis in obese mice
  2593. Macronutrient-mediated inflammation and oxidative stress: relevance to insulin resistance, obesity, and atherogenesis
  2594. Macrophage cannabinoid 1 receptor promotes obesity-induced insulin resistance and inflammation
  2595. Macrophage function in obesity-induced inflammation and insulin resistance
  2596. Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity
  2597. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity
  2598. Macrophage lamin A/C regulates inflammation and the development of obesity-induced insulin resistance
  2599. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities
  2600. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity
  2601. Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation
  2602. Macrophage-specific de novo synthesis of ceramide is dispensable for inflammasome-driven inflammation and insulin resistance in obesity
  2603. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization
  2604. Macrophages in obesity and insulin resistance
  2605. Macrophages, inflammation, adipose tissue, obesity and insulin resistance
  2606. Making of a unique birth control vaccine against hCG with additional potential of therapy of advanced stage cancers and prevention of obesity and insulin resistance
  2607. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance
  2608. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
  2609. Management of obesity in non-insulin-dependent diabetes mellitus
  2610. Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
  2611. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations
  2612. Manganese [III] tetrakis [5, 10, 15, 20]-benzoic acid porphyrin reduces adiposity and improves insulin action in mice with pre-existing obesity
  2613. Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity
  2614. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
  2615. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss
  2616. Markers of Iron Status as Predictors, Effect Modifiers and Outcomes in an RCT of Growth Hormone and Rosiglitazone for obesity and insulin Resistance in Adults …
  2617. Mass spectrometry for measuring protein secretion from insulin sensitive tissues during obesity
  2618. Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity
  2619. Maternal diet-induced obesity during suckling period programs offspring obese phenotype and hypothalamic leptin/insulin resistance
  2620. Maternal diet‐induced obesity alters muscle mitochondrial function in offspring without changing insulin sensitivity
  2621. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring
  2622. Maternal exercise attenuates the lower skeletal muscle glucose uptake and insulin secretion caused by paternal obesity in female adult rat offspring
  2623. Maternal folate status and obesity/insulin resistance in the offspring: a systematic review
  2624. Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity and insulin resistance: a prospective observational cohort study
  2625. Maternal obesity Affects the Glucose-insulin Axis During the First Trimester of Human Pregnancy
  2626. Maternal obesity and Excessive Gestational Weight Gain Alter the Maternal-Fetal insulin-Like Growth Factor Axis
  2627. Maternal obesity and western-style diet impair fetal and juvenile offspring skeletal muscle insulin-stimulated glucose transport in nonhuman primates
  2628. Maternal obesity associates with foetoplacental vascular dysfunction involving endoplasmic reticulum stress and altered insulin vascular reactivity
  2629. Maternal obesity at conception and insulin sensitivity in late gestation alters placental structure but not fetal biometry at birth in the horse
  2630. Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways
  2631. Maternal obesity has sex‐dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring
  2632. Maternal obesity in ewes results in reduced fetal pancreatic β-cell numbers in late gestation and decreased circulating insulin concentration at term
  2633. Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age
  2634. Maternal obesity leads to an inflammatory response and insulin resistance in ovarian tissuse
  2635. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti‐inflammatory and insulin‐sensitizing properties
  2636. Maternal obesity-impaired insulin signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring
  2637. Maternal pregravid obesity changes gene expression profiles toward greater inflammation and reduced insulin sensitivity in umbilical cord
  2638. Maternal prepregnancy obesity and insulin treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational …
  2639. Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring
  2640. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues
  2641. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
  2642. Maturity-onset diabetes of the young: recent findings indicate insulin resistance/obesity are not factors
  2643. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
  2644. McArdle’s disease with insulin resistance caused by obesity
  2645. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
  2646. Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin …
  2647. Measurement of obesity by anthropometry and bioelectric impedance analysis: correlation with fasting lipids and insulin resistance in an Asian population.
  2648. Mechanism of action of magnesium lithospermate B against aging and obesity-induced ER stress, insulin resistance, and inflammsome formation in the liver
  2649. Mechanism of ER stress and inflammation for hepatic insulin resistance in obesity
  2650. Mechanism of hyperglycaemia coexistence with hypertension: obesity interaction with insulin resistance approach.
  2651. Mechanism of insulin-resistance in the adipose cell in the aging-rat model of obesity
  2652. #VALUE!
  2653. Mechanism of programmed obesity: altered central insulin sensitivity in growth-restricted juvenile female rats
  2654. Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.
  2655. Mechanism Research of Reducing obesity-Induced insulin Resistance in the White Adipose Tissue by Knockdown of Neuropeptide Y Expression in the Dorsomedial …
  2656. Mechanism, treatment, and evaluation of obesity-induced insulin resistance and type 2 diabetes
  2657. Mechanisms in obesity-related hypertension: role of insulin and catecholamines
  2658. Mechanisms linking obesity to insulin resistance and type 2 diabetes
  2659. Mechanisms linking the adipocyte renin angiotensin system to obesity, inflammation and insulin resistance
  2660. Mechanisms mediating beneficial effects of Eicosapentaenoic Acid (EPA) in insulin resistance and obesity: Studies in muscle
  2661. Mechanisms of agouti-induced obesity: Effects on adipocyte metabolism and interaction with insulin.
  2662. Mechanisms of cardiovascular diseases development in obesity and insulin resistance: focus on atherothrombosis
  2663. Mechanisms of coronary dysfunction in obesity and insulin resistance
  2664. Mechanisms of insulin action and identification of defects leading to insulin resistance in maternal obesity and gestational diabetes
  2665. Mechanisms of insulin Resistance at the Crossroad of obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
  2666. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
  2667. Mechanisms of insulin resistance in obesity
  2668. Mechanisms of insulin resistance in obesity
  2669. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes
  2670. Mechanisms of macrophage activation in obesity-induced insulin resistance
  2671. Mechanisms of obesity-associated insulin resistance: many choices on the menu
  2672. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies
  2673. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM
  2674. Mechanisms underlying obesity-related insulin resistance
  2675. Mechanistic links between obesity, insulin, and cancer
  2676. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity
  2677. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
  2678. Mediators of Impaired Adipogenesis in obesity-Associated insulin Resistance and T2DM
  2679. MEDITERRANEAN DIET ADHERENCE. WHICH RELATIONSHIP WITH obesity AND insulin RESISTANCE
  2680. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance
  2681. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity.
  2682. #VALUE!
  2683. Merchanism of obesity-related hypertension: from insulin to leptin
  2684. Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance
  2685. META060 protects against diet-induced obesity and insulin resistance in a high-fat–diet fed mouse
  2686. METABOLIC CHANGES ASSOCIATED WITH obesity AND THE ROLE OF insulin
  2687. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity
  2688. Metabolic concomitants of hypophagia during recovery from insulin-induced obesity in rats
  2689. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges
  2690. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance
  2691. Metabolic dysregulation of the insulin–glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971–2008)
  2692. Metabolic endotoxemia initiates obesity and insulin resistance
  2693. Metabolic factors in the insulin resistance in human obesity
  2694. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance
  2695. Metabolic inflammation and insulin resistance in obesity
  2696. Metabolic inflammation: connecting obesity and insulin resistance
  2697. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus
  2698. Metabolic perturbations in Welsh Ponies with insulin dysregulation, obesity, and laminitis
  2699. Metabolic predispositions to laminitis in horses and ponies: obesity, insulin resistance and metabolic syndromes
  2700. Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the diogenes study and the Maastricht study
  2701. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
  2702. Metabolic syndrome and insulin resistance are associated with chronic kidney disease in nondiabetic adults with abdominal obesity
  2703. Metabolic syndrome and insulin resistance in subjects with morbid obesity
  2704. Metabolic syndrome in humans and horses: The relationship between obesity and insulin resistance
  2705. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer
  2706. Metabolic syndrome: relationship between obesity, insulin resistance and systemic hypertension in small animals.
  2707. Metabolically activated macrophages in obesity and insulin resistance
  2708. Metabolism of sphingolipids in experimental obesity and insulin resistance
  2709. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance
  2710. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non‐insulin‐dependent diabetes
  2711. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index …
  2712. Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density
  2713. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice
  2714. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesityMGL1 and obesity-induced inflammation
  2715. Mice deficient for the Sam68 RNA binding protein are protected from dietary obesity and insulin resistance
  2716. Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance
  2717. Mice Expressing Human insulin Receptors In Skeletal Muscle Are Resistant To The Development Of obesity
  2718. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity
  2719. Mice heterozygous for tumor necrosis factor-α converting enzyme are protected from obesity-induced insulin resistance and diabetes
  2720. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
  2721. Mice Lacking OPA1 in Adipose Tissue Are Resistant to Diet-Induced obesity and insulin Resistance
  2722. Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
  2723. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity
  2724. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity
  2725. Microarray gene expression profiling in obesity and insulin resistance
  2726. MicroRNA-125a-3p expression in abdominal adipose tissues is associated with insulin signalling gene expressions in morbid obesity: observations in Taiwanese
  2727. microRNA-dependent control of MODY gene expression contributes to obesity-associated insulin resistance
  2728. MicroRNAs in insulin resistance and obesity
  2729. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension
  2730. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension
  2731. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity‐associated insulin resistance and hypertension
  2732. Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance
  2733. Microvascular dysfunction: Potential role in the pathogenesis of obesity-associated hypertension and insulin resistance
  2734. Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs
  2735. Mid-upper arm circumference as a simple tool for identifying central obesity and insulin resistance in type 2 diabetes
  2736. Midkine, a potential link between obesity and insulin resistance
  2737. Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity
  2738. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance
  2739. Mind over metabolism: the cephalic phase in relation to non-insulin-dependent diabetes and obesity
  2740. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
  2741. Mineralocorticoids and cardiovascular disease in females with insulin resistance and obesity
  2742. Minor diplotypes of FMO3 might protect children and adolescents from obesity and insulin resistance
  2743. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via …
  2744. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions
  2745. miR-26b is decreased in obesity and is associated with insulin resistance and visfatin levels
  2746. miR-30a remodels subcutaneous adipose tissue inflammation to improve insulin sensitivity in obesity
  2747. MiR-377 promotes white adipose tissue inflammation and decreases insulin sensitivity in obesity via suppression of sirtuin-1 (SIRT1)
  2748. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease
  2749. miRNA signatures of insulin resistance in obesity
  2750. Mitochondrial DNA content and function, childhood obesity, and insulin resistance
  2751. Mitochondrial dysfunction in the pathogenesis of insulin resistance associated with obesity, diabetes, and aging
  2752. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance
  2753. Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice
  2754. Mitogen-Activated Protein Kinases, Inhibitory-κB Kinase, and insulin Signaling in Human Omental Versus Subcutaneous Adipose Tissue in obesity
  2755. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity
  2756. Model of high-fat diet-induced obesity associated to insulin resistance and glucose intolerance
  2757. Moderate caloric restriction in lactating rats protects offspring against obesity and insulin resistance in later life
  2758. Moderate Lactate Administration Activates Adipose Tissue Macrophage PKA-AMPKα1 Pathway to Alleviate obesity-Associated insulin Resistance in Mice
  2759. Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in …
  2760. Moderating role of cognitive ability on the obesity: inflammation: insulin resistance triplet
  2761. Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and …
  2762. Modulation of cell-mediated immunity to prevent high-fat diet-induced obesity and insulin resistance
  2763. Modulation of cell-mediated immunity to suppress high fat diet-induced obesity and insulin resistance
  2764. Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?
  2765. Modulation of heat shock factor 1 activity through silencing of Ser303/Ser307 phosphorylation supports a metabolic program leading to age-related obesity and insulin …
  2766. Modulation of HSF1 Activity Through Silencing of Ser303/Ser307 Phosphorylation Supports A Metabolic Program Leading to Age-related obesity and insulin …
  2767. Modulation of obesity and insulin Resistance by the Redox Enzyme and Adaptor Protein p66Shc
  2768. Molecular analysis of the mouse agouti gene and the role of dominant agouti-locus mutations in obesity and insulin resistance
  2769. Molecular Aspects of obesity and insulin Resistance in Metabolic Syndrome and Neurological Disorders
  2770. Molecular aspects of the link between obesity, insulin resistance and breast cancer.
  2771. Molecular Basis of Inflammation and insulin Resistance in obesity
  2772. Molecular interactions between inflammation and insulin resistance in obesity.
  2773. Molecular investigation of genetic factors associated with insulin resistance and obesity in a South African population
  2774. Molecular mechanism of insulin resistance and obesity
  2775. Molecular mechanism of insulin resistance in human obesity
  2776. Molecular mechanism of insulin resistance in obesity and type 2 diabetes
  2777. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach
  2778. Molecular mechanisms mediating the beneficial metabolic effects of [Arg4] tigerinin-1R in mice with diet-induced obesity and insulin resistance
  2779. Molecular mechanisms of insulin action in human skeletal muscle and adipose tissue: Implications for diabetes and obesity
  2780. Molecular mechanisms of insulin resistance in obesity
  2781. Molecular mechanisms of insulin resistance in obesity and type 2 diabetes mellitus
  2782. Molecular mechanisms of insulin resistance, obesity and metabolic syndrome
  2783. Molecular mechanisms underlying obesity-induced hypothalamic inflammation and insulin resistance: pivotal role of resistin/TLR4 pathways
  2784. Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus
  2785. Molecular pathways linking adipose innervation to insulin sensitivity in obesity and type 2 diabetes
  2786. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin
  2787. Monocyte chemoattractant protein 1 in obesity and insulin resistance
  2788. Monocyte chemoattractant protein‐1 in obesity and type 2 diabetes. insulin sensitivity study
  2789. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity
  2790. Monomeric Tartrate Resistant Acid Phosphatase Induces insulin Sensitive obesity
  2791. Monounsaturated fatty acid–enriched high-fat diets impede adipose NLRP3 inflammasome–mediated IL-1β secretion and insulin resistance despite obesity
  2792. Morbid obesity is associated with hepatic inflammation independent of liver fat content and insulin sensitivity
  2793. Moringa olifeira Lam. stimulates activation of the insulin-dependent akt pathway. Antidiabetic effect in a diet-induced obesity (DIO) mouse model
  2794. Morning circadian misalignment is associated with insulin resistance in girls with obesity and polycystic ovarian syndrome
  2795. MR Spectroscopy in obesity and its Complications: Diabetes and insulin Resistance
  2796. mRNA expression of diacylglycerol kinase isoforms in insulin‐sensitive tissues: effects of obesity and insulin resistance
  2797. MRP14 enhances the ability of macrophage to recruit T cells and promotes obesity-induced insulin resistance
  2798. Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment
  2799. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity
  2800. Multiple Abnormalities of Myocardial insulin Signaling in Pigs with Diet-Induced obesity
  2801. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short-and long …
  2802. Multiple Sclerosis and obesity. insulin Impairs IL-10-Mediated Regulatory T Cell Function (P1. 372)
  2803. Munc18c in adipose tissue is downregulated in obesity and is associated with insulin
  2804. Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4
  2805. Muscle insulin Resistance in Youth with obesity and Normoglycemia is Associated with Altered Fat Metabolism
  2806. Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment
  2807. Muscle mitochondrial oxidative phosphorylation activity, but not content, is altered with abdominal obesity in sedentary men: synergism with changes in insulin …
  2808. Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation and insulin resistance in mice with diet-induced obesity
  2809. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
  2810. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance
  2811. Myeloid RAGE Downregulates Lipid Metabolism in Obese Adipose Tissue and Increases Whole-Body obesity and insulin Resistance
  2812. Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity
  2813. Myeloperoxidase deletion prevents high-fat diet–induced obesity and insulin resistance
  2814. Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity?
  2815. Myocardial metabolism and cardiac performance in obesity and insulin resistance
  2816. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance
  2817. Myostatin as a Potential Therapeutic Target for obesity and insulin Resistance
  2818. Myostatin blockade with a form of the ActRIIB receptor has potent anti‐obesity and insulin sensitizing actions
  2819. Myostatin knockout mice are protected from high-fat diet induced obesity and insulin resistance.
  2820. Myricanol modulates skeletal muscle–adipose tissue crosstalk to alleviate high‐fat diet‐induced obesity and insulin resistance
  2821. Myricetin-induced brown adipose tissue activation prevents obesity and insulin resistance in db/db mice
  2822. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
  2823. N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats
  2824. Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance
  2825. NADPH Oxidase and (-)-Epicatechin in the Modulation of obesity-Associated insulin Resistance
  2826. NDUFAB1 protects against obesity and insulin resistance by enhancing mitochondrial metabolism
  2827. Neck and wrist circumferences propose a reliable approach to qualify obesity and insulin resistance
  2828. Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity
  2829. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin
  2830. Neonates from women with pregestational maternal obesity show reduced umbilical vein endothelial response to insulin
  2831. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance
  2832. NESFATINEMIA AND insulin RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND obesity
  2833. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity
  2834. Netrin-1 Promotes Macrophage Accumulation and insulin Resistance in obesity
  2835. Networking pathways unveils association between obesity and non-insulin dependent diabetes mellitus
  2836. Neural correlates of stress-and food cue–induced food craving in obesity: association with insulin levels
  2837. Neuroendocrine factors regulating blood glucose, plasma FFA and insulin in the development of obesity
  2838. NEUROENDOCRINE MODEL OF obesity WORSEN insulin RESISTANCE OF SPONTANEOUSLY HYPERTENSIVE RATS: A NEW MODEL OF TYPE 2 …
  2839. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity
  2840. Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity
  2841. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance
  2842. Neutrophil elastase is a key player in inflammation, obesity, and insulin resistance
  2843. New developments in diabetes obesity and insulin resistance.
  2844. New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance
  2845. New insights into the role of serum amyloid A (SAA) on obesity and insulin resistance
  2846. New insights into TNFα/PTP1B and PPARγ pathway through RNF213-a link between inflammation, obesity, insulin resistance, and Moyamoya disease.
  2847. New insights into TNFα/PTP1B and PPARγ pathway through RNF213-a link between inflammation, obesity, insulin resistance, and Moyamoya disease
  2848. Newly identified set of obesity‐related genotypes and abdominal fat influence the risk of insulin resistance in a Korean population
  2849. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the …
  2850. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity
  2851. NK cells in human visceral adipose tissue contribute to obesity‐associated insulin resistance through low‐grade inflammation
  2852. NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
  2853. NK cells link obesity-induced adipose stress to inflammation and insulin resistance
  2854. NK cells link obesity-induced adipose tissue stress to inflammation and insulin resistance
  2855. NLRP3 inflammasome regulates obesity induced systemic inflammation and insulin signaling (117.4)
  2856. No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease
  2857. No decrease in free IGF‐I with increasing insulin in obesity‐related insulin resistance
  2858. No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hsaa1+ …
  2859. No evidence for involvement of the calpain-10 genehigh-risk’haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity
  2860. No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus
  2861. No need to sweat: is dieting enough to alleviate insulin resistance in obesity?
  2862. No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity
  2863. NO to Lysosomes: A Signal for insulin Resistance in obesity
  2864. NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity?
  2865. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice
  2866. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss
  2867. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
  2868. Non-insulin-dependent (Type II) diabetes mellitus and obesity in Asians in UK-scope for future studies
  2869. Non-insulin-dependent diabetes and obesity in the black and Hispanic population: culturally sensitive management
  2870. Non-insulin-dependent diabetes mellitus and visceral obesity: Italian epidemiologic study and analysis of risk factors
  2871. Non-insulin-dependent diabetes mellitus in the elderly: influence of obesity and physical inactivity
  2872. Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: relationship with insulin resistance
  2873. Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
  2874. Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis, inflammation, obesity and insulin resistance
  2875. Nonirritative lesions of VMH: effects on plasma insulin, obesity, and hyperreactivity
  2876. Norathyriol reverses obesity-and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B
  2877. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country
  2878. #VALUE!
  2879. Normalization of obesity-associated insulin resistance through immunotherapy
  2880. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance
  2881. Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance
  2882. Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study
  2883. Novel mechanisms of insulin resistance and weight gain in diet induced obesity
  2884. Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’
  2885. Novel phosphorylation of PPARγ ameliorates obesity-induced adipose tissue inflammation and improves insulin sensitivity
  2886. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
  2887. Nuclear factor-κB (NF-κB) expression in high fat diet-induced obesity and insulin resistance in rats.
  2888. Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance
  2889. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated …
  2890. Nucleic acid-targeting pathways promote inflammation in obesity-related insulin resistance
  2891. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension
  2892. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics
  2893. Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice
  2894. NYGGF4 as a new therapeutic target for obesity-associated insulin resistance
  2895. O-1: The leptin-insulin axis: Interactions in the development of obesity and diabetes
  2896. Obes Surg.: Metabolic syndrome and insulin resistance in subjects with morbid obesity
  2897. obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions
  2898. obesity affects myocardial vasoreactivity and coronary flow response to insulin
  2899. obesity Alters Aortic Vasorelaxation Mediated by insulin and insulin‐like Growth Factor‐1
  2900. obesity Amplifies the Sympathoexcitatory Response to insulin in Male, but not Female, Rats: Role of Neuropeptide Y Inputs into the Paraventricular Nucleus
  2901. obesity and adipose tissue distribution in men: relation to sex steroids and insulin
  2902. obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin
  2903. obesity and arterial hypertension. Relation between insulin secretion, peripheral insulin resistance and pressure indices
  2904. obesity and autonomic neuropathy in non-insulin-dependent diabetes mellitus
  2905. obesity and cancer risk: the role of the insulin–IGF axis
  2906. obesity and cancer, a case for insulin signaling
  2907. obesity and chronic leptin resistance foster insulin resistance: An analytical overview
  2908. obesity and diabetes: pathophysiology of obesity-induced hyperglycemia and insulin resistance
  2909. obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings
  2910. obesity and fatty acids in the etiology of insulin resistance
  2911. obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women
  2912. obesity and high blood pressure: a clinical phenotype for the insulin resistance syndrome in African Americans
  2913. obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal …
  2914. obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver
  2915. obesity and insulin levels
  2916. obesity and insulin resistance
  2917. obesity and insulin resistance
  2918. obesity and insulin resistance
  2919. obesity and insulin resistance
  2920. obesity and insulin Resistance
  2921. obesity and insulin resistance (IR) negativley impact cumulus oocyte complex (COC) quality
  2922. obesity and insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
  2923. obesity and insulin resistance after chemotherapy in patients with acute lymphoblastic leukemia
  2924. obesity and insulin resistance among adolescents from Chiapas
  2925. obesity and insulin resistance among infertile women with polycystic ovarian syndrome
  2926. obesity and insulin resistance are associated with reduced activity in core memory regions of the brain
  2927. obesity and insulin resistance are inversely associated with serum and adipose tissue carotenoid concentrations in adults
  2928. obesity and insulin resistance are significant predictors of serum leptin levels
  2929. obesity and insulin resistance are the central issues in prevention of and care for comorbidities
  2930. obesity and insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome.
  2931. obesity and insulin resistance as risk factors for chronic kidney disease
  2932. obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS
  2933. obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
  2934. obesity and insulin Resistance in Adolescents
  2935. obesity and insulin Resistance in Adolescents
  2936. obesity and insulin resistance in adolescents: impact of renin angiotensin system
  2937. obesity and insulin resistance in apparently healthy Korean men
  2938. obesity and insulin resistance in breast cancer–chemoprevention strategies with a focus on metformin
  2939. obesity and insulin resistance in childhood
  2940. obesity and insulin Resistance in Childhood
  2941. obesity and insulin resistance in childhood and adolescence
  2942. obesity and insulin resistance in children
  2943. obesity and insulin resistance in children
  2944. obesity and insulin resistance in children.
  2945. obesity and insulin resistance in human growth hormone transgenic rats
  2946. obesity and insulin resistance in humans: a dose-response study
  2947. obesity and insulin resistance in nonalcoholic fatty liver
  2948. obesity and insulin resistance in patients with non-alcoholic fatty liver disease diagnosed by non invasive diagnostic methods
  2949. obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy
  2950. obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.
  2951. obesity and insulin resistance in resistant hypertension: implications for the kidney
  2952. obesity and insulin resistance in Swedish subjects
  2953. obesity and insulin resistance in the obese-hyperglycemic mouse (obob)
  2954. obesity and insulin resistance in women with polycystic ovary syndrome
  2955. obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome
  2956. obesity and insulin resistance increases sensitivity to sepsis-induced hepatotoxicity
  2957. obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet
  2958. obesity and insulin resistance is associated with lower atp binding cassette transporter A1 (Abca1) expression in visceral adipose tissue
  2959. obesity and insulin resistance promote atherosclerosis through an IFNγ-regulated macrophage protein network
  2960. obesity and insulin Resistance Rates in a Population Under 40 Years Old Who Admitted to a Family Medicine Outpatient Clinic
  2961. obesity and insulin resistance screening tools in American adolescents: National Health and Nutrition Examination Survey (NHANES) 1999 to 2010
  2962. obesity and insulin Resistance Status: The Impact of Using Different International Growth Standards in Romanian Children.
  2963. obesity and insulin resistance syndrome
  2964. obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects
  2965. obesity and insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women
  2966. obesity and insulin resistance, risk factors for gingivitis in children?
  2967. obesity and insulin Resistance: A Review of Molecular Interactions
  2968. obesity and insulin resistance: An abridged molecular correlation
  2969. obesity and insulin resistance: an ongoing saga
  2970. obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors
  2971. obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism
  2972. obesity and insulin resistance: is it due to body fat, energy balance, or gut factors?
  2973. obesity and insulin resistance: lessons learned from the Pima Indians
  2974. obesity and insulin Resistance: Management in Diabetes.
  2975. obesity and insulin resistance:“window” to myocardial dysfunction
  2976. obesity and insulin secretion in fasting high school students
  2977. obesity and insulin sensitivity effects on cardiovascular risk factors: Comparisons of obese dysglycemic youth and adults
  2978. obesity and insulin-like growth factor-I in African Americans and whites
  2979. obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon
  2980. obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic …
  2981. obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin
  2982. obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF 1
  2983. obesity and non-insulin dependent diabetes mellitus. 22-23 April 1998, The Royal Society, London, UK.
  2984. obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma
  2985. obesity and non-insulin-dependent diabetes mellitus. Considerations on an epidemiological study
  2986. obesity and Plasma Levels of insulin and Growth Hormone
  2987. obesity and sex influence insulin resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats
  2988. #VALUE!
  2989. obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study
  2990. obesity and the insulin resistance syndrome
  2991. obesity and the insulin resistance syndrome
  2992. obesity and the Risk of Recurrent Vascular Events in Patients with Ischemic Stroke: Insights from the insulin Resistance Intervention after Stroke (IRIS) Trial
  2993. obesity and the use of insulin: a study of patients with type 2 diabetes in the UK
  2994. obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis
  2995. obesity and type 2 diabetes mellitus (T2DM) have been associated with increased levels of circulating branched-chain amino acids (BCAAs) that may be …
  2996. obesity and Type 2 Diabetes Mellitus: Adipocytokines as Markers of insulin Resistance
  2997. obesity as a risk factor for developing non-insulin dependent diabetes mellitus–obesity and insulin resistance
  2998. obesity as a risk factor for non-insulin-dependent diabetes mellitus in Korea.
  2999. obesity as associated factors for insulin, Fasting blood sugar, and Hemoglobin A1c in Korean adults
  3000. obesity associated insulin resistance occurs in hypopituitary subjects
  3001. obesity attenuates the contribution of African admixture to the insulin secretory profile in peripubertal children: a longitudinal analysis
  3002. obesity blunts insulin-mediated microvascular recruitment in human forearm muscle
  3003. obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats
  3004. obesity Does Not Equal insulin Resistance
  3005. obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
  3006. obesity does not modulate insulin secretion in Indian patients with non-insulin-dependent diabetes in the young
  3007. obesity Effect on Homeostasis Model Assessment of insulin Resistance (HOMA-IR) Value in Various Metabolic Syndrome (MS) Components
  3008. obesity genes and insulin resistance
  3009. obesity hypertension, salt sensitivity and insulin resistance.
  3010. obesity Improves Myocardial Ischaemic Tolerance and ‘RISK’Signalling in Middle-aged insulin-insensitive Rats
  3011. obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats
  3012. obesity in insulin receptor substrate‐2–deficient mice: disrupted control of arcuate nucleus neuropeptides
  3013. obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity
  3014. obesity in Osborne-Mendel and S 5B/Pl rats: effects of sucrose solutions, castration, and treatment with estradiol or insulin
  3015. obesity in polycystic ovary syndrome: insulin sensitizing therapy
  3016. obesity in relation to inflammatory biomarkers, adiponectin gene variability, and insulin resistance among middle-aged Egyptian women
  3017. obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance
  3018. #VALUE!
  3019. obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic …
  3020. obesity Increases the Risk of Developing insulin Resistance and Promote Metabolic Syndrome: A Study among Obese and On-Obese Non-Diabetic Subjects
  3021. obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a …
  3022. obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.
  3023. obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.(Abstracts: recently published abstracts)
  3024. obesity induced by high-fat diet promotes insulin resistance in the ovary
  3025. obesity induced infertility rescued by ovarian theca cellspecific knockout of the insulin receptor.
  3026. obesity induced insulin resistance and oxidative stress in mice fed a high fat diet
  3027. obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia
  3028. obesity Influence on insulin Activity and Resting Metabolic Rate in Type 2 Diabetes
  3029. obesity is a critical risk factor for worsening of glucose tolerance in a family with the mutant insulin receptor
  3030. obesity is associated with activated and insulin resistant immune cells
  3031. obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity
  3032. obesity is associated with impaired insulin-mediated potassium uptake
  3033. obesity is associated with increased basal and postprandial β-cell insulin secretion even in the absence of insulin resistance
  3034. obesity is associated with increased seminal insulin and leptin alongside reduced fertility parameters in a controlled male cohort
  3035. obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents
  3036. obesity is associated with insulin resistance but not skeletal muscle dysfunction or all-cause mortality
  3037. obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients
  3038. obesity is the major cause of alterations in insulin secretion and calcium fluxes by isolated islets from aged rats
  3039. obesity is the major factor determining insulin sensitivity and androgen production in women with anovulary cycles
  3040. obesity leads to impairments in the morphology and organization of human skeletal muscle lipid droplets and mitochondrial networks, which are resolved with gastric …
  3041. obesity May Connect insulin Resistance to Decreased Neuronal Viability in Human Diabetic Brain
  3042. obesity may have more pronounced effect on the occurrence of insulin resistance than hypertension
  3043. obesity mediates the association between Mediterranean diet consumption and insulin resistance and inflammation in US adults
  3044. obesity modifies the association between serum 25-hydroxyvitamin D and insulin resistance in Korean general population without increased fasting glucose levels
  3045. obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity
  3046. obesity Modulates the Association among APOE Genotype, insulin, and Glucose in Men
  3047. obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
  3048. obesity preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations of insulin resistance and lipid metabolism
  3049. obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways
  3050. obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children
  3051. obesity Related to insulin Response and Counterregulatory Hormones in NIDDM Patients
  3052. obesity resistance and enhanced insulin sensitivity in Ahnak-/-mice fed a high fat diet are related to impaired adipogenesis and increased energy expenditure
  3053. obesity status affects the relationship between protein intake and insulin sensitivity in late pregnancy
  3054. obesity status influences the relationship among serum osteocalcin, iron stores and insulin sensitivity
  3055. obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women
  3056. obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker Fatty rats
  3057. obesity with insulin resistance: experimental insights
  3058. obesity—insulin resistance–type 2 diabetes mellitus
  3059. obesity-associated extracellular and ultrastructural changes in adipocytes: Impact on insulin sensitivity
  3060. obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development and insulin sensitivity
  3061. obesity-associated gingival vascular inflammation and insulin resistance
  3062. obesity-Associated Inflammation And Its Role In insulin Resistance
  3063. obesity-associated insulin resistance adversely affects skin function
  3064. obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity
  3065. obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels
  3066. obesity-associated interleukin-6 contributes to hepatic insulin resistance in mice
  3067. obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery
  3068. obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation
  3069. obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation
  3070. obesity-induced adipose tissue inflammation and insulin resistance
  3071. obesity-induced Brain insulin Resistance Exacerbates TBI Outcome
  3072. obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance
  3073. obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
  3074. obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell
  3075. obesity-Induced Inflammation and insulin Resistance
  3076. obesity-induced inflammation and insulin resistance
  3077. obesity-induced inflammation and insulin resistance: A mini-review on T-cells
  3078. obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms
  3079. obesity-Induced insulin Resistance in Human Skeletal Muscle Is Characterised by
  3080. obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase
  3081. obesity-induced insulin resistance via changes in the DNA methylation profile of insulin pathway genes
  3082. obesity-induced insulin resistance via changes in the DNA methylation profile of insulin pathway genes
  3083. obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling
  3084. obesity-induced mouse benign prostatic hyperplasia (BPH) is improved by treatment with resveratrol: implication of oxidative stress, insulin sensitivity and neuronal …
  3085. obesity-induced overexpression of miR-802 impairs insulin transcription and secretion
  3086. obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism
  3087. obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats
  3088. obesity-induced reduced expression of the lncRNA ROIT impairs insulin transcription by downregulation of Nkx6. 1 methylation
  3089. obesity-inducing hypothalamic knife cuts: effects on lipolysis and blood insulin levels
  3090. obesity-linked insulin resistance in children–an emerging problem: The EarlyBird Study (31)
  3091. obesity-Linked insulin Resistance: Is Interleukin-6 a Friend or Foe?
  3092. obesity-linked PPARγ S273 phosphorylation promotes insulin resistance through Growth Differentiation Factor 3
  3093. obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia
  3094. obesity-related changes in the vascular actions of insulin
  3095. obesity-related diseases and syndromes: insulin resistance, type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, and metabolic …
  3096. obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent
  3097. obesity-related hypertension and the insulin resistance syndrome.
  3098. obesity-Related Hypertension and the Role of insulin and Leptin in High-Fat–Fed Rabbits
  3099. obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin
  3100. obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance
  3101. obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies
  3102. obesity-related insulin resistance is reversible after weight loss
  3103. obesity-related insulin resistance: implications for the surgical patient
  3104. obesity-related insulin resistance: implications for the surgical patient
  3105. obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome
  3106. obesity-related thyroiditis in childhood: relationship with insulin resistance
  3107. obesity-Related Vascular Functional Change is Associated with insulin Resistance in Children
  3108. obesity-stroke paradox exists in insulin-resistant patients but not insulin sensitive patients
  3109. obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins
  3110. obesity‐induced insulin resistance and macrophage infiltration of the adipose tissue: A vicious cycle
  3111. obesity‐induced miR‐15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes
  3112. obesity–insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice
  3113. obesity, abdominal obesity, and insulin resistance
  3114. obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history
  3115. obesity, adipocytokines, and insulin resistance in breast cancer
  3116. obesity, adipogenesis and insulin resistance
  3117. obesity, adipogenesis and insulin resistance
  3118. obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).
  3119. obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women
  3120. obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance
  3121. obesity, Body Composition and insulin Resistance in Women with and without Bipolar Disorder
  3122. obesity, body fat distribution and other risk factors of non-insulin-dependent diabetes mellitus in different ethnic groups living in East Anglia
  3123. obesity, body fat distribution, insulin resistance and link with type 2 diabetes mellitus
  3124. obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity
  3125. obesity, diabetes and insulin resistance. Alterations of insulin signalling
  3126. obesity, diabetes, and insulin resistance: implications from molecular biology, epidemiology, and experimental studies in humans and animals. Synopsis of the …
  3127. obesity, Dyslipidemia and insulin Resistance in Survivors of Childhood Cancer
  3128. obesity, ectopic lipids, and insulin resistance Tissue-specific defects in nutrient handling
  3129. obesity, fasting plasma insulin, and c‐reactive protein levels in healthy children
  3130. obesity, free fatty acids, and insulin resistance
  3131. obesity, hyperinsulinemia, and portal blood flow: a theoretic study of the effects of increased portal blood flow upon fasting peripheral insulin concentrations
  3132. obesity, HYPERinsulinEMIA, THE insulin AND insulin-LIKE GROWTH FACTOR 1 RECEPTORS, AND RISK OF COLORECTAL CANCER
  3133. obesity, hyperlipidemia and non-insulin-dependent diabetes: A unified theory
  3134. obesity, hypertension and insulin resistance
  3135. obesity, hypertension and insulin resistance in childhood–a pilot study
  3136. obesity, HYPERTENSION AND insulin RESISTANCE IN CHILDHOOD.
  3137. obesity, hypertension, and insulin resistance
  3138. obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese
  3139. obesity, inflammation and insulin resistance: role of gp 130 receptor ligands
  3140. obesity, inflammation, and insulin resistance
  3141. obesity, inflammation, and insulin resistance
  3142. obesity, inflammation, and insulin resistance
  3143. obesity, inflammation, and insulin resistance–a mini-review
  3144. obesity, insulin and chemoresistance in colon cancer
  3145. obesity, insulin and hypertension
  3146. obesity, insulin and triglycerides
  3147. obesity, insulin resistance and assisted conception
  3148. obesity, insulin resistance and breast cancer outcomes
  3149. obesity, insulin resistance and cancer risk
  3150. obesity, insulin Resistance and Cancer: The PI3K connection
  3151. obesity, insulin resistance and comorbidities? Mechanisms of association
  3152. obesity, insulin resistance and diabetes in the sand rat exposed to a hypercaloric diet; possible protective effect for IL1-β
  3153. obesity, insulin resistance and diabetes—a worldwide epidemic
  3154. obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors
  3155. obesity, insulin resistance and endometrial cancer risk
  3156. obesity, insulin Resistance and Exercise [J]
  3157. obesity, insulin resistance and hepatic perfusion
  3158. obesity, insulin resistance and increase in adipokines levels: importance of the diet and physical activity
  3159. obesity, insulin Resistance and insulin.
  3160. obesity, insulin resistance and isolated low high‐density‐lipoprotein cholesterol in Chinese subjects
  3161. obesity, insulin resistance and kidney disease risk: insights into the relationship
  3162. obesity, insulin resistance and lifestyle factors: implications for prostate cancer screening
  3163. obesity, insulin Resistance and Loss of Dipping are Associated With Pulse Wave Velocity in Prepubertal Children
  3164. obesity, insulin resistance and oxidative stress: implication for breast carcinogenesis.
  3165. obesity, insulin Resistance and Pediatric Bone
  3166. obesity, insulin Resistance and Placental Dysfunction Ā Foetal Growth
  3167. obesity, insulin resistance and Polycystic ovary syndrome
  3168. obesity, insulin resistance and pregnancy outcome
  3169. obesity, insulin resistance and skeletal muscle characteristics
  3170. obesity, insulin resistance and the implication of thiazolidinediones
  3171. obesity, insulin resistance and the prevalence of atopy and asthma in US adults
  3172. obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer
  3173. obesity, insulin Resistance Pathway Factors, and Colon Cancer
  3174. obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets
  3175. obesity, insulin resistance, adiponectin, and PPAR-γ gene expression in broiler chicks fed diets supplemented with fat and green tea (Camellia sinensis) extract
  3176. obesity, insulin resistance, and Alzheimer’s disease
  3177. obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors
  3178. obesity, insulin resistance, and capillary recruitment
  3179. obesity, insulin resistance, and cardiovascular disease
  3180. obesity, insulin resistance, and colorectal cancer: could miRNA dysregulation play a role?
  3181. obesity, insulin resistance, and HCV: implications for pathogenesis
  3182. obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women
  3183. obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging: atherosclerosis risk in communities study
  3184. obesity, insulin resistance, and inflammaging
  3185. obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus
  3186. obesity, insulin resistance, and metabolic syndrome: a study in WNIN/Ob rats from a pancreatic perspective
  3187. obesity, insulin resistance, and microvascular adaptation
  3188. obesity, insulin resistance, and microvessel density
  3189. obesity, insulin resistance, and nocturnal systolic blood pressure
  3190. obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
  3191. obesity, insulin resistance, and renal function
  3192. obesity, insulin resistance, and skeletal muscle nitric
  3193. obesity, insulin resistance, and skeletal muscle nitric oxide synthase
  3194. obesity, insulin resistance, and skeletal muscle nitric oxide synthase
  3195. obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks
  3196. obesity, insulin resistance, and the pathway to type 2 diabetes
  3197. obesity, insulin resistance, and the renal circulation
  3198. obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population
  3199. obesity, insulin resistance, and the risk of colonic adenoma
  3200. obesity, insulin resistance, and type 1 diabetes mellitus
  3201. obesity, insulin resistance, and type 2 diabetes in children and adolescents
  3202. obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications
  3203. obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension …
  3204. obesity, insulin resistance, hypertension and sleep in the child
  3205. obesity, insulin resistance, NASH and hepatocellular carcinoma
  3206. obesity, insulin resistance, oxidative stress, and inflammation in mouse models of the metabolic syndrome and atherosclerosis
  3207. obesity, insulin resistance, type 2 diabetes and free fatty acids
  3208. obesity, insulin resistance, β-cell autoimmunity, and the changing clinical epidemiology of childhood diabetes
  3209. obesity, insulin secretion and insulin action: reinterpreting the disposition index
  3210. obesity, insulin, and colon cancer.
  3211. obesity, insulin, and hypertension: why outliers count
  3212. obesity, insulin, sex steroids and ovulation
  3213. obesity, leptin resistance, and the effects of insulin reduction
  3214. obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery
  3215. obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity
  3216. obesity, NIDDM, Adipogenesis and insulin Resistance-IBC’s Ninth International Conference.
  3217. obesity, non-insulin-dependent diabetes mellitus and age, but not estrogen, were associated with changes of (delta) 6 and (delta) 5 desaturase enzyme activity …
  3218. obesity, occupational work and parental history as risk factors for non-insulin-dependent diabetes mellitus
  3219. #VALUE!
  3220. obesity, oxidative stress, and their effect on serum heme oxygenase-1 concentrations and insulin in children aged 3 to 5 years in a pediatric hospital of the Ministry of …
  3221. obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan
  3222. obesity, syndrome X, and diabetes: the role of HISS-dependent insulin resistance altered by sucrose, an antioxidant cocktail, and age
  3223. obesity, type 2 diabetes, and cancer: the insulin and IGF connection
  3224. obesity, Type 2 Diabetes, and Cancer: The insulin and insulin-Like Growth Factor Connection.
  3225. obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1
  3226. obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo …
  3227. obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels
  3228. obesity: Adipogenesis and insulin Resistance.
  3229. obesity: changes in lipid metabolism and the role of insulin
  3230. obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
  3231. obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
  3232. #VALUE!
  3233. Obstructive sleep apnea and insulin resistance in children with obesity
  3234. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin …
  3235. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity
  3236. OGTT, insulin Releasing Test and Changes of Plasma Lipids in obesity
  3237. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high …
  3238. Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high …
  3239. Omega-3 index, obesity and insulin resistance in children
  3240. Omega-3 PUFA and probiotics as a single formulation for insulin resistance and obesity: Evidence from animals to randomized clinical studies
  3241. Omental adipose tissue fibrosis and insulin resistance in severe obesity
  3242. On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history
  3243. On the pathogenesis of type II diabetes with special reference to diminished insulin response and obesity: a 5-12 year follow-up study of subjects with borderline …
  3244. #VALUE!
  3245. OPA 1 deficiency promotes secretion of FGF 21 from muscle that prevents obesity and insulin resistance
  3246. Operative risk factors in the metabolic syndrome: Is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
  3247. Optimal waist circumference cutoff value based on insulin resistance and visceral obesity in Koreans with type 2 diabetes
  3248. OR-43: A neuroendocrine model of obesity worsen insulin resistance of spontaneously hypertensive rats: a new model of type 2 diabetes
  3249. OR01-3 microRNA-34a-mediated FGF21 resistance in the adipose tissue contributes to insulin resistance and hypoadiponectinemia in diet-induced obesity
  3250. OR26-03 Lower Serum Myostatin Levels Are Associated with Higher insulin Sensitivity in Adults with Overweight/obesity
  3251. Oral administration of alkylglycerols differentially modulates high-fat diet-induced obesity and insulin resistance in mice
  3252. Oral glutamine supplementation reduces obesity, pro-inflammatory markers, and improves insulin sensitivity in DIO wistar rats and reduces waist circumference in …
  3253. Oral hormonal therapy with ethinylestradiol–levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating …
  3254. Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota
  3255. Original Research Article Correlation between insulin resistance and metabolic syndrome in obesity adolescents
  3256. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-κB signaling …
  3257. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
  3258. Osteoprotegerin and insulin resistance in childhood obesity: a new interplay?
  3259. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity
  3260. Over Expression of the insulin Like Growth Factor Type 1 Receptors in Endothelial Cells Protects Against the Development of obesity
  3261. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction
  3262. Overactivation of the adipose tissue renin angiotensin system contributes to insulin resistance in high‐fat diet‐induced obesity
  3263. Overall and abdominal obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomisation study
  3264. Overall and central obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis
  3265. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass
  3266. Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young …
  3267. Overexpression of C-type natriuretic peptide in endothelial cells protects against insulin resistance and inflammation during diet-induced obesity
  3268. Overexpression of c‐myc in the liver prevents obesity and insulin resistance
  3269. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity
  3270. Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle …
  3271. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance
  3272. Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity‐related insulin resistance
  3273. Overfeeding-induced obesity in rats: insulin sensitivity and autonomic regulation of metabolism
  3274. Overview: low density lipoprotein subclass phenotype B as a biochemical marker for visceral obesity and insulin resistance
  3275. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes
  3276. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy
  3277. Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China
  3278. OX40 promotes obesity-induced adipose inflammation and insulin resistance
  3279. Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity
  3280. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance
  3281. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.
  3282. Oxidative stress is associated with C‐reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance
  3283. Oxidized LDL is associated with metabolic syndrome traits independently of central obesity and insulin resistance
  3284. #VALUE!
  3285. P-135: obesity, insulin resistance, cardiac structure, and renin-angiotensin system genes in essential hypertension
  3286. P-138: Bmi-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity
  3287. P-443: Preliminary results of topiramate in an experimental model of obesity, insulin resistance and hypertension (obese Zucker rats)
  3288. P-495: Relationships between endogenous insulin secretion and insulin resistance and blood pressure in obesity
  3289. P-572: Clinical study on the role of leptin and insulin resistance in the pathogenesis of obesity related hypertension
  3290. P-77: Risk of cardiovascular morbidity is correalted with insulin resistance, but not with obesity in a bariatric surgical population
  3291. p-Coumaric Acid Enriched-Peanut Sprout Improves High Fat Diet-Induced obesity and insulin Resistance by Inhibiting Macrophage Recruitment
  3292. P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance
  3293. P‐selectin deficiency protects against high‐fat diet‐induced obesity and insulin resistance (641.1)
  3294. P2-03-01: Genetic Reduction of Circulating insulin-Like Growth Factor (IGF)-1 Differentially Impacts the Effects of Diet-Induced obesity and Calorie Restriction on …
  3295. P20 Study of insulin cardiovascular resistance in an animal model of childhood obesity by over-feeding during lactation
  3296. P2X7 Receptor in the Management of Energy Homeostasis: Implications for obesity, Dyslipidemia, and insulin Resistance
  3297. P5. 64 Effect of morbid obesity in skeletal muscle and its association with insulin resistance
  3298. P5299 Epicardial obesity as a significant predictor of leptino and insulin resistance
  3299. P649 A possible role for the ATM protein in the myocardial pathology associated with obesity and insulin resistance.
  3300. p66 (ShcA): linking mammalian longevity with obesity-induced insulin resistance
  3301. p66ShcA: linking mammalian longevity with obesity-induced insulin resistance
  3302. P704 obesity and insulin resistance are not associated with endothelial dysfunction in rat aortas.
  3303. PAI-1, obesity, and insulin resistance
  3304. PAI-1, obesity, insulin resistance and risk of cardiovascular events
  3305. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway
  3306. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice
  3307. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance
  3308. Pancreatic acinar cell-specific overexpression of group 1B phospholipase A 2 exacerbates diet-induced obesity and insulin resistance in mice
  3309. Pancreatic beta-cell insulin signaling in genetic and dietary models of obesity and insulin resistance
  3310. Pancreatic β-cell adaptive plasticity in obesity increases insulin production but adversely affects secretory function
  3311. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women
  3312. Parathyroid Hormone and insulin Resistance in Distinct Phenotypes of Severe obesity: A Cross-Sectional Analysis in Middle-Aged Men and Premenopausal Women
  3313. Parthenolide Reverses obesity-Induced insulin Resistance [J]
  3314. Partial reversal of obesity-induced insulin resistance owing to anti-inflammatory immunomodulatory potential of flaxseed oil
  3315. Partly replacing meat protein with soy protein alters insulin resistance and blood lipids in postmenopausal women with abdominal obesity
  3316. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus
  3317. Past and Present obesity, Parameters of Body Fat and Blood Pressure in Korean Patients with Non-insulin Dependent Diabetes Mellitus (NIDDM)
  3318. Pathogenesis and clinical features of obesity and insulin resistance
  3319. Pathogenesis of insulin resistance and glucose intolerance in childhood obesity
  3320. Pathogenesis of insulin resistance in metabolic obesity
  3321. PATHOGENESIS OF insulin RESISTANCE IN PREGNANT WOMEN WITH obesity PATOGENEZA insulinOOPORNOŚCI U KOBIET CIĘŻARNYCH Z …
  3322. Pathogenetic Relationship Between insulin Resistance, insulin Secretion and Impaired Glucose Tolerance in Patients With obesity
  3323. Pathogenic role of inflammatory cytokines in obesity: from insulin resistance to diabetes mellitus
  3324. Pathologic Remodeling of Myocardial Cardiolipin in a Porcine Model of Diet-Induced obesity and insulin Resistance
  3325. Pathomechanism of insulin resistance in men with central obesity: correlation of GGT, GPx, hs-CRP and plasma total cysteine
  3326. Pathophysiological connections between gallstone disease, insulin resistance, and obesity
  3327. Pathophysiology and Management of Dyslipidemias Associated with obesity, Type 2 Diabetes, and Other insulin-Resistant States
  3328. Pathophysiology in Animal models of Diet-Induced obesity: A critical Role for insulin Resistance
  3329. Pathophysiology of diabetes mellitus type 2: roles of obesity, insulin resistance and β-cell dysfunction
  3330. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus
  3331. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
  3332. Pathways involved in lipid-induced insulin resistance in obesity
  3333. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
  3334. Pattern of plasma lipids and insulin blood levels in male patients with non-insulin-dependent diabetes mellitus and moderate obesity
  3335. Patterns of glycemia during the insulin resistance of pregnancy: obesity, gestational diabetes and relationship to neonatal adiposity
  3336. PBI-4547 Improves Glucose Metabolism and insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of obesity and Metabolic Syndrome
  3337. PC4 CONSEQUENCE OF CARBOHYDRATE AND FAT CONTENT OF WEANING DIET ON DEVELOPMENT OF obesity, BLOOD insulin, LEPTIN AND LIPIDS …
  3338. PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma
  3339. PDK4 augments ER–mitochondria contact to dampen skeletal muscle insulin signaling during obesity
  3340. Peculiarities of asthma and insulin resistance depending on the types of obesity
  3341. Peculiarities of cardiovascular syndrome in children and adolescents with obesity in dependence of level of insulin resistance
  3342. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification
  3343. Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls
  3344. Perforin is a novel immune regulator of obesity-related insulin resistance
  3345. Pericardial fat, insulin resistance, and left ventricular structure and function in morbid obesity
  3346. Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults
  3347. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
  3348. Peripheral insulin Resistance Accounts for Endothelial Dysfunction in obesity
  3349. Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPARα suppression
  3350. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance
  3351. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
  3352. Peroxisome proliferator-activated receptor y2 Pro115Gln and G972R insulin substrate receptor-1 variants in obesity and insulin resistance
  3353. Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development
  3354. Persistent adipose tissue insulin responsiveness during fasting of weanling rats with hypothalamic obesity
  3355. Personalized dietary management of overweight and obesity based on measures of insulin and glucose
  3356. PERTURBATION IN IMMUNE-METABOLIC FUNCTION ASSOCIATED WITH obesity INDUCED insulin RESISTANCE IN HUMANS
  3357. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue
  3358. Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
  3359. Pharmacological effects of palmitoylethanolamide on hypertension, insulin-resistance and obesity in murine models
  3360. Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity
  3361. Pharmacological Inhibition of NLRP3 Inflammasome by Parthenolide Improves obesity-Induced insulin Resistance in Diet-Induced Obese Mice
  3362. Pharmacological Strategies for insulin Sensitivity in obesity and Cancer: Thiazolidinediones and Metformin
  3363. Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity
  3364. Pharmacological treatment of insulin resistance in obesity.
  3365. Pharyngeal collapsibility during sleep is elevated in insulin-resistant females with morbid obesity
  3366. Phenotypic characterisation of human amylin transgenic mice: altered hormone signalling in the brain underlying obesity and insulin resistance
  3367. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity
  3368. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
  3369. Phosphatidylinositol-4-phosphate-5-kinase α deficiency alters dynamics of glucose-stimulated insulin release to improve glucohomeostasis and decrease obesity in …
  3370. PHOSPHO1 is a skeletal regulator of insulin resistance and obesity
  3371. PHOSPHO1, a novel skeletal regulator of insulin resistance and obesity
  3372. Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistance
  3373. Phospholipid Transfer Protein Deficiency Attenuates High-Fat Diet–Induced obesity and insulin Resistance
  3374. Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance
  3375. Physical activity energy expenditure is associated with 2-h insulin independently of obesity among Inuit in Greenland
  3376. Physical activity impacts insulin sensitivity post metabolic bariatric surgery in adolescents with severe obesity
  3377. Physical activity, eating patterns, and insulin resistance in obesity
  3378. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity
  3379. Physical and Metabolic Characteristics of p62 Knockout Mouse: A New Animal Model of obesity/insulin Resistance
  3380. Physical inactivity and obesity underlie the insulin resistance of aging
  3381. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus
  3382. Physical Training in Human obesity II. Effects on Plasma insulin in Glucose-Intolerant Subjects without Marked Hyperinsulinemia
  3383. Physical training in hyperplastic obesity. V. Effects of atropine on plasma insulin.
  3384. Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome
  3385. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and …
  3386. Physiopathology and Possible Etiology of Hormonal Dysregulations and insulin Resistance in Obese Rats: a Potential Model for Some Human obesity
  3387. Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice
  3388. PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
  3389. PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
  3390. Pigment epithelium-derived factor contributes to insulin resistance in obesity
  3391. Pituitary lesions, obesity, and mesenteric Lipomas in insulin-resistant horses
  3392. PKCβ-induced Selective IRS1 Dysfunction and insulin Resistance in Renal Glomeruli of Rodent Models of Diabetes and obesity
  3393. Plasma Active Ghrelin Level in Patients with Type 2 Diabetes Mellitus and its Interrelationship with insulin resistance, Hypertension, Dyslipidemia and obesity
  3394. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians
  3395. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
  3396. Plasma amino acid levels and insulin secretion in obesity
  3397. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements
  3398. Plasma B-cell tropin, insulin secretion and obesity
  3399. Plasma cell glycoprotein-1, interleukin-6 and tumor necrosis factor-alfa as candidate genes for insulin resistance, obesity and type 2 diabetes (PC-1 …
  3400. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
  3401. Plasma concentrations of insulin and free fatty acids in dietary-induced obesity of Wistar-rats before and after glucose stimulation.
  3402. Plasma CTRP-3 concentrations in Chinese patients with obesity and type II diabetes negatively correlate with insulin resistance
  3403. Plasma free fatty acids do not provide the link between obesity and insulin resistance or β‐cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings …
  3404. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels
  3405. Plasma high-density lipoprotein cholesterol but not apolipoprotein AI is a good correlate of the visceral obesity—insulin resistance dyslipidemic syndrome
  3406. Plasma insulin A-chain in obesity and diabetes
  3407. Plasma insulin and growth hormone levels in obesity and diabetes
  3408. Plasma insulin changes in obesity with or without abnormal glucose tolerance
  3409. Plasma insulin in patients with coronary sclerosis and in obesity.
  3410. Plasma insulin levels during pregnancy, in obesity and potential diabetes
  3411. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients.
  3412. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
  3413. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus
  3414. Plasma Leptin and insulin Resistance Correlation with obesity in Pre Pubertal Children.
  3415. Plasma leptin concentration, obesity, and insulin resistance in healthy Korean population
  3416. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan—The Taipei Children Heart Study
  3417. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1
  3418. Plasma Leptin, insulin Resistance, and obesity Index of Type 2 Diabetics and Normal Subjects among Koreans.
  3419. Plasma levels of ghrelin, des-acyl ghrelin and LEAP2 in children with obesity: correlation with age and insulin resistance
  3420. Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively
  3421. Plasma lipid profiling of tissue-specific insulin resistance in human obesity
  3422. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment
  3423. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects
  3424. Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity
  3425. Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome
  3426. Plasma profiles of glucose, insulin and lipids in the male WBN/Kob-Leprfa rat, a new model of type 2 diabetes with obesity
  3427. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance
  3428. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity
  3429. Plasma retinol-binding protein 4 and insulin resistance in overweight and obesity: effect of weight loss
  3430. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance
  3431. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity
  3432. Plasma tocopherols and carotenes are decreased in spanish children and adolescents with insulin resistance, independently of obesity
  3433. Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric measurements indices
  3434. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes
  3435. Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk
  3436. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM
  3437. Platelet-endothelial interactions in atherosclerosis-prone arteries in a non-human primate model of obesity and insulin resistance
  3438. Plenary 3 Role of inflammation in the etiology of obesity induced insulin resistance and Type 2 diabetes
  3439. PLTP Deficiency Attenuates High Fat Diet Induced obesity and insulin Resistance
  3440. POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuates obesity, Non-Alcoholic Fatty Liver, and insulin Resistance via Inhibitions …
  3441. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity
  3442. Polycystic ovaries, obesity and insulin resistance in women with epilepsy
  3443. Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins
  3444. Polycystic Ovary Syndrome is Associated with insulin Resistance Independent of obesity, Vitamin D Status and Inflammatory Activation
  3445. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth
  3446. Polycystic Ovary Syndrome, obesity and insulin Resistance
  3447. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
  3448. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated …
  3449. Polymorphisms in inflammatory pathway markers and their association with obesity and insulin resistance in populations of the African diaspora
  3450. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
  3451. Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the insulin Resistance Atherosclerosis Family …
  3452. Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle
  3453. Pomegranate seed oil prevents diet induced obesity and insulin resistance in mice
  3454. Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice
  3455. Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians
  3456. Populus balsamifera extract and its active component salicortin reduce obesity and attenuate insulin resistance in a diet-induced obese mouse model
  3457. Populus balsamifera L.(Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model
  3458. Positive association between musclin and insulin resistance in obesity: evidence of a human study and an animal experiment
  3459. Positive association of obesity and insulin resistance with bone mineral density in Tunisian postmenopausal women
  3460. Possible criteria for obesity based on insulin resistance in Japanese college athletes
  3461. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia.
  3462. Possible role of pancreatic insulin and glucagon in the hyperlipidemia and obesity of obese strain of chicken
  3463. Possible Treatment Options for insulin Resistance in obesity via Branched-Chain Amino Acid Pathway
  3464. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance
  3465. Postnatal deficiency of essential fatty acids in mice results in resistance to diet-induced obesity and low plasma insulin during adulthood
  3466. Postnatal environment overrides genetic and prenatal factors influencing offspring obesity and insulin resistance
  3467. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus
  3468. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance
  3469. Postprandial Dyslipidemia and Intestinal Dysfunction in Adolescents with obesity and insulin Resistance
  3470. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM: Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity
  3471. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects
  3472. Potential cellular and genetic mechanisms for insulin resistance in the common disorders of diabetes and obesity
  3473. Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood
  3474. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression
  3475. Potential Mechanism (s) of obesity-Induced insulin Resistance in Skeletal Muscle: The Role of Exercise
  3476. Potential Role Of Endoplasmic Reticulum Redox Changes In Endoplasmic Reticulum Stress And Impaired Protein Folding In obesity-Associated insulin Resistance
  3477. Potential Role of insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for obesity-Related insulin Resistance
  3478. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy
  3479. Potential Roles of Adipocyte Extracellular Vesicle–Derived miRNAs in obesity-Mediated insulin Resistance
  3480. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance
  3481. PP. 28.18: insulin RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND ABDOMINAL obesity DEPENDING ON ACE AND PPAR-GAMMA2 …
  3482. PP180. Maternal plasma endotoxin increases significantly across pregnancy with no association with obesity, inflammation, or insulin sensitivity
  3483. PPAR-γ2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity
  3484. PPAR-γ2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity
  3485. PPARγ2 protects against obesity by means of a mechanism that mediates insulin resistance
  3486. Praliciguat, a clinical-stage sGC stimulator, improved glucose tolerance and insulin sensitivity and lowered triglycerides in a mouse diet-induced obesity model
  3487. PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity
  3488. Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008–2011)
  3489. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study
  3490. Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons
  3491. Predictive Models of insulin Resistance Derived from Simple Morphometric and Metabolic Measurements Related to obesity in Baboons.
  3492. Predictors of insulin resistance in children versus adolescents with obesity
  3493. Predictors of insulin Resistance in Indonesian Adolescents with obesity
  3494. Predictors of insulin resistance in obesity and type 2 diabetes mellitus—The role of magnesium
  3495. Predictors of insulin resistance in patients with obesity: a pilot study
  3496. Predisposition to insulin resistance and obesity due to staple consumption of rice: Amylose content versus germination status
  3497. Predominance of insulin Resistance Over Beta-Cell Dysfunction as a Diabetes Risk Factor in Chinese Adults: Impact of obesity in a Nationwide Prospective Study
  3498. Predominant role of obesity/insulin resistance in oxidative stress development
  3499. Pregnancy, obesity and insulin resistance: maternal overnutrition and the target windows of fetal development
  3500. Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal …
  3501. Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines
  3502. Preoperative revelation of insulin resistance as a criterion of debulking necessity in patients with obesity
  3503. Preperitoneal fat thickness in childhood obesity: association with serum insulin concentration
  3504. Preserved endothelial function in human obesity in the absence of insulin resistance
  3505. Pressure overload exacerbates insulin resistance in obesity and type 2 diabetes
  3506. Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girls
  3507. Prevalence and clinical characteristics of children and adolescents with metabolically healthy obesity: Role of insulin sensitivity
  3508. Prevalence and correlates of obesity in insulin dependent diabetic patients.
  3509. Prevalence and Regional Differences of obesity in Young Women Latent obesity and insulin Resistance
  3510. Prevalence and treatment of depression are differentially associated with insulin resistance and obesity
  3511. Prevalence of Atherogenic Index and Its Relationship to Abdominal obesity, Hypertension and insulin Resitance in Obese Pediatric Patients of South Bronx
  3512. Prevalence of insulin Resistance and Impaired Glucose Tolerance among Children and Adolescents with obesity.
  3513. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity
  3514. Prevalence of insulin Resistance and its Association with obesity and Alcoholism in Male Medical Students of Bhopal
  3515. Prevalence of insulin resistance in urban Indian school going children with overweight/obesity: A cross-sectional study
  3516. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight
  3517. Prevalence of obesity in Korean Adult insulin-Dependent Diabetic Patients
  3518. Prevalence of obesity in Korean non-insulin-dependent diabetic patients
  3519. Prevalence of obesity, Dyslipidemia, and insulin Resistance in Childhood Cancer Survivors
  3520. Prevalence of obesity, hyperlipemia and insulin resistance in children with suprasellar brain tumors
  3521. Prevalence of the insulin resistance syndrome in obesity
  3522. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer
  3523. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid–binding resin
  3524. Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable
  3525. Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice
  3526. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1
  3527. Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to …
  3528. Preventive effects of salvia officinalis leaf extract on insulin resistance and inflammation, in high fat diet-induced-obesity mice model
  3529. Preventive effects of salvia officinalis leaf extract on insulin resistance and inflammation, in high fat diet-induced-obesity mice model
  3530. Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: interrelations with obesity in Egyptian non-diabetic obese children and adolescents
  3531. Pro-inflammatory CD11c+ CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity
  3532. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 …
  3533. Probiotics improve obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats
  3534. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
  3535. Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance
  3536. Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation
  3537. Programming of infant neurodevelopment by maternal obesity: potential role of maternal inflammation and insulin resistance
  3538. Progress and controversies: treating obesity and insulin resistance in the context of hypertension
  3539. Progress in the Study of the Association between Adipocyte Fatty Acid Binding Protein and PTEN and Their Correlation with obesity and insulin Resistance
  3540. Progression of obesity-induced insulin resistance in response to a high-fat diet is delayed in IL-1 receptor type I-knock-out mice
  3541. Progressive defect of insulin action on glycogen synthase in obesity and diabetes
  3542. Progressive obesity alters ovarian insulin, phosphatidylinositol-3 kinase, and chemical metabolism signaling pathways and potentiates ovotoxicity induced by …
  3543. Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC
  3544. Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation
  3545. Promising Effect of Irisin in Reduction of obesity And insulin Resistance: A Review
  3546. Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster …
  3547. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity
  3548. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver
  3549. Protection against diet-induced obesity and obesity– related insulin resistance in Group 1B PLA2-deficient mice
  3550. Protection from diet‐induced obesity and insulin resistance in mice lacking CCL19‐CCR7 signaling
  3551. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1
  3552. Protection From obesity and Systemic insulin Resistance by Hepatocyte Growth Factor in Mice
  3553. Protection from obesity-induced insulin resistance in mice lacking TNF-α function
  3554. Protective role for B-1b B cells and IgM in obesity-associated inflammation, glucose intolerance, and insulin resistance
  3555. Protein inhibitor of activated STAT 1 (PIAS1) protects against obesity-induced insulin resistance by inhibiting inflammation cascade in adipose tissue
  3556. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
  3557. Protein oxidation in obesity and insulin resistance
  3558. Protein-restriction diet during the suckling phase programs rat metabolism against obesity and insulin resistance exacerbation induced by a high-fat diet in adulthood
  3559. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance
  3560. Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array
  3561. Proteomic and biochemical analysis of adipose protein carbonylation in obesity linked insulin resistance
  3562. PS1-1. TLR-3 is highly expressed in human adipocytes, but deficiency of TLR3 does not protect against obesity-induced inflammation and insulin resistance in mice
  3563. PS15-78. Increased adipose tissue oxygen tension in obesity is accompanied by insulin resistance, impaired adipose tissue capillarisation and inflammation
  3564. PS19-89. Absence of JNK1 protects mice against age-induced obesity and insulin resistance
  3565. PS2-9. Effect of B-and T-cell deficiency on obesity-induced inflammation and insulin resistance
  3566. PS8-44. FcR-γ-chain-/-mice are protected against diet-induced obesity and diet-induced insulin resistance
  3567. PS8-45. insulin resistance in 4-5 year old children with overweight and obesity
  3568. PTEN Mutations as a Cause of Constitutive insulin Sensitivity and obesity
  3569. PTEN mutations as a cause of constitutive insulin sensitivity and obesity in human beings
  3570. PTEN mutations increase insulin sensitivity and obesity
  3571. PTEN targeting: the search for novel insulin sensitisers provides new insight into obesity research
  3572. PTPRT regulates high-fat diet-induced obesity and insulin resistance
  3573. Pu’erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo …
  3574. Purified Betacyanins from Hylocereus undatus Peel Ameliorate obesity and insulin Resistance in High-Fat-Diet-Fed Mice
  3575. PWD/PhJ and WSB/EiJ mice are resistant to diet-induced obesity but have abnormal insulin secretion
  3576. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice
  3577. Pyruvate attenuate lipid metabolic disorders and insulin resistance in obesity induced in rats
  3578. PYY (3–36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity
  3579. QTL mapping of genes controlling plasma insulin and leptin concentrations: metabolic effect of obesity QTLs identified in an F2 intercross between C57BL/6J and …
  3580. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer
  3581. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese …
  3582. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7.
  3583. Race affects the association of obesity measures with insulin sensitivity
  3584. Race, Childhood insulin, Childhood Caloric Intake, and Class 3 obesity at Age 24: 14‐Year Prospective Study of Schoolgirls
  3585. Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity
  3586. Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans
  3587. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin
  3588. Rapid development of cardiac dysfunction in a canine model of insulin resistance and moderate obesity
  3589. Raspberry alleviates obesity-induced inflammation and insulin resistance in skeletal muscle through activation of AMP-activated protein kinase (AMPK) α1
  3590. #VALUE!
  3591. Re: Maternal lipids are associated with newborn adiposity independent of GDM status, obesity and insulin resistance: a prospective observational cohort study …
  3592. Recent advances in obesity-induced inflammation and insulin resistance
  3593. Recent advances in the relationship between obesity, inflammation, and insulin resistance
  3594. Recessive Inheritance of obesity in Familial Non—insulin-Dependent Diabetes Mellitus, and Lack of Linkage to Nine Candidate Genes
  3595. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance
  3596. Red pitaya betacyanins protects from diet‐induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice
  3597. Red wine polyphenols do not improve obesity‐associated insulin resistance: A randomized controlled trial
  3598. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
  3599. Reduced [Beta]-cell Compensation to insulin Resistance Associated with obesity in Familial Type 2 Diabetes
  3600. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake
  3601. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity
  3602. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet
  3603. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
  3604. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
  3605. Reduced Cardiolipin Synthesis Protects Against the Development of obesity and insulin Resistance
  3606. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross …
  3607. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance
  3608. Reduced gluteal expression of adipogenic and lipogenic genes in black South African women is associated with obesity-related insulin resistance
  3609. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass
  3610. Reduced hepatic insulin clearance in rats with dietary-induced obesity
  3611. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels
  3612. Reduced insulin suppression of glucose appearance is related to susceptibility to dietary obesity in rats
  3613. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans
  3614. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance
  3615. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
  3616. Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity
  3617. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
  3618. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 …
  3619. Reductions in adipose tissue mitochondrial content in high fat diet‐induced obesity and lean models of insulin resistance
  3620. Reevaluation of fatty acids, obesity, and insulin resistance
  3621. Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity
  3622. Regulated membrane transport of free fatty acids in adipocytes: role in obesity and non-insulin dependent diabetes mellitus.
  3623. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance
  3624. Regulation of Autotaxin and its Role in obesity-Induced Tissue insulin Resistance
  3625. Regulation of B‐type natriuretic peptide synthesis by insulin in obesity in male mice
  3626. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity
  3627. Regulation of HIF-1α activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia
  3628. Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
  3629. Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
  3630. Regulation of human vascular redox state in obesity and insulin resistance
  3631. Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice
  3632. Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription
  3633. Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction
  3634. Regulation of Nephron Afferent Arteriole Resistance in obesity: Role of insulin and Connecting Tubule Glomerular Feedback
  3635. REGULATION OF obesity AND insulin RESISTANCE BY FOENICULUM VULGARE AND ANETHUM GRAVEOLENS EXTRACT IN HIGH-FAT DIET-INDUCED …
  3636. Regulation of obesity and insulin resistance by hypoxia-inducible factors
  3637. Regulation of obesity and insulin resistance by nitric oxide
  3638. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents
  3639. Regulatory function of interferon regulatory factor 3 in obesity, inflammation and insulin resistance (HUM7P. 287)
  3640. Regulatory role of CD40 in obesity-induced insulin resistance
  3641. Relating smoking, obesity, insulin resistance and ovarian biomarker changes to the final menstrual period (FMP)
  3642. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in …
  3643. Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes
  3644. Relation between obesity in young adulthood and risk of non-insulin-dependent diabetes mellitus
  3645. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
  3646. Relation of Chemerin to insulin Resistance, Inflammation and obesity in Egyptian Type II Diabetics
  3647. Relation of circulating oxidized LDL to obesity and insulin resistance in children
  3648. Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and meta-analysis
  3649. Relation of depot-specific adipose inflammation to insulin resistance in human obesity
  3650. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity
  3651. Relation of obesity and Chronic Inflammation, insulin Resistance
  3652. Relation of obesity to insulin secretion and clearance in adolescents: the Bogalusa Heart Study.
  3653. Relation of plasma kisspeptin levels with obesity and insulin resistance in polycystic ovary syndrome
  3654. Relation of the degree of obesity in childhood to adipose tissue insulin resistance
  3655. Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender
  3656. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men
  3657. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D
  3658. Relationship among obesity, blood lipids and insulin resistance in Bangladeshi adults
  3659. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome
  3660. Relationship among resistance to the insulin and obesity in Zacatecas population
  3661. Relationship among serum adiponectin level, obesity and insulin resistance.
  3662. Relationship between adiponectin, obesity and insulin resistance
  3663. Relationship between alteration of serum leptin level and insulin resistance in simple obesity patients
  3664. Relationship between beta~ 3-AR gene and obesity, type 2 diabetes, insulin resistance in Chiness Hans population
  3665. Relationship between Body Mass Index and insulin Resistance and Beta Cell Function by obesity Type in Obese Middle-Aged Men
  3666. Relationship between degree of obesity and in vivo insulin action in man
  3667. Relationship between expression of resistin and insulin resistance in diet-induced obesity and obesity resistant rats [J]
  3668. Relationship between Fat Distribution and Leptin-insulin: Needle-Knife Treatment for Simple obesity-A Clinical Study.
  3669. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men
  3670. Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity
  3671. Relationship between immunoreactive insulin and plasma somatomedin-C/insulin-like growth factor-I concentration in childhood obesity
  3672. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
  3673. Relationship between insulin and somatotropin in obesity.
  3674. Relationship between insulin Resistance and Blood Lipids Level in Children with Simple obesity [J]
  3675. Relationship between insulin resistance and free fatty acids in children with simple obesity [J]
  3676. Relationship between insulin resistance and serum high sensitivity C-reactive protein, blood lipids level in adult with simple obesity [J]
  3677. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity
  3678. Relationship between insulin Resistance and Tumor Necrosis Factor-alpha in Children with Simple obesity
  3679. Relationship between insulin resistance, incidence of fatty liver and serum ferritin level in adults with simple obesity
  3680. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity
  3681. Relationship between insulin resistance, insulin secretion and insulin metabolism in simple obesity.
  3682. Relationship between insulin Resistance, obesity and Lipid Profile in Diabetic Women with Polycystic Ovarian Syndromes (POS)
  3683. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men
  3684. Relationship between insulin sensitivity and degree of obesity in mild hypertension
  3685. Relationship between insulin sensitivity, obesity, body fat distribution and β-endorphinaemia in obese women
  3686. Relationship between insulin-sensitive obesity and retinal microvascular abnormalities.
  3687. Relationship between Intra-abdominal obesity and insulin Resistance
  3688. Relationship between leptin level, index of insulin resistance and the main indicators of carbohydrate and lipid metabolism in patients with varying degrees of obesity
  3689. Relationship between Metabolic Syndrome, Metabolic Syndrome Score, insulin Resistance and Beta Cell Function in Korean Adults with obesity
  3690. Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins
  3691. Relationship between obesity and insulin and lipoprotein metabolism in postmenopausal women
  3692. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in man
  3693. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.
  3694. Relationship between obesity and related indicators with insulin resistance among the residents over 50-year-old in Wuxi area
  3695. Relationship between obesity and serun insulin and C-peptide levels in long-term female psychiatric inpatients [J]
  3696. Relationship between obesity and the increased risk of major complications in non‐insulin‐dependent diabetes mellitus
  3697. Relationship between obesity-associated non-ovulation menstruation dysfunction and insulin resistance
  3698. Relationship between obesity, IL-17 and IL-23 and insulin resistance
  3699. Relationship between obesity, inflammation and insulin resistance: new concepts
  3700. Relationship between obesity, insulin resistance and adipokines in morbidly obese women
  3701. Relationship between obesity, insulin resistance, and coronary heart disease risk
  3702. Relationship between obesity, metabolic syndrome and insulin resistance in children [J]
  3703. Relationship between plasma membrane glycoprotein gene and obesity, type 2 diabetes mellitus, insulin resistance in Chinese population
  3704. Relationship between plasma membrane glycoprotein geneand obesity, insulin resistance
  3705. Relationship between plasma progranulin and insulin resistance in patients with type 2 diabetes mellitus and obesity
  3706. Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging Study
  3707. Relationship between serum adiponectin, obesity and insulin resistance in nonalcoholic fatty liver disease
  3708. Relationship between Serum Leptin Level and RAAS, insulin Sensitivity in Patients with obesity-related Hypertension
  3709. Relationship between serum levels of 1-84 parathormone (PTH1-84) and obesity, HOMA insulin-sensitivity or beta-cells function (HOMA-B) in type 2 diabetic patients
  3710. Relationship between serum lipoprotein ratios and insulin resistance in obesity
  3711. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity
  3712. Relationship between serum tumor necrosis factor-aand insulin in the obesity
  3713. Relationship between Simple obesity and Risk Factors of insulin Resistance Syndrome in Children [J]
  3714. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
  3715. Relationship between sub-clinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a color Doppler imaging study …
  3716. Relationship between the plasma resistin, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
  3717. Relationship between TNF-α, obesity and insulin Resistant in Patients with Type Ⅱ Diabetes Mellitus
  3718. Relationship between urinary sodium-creatinine ratios and insulin resistance in Korean children and adolescents with obesity
  3719. Relationship between visceral obesity and insulin resistance in SD rats induced by high fat diets
  3720. #VALUE!
  3721. #VALUE!
  3722. Relationship of abdominal obesity measured by DXA and waist circumference with insulin sensitivity in Hispanic and non‐Hispanic white individuals: The San Luis …
  3723. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity
  3724. RELATIONSHIP OF HUMAN SERUM LEPTIN WITH insulin SERUM LIPIDS AND obesity [J]
  3725. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity
  3726. Relationship of Internalized Racism to Abdominal obesity and Blood Pressure in Black Women: Implications for the insulin Resistance Syndrome in African Americans
  3727. Relationship of islet function to insulin action in human obesity
  3728. Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins, obesity, ana insulin Resistance in Japanese Men
  3729. Relationship of monocyte chemoattractant protein 1 (MCP-1) with insulin resistance and body mass index, but not with thermogenetic hormones in obesity
  3730. Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study
  3731. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors
  3732. Relationship of obesity to adipose tissue insulin resistance
  3733. Relationship of obesity to insulin resistance in Egyptian women: role of leptin
  3734. Relationship of obesity with insulin resistance in polycystic ovarian syndrome
  3735. Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?
  3736. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity–clinical …
  3737. Relationship of serum CXCL5 with obesity and insulin resistance
  3738. Relationship of serum resistin with insulin resistance and obesity
  3739. Relationships among autonomic dysfunction, obstructive sleep apnea, and insulin resistance in childhood obesity
  3740. Relationships among B-endorphin (B-EP), insulin and atrial natriuretic peptide (ANP) in patients with simple obesity
  3741. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse,
  3742. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk
  3743. Relationships Among Left Ventricular Geometry, Arterial-Ventricular Stiffening and insulin Resistance in Childhood obesity
  3744. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans
  3745. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans.
  3746. #VALUE!
  3747. Relationships between diet, obesity and insulin dysregulation in horses and ponies
  3748. Relationships between glycaemic abnormalities, obesity and insulin resistance in nondiabetic Polynesians of New Caledonia
  3749. Relationships between HDL2-C subfractions and obesity in non-insulin-dependent diabetics
  3750. Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity.
  3751. Relationships between obesity, body composition and continuous glucose monitoring parameters in subjects with type 2 diabetes on insulin therapy
  3752. Relationships between Parameters of insulin Sensitivity, obesity and Liver Aminotransferases in Patients with Nonalcoholic Fatty Liver Disease
  3753. Relationships between Plasma Carnitine, Free Fat Acid Levels and insulin Resisitance in Children with Simple obesity
  3754. Relationships between Plasma Carnitine, Free Fat Acid Levels and insulin Resisitance in Children with Simple obesity [J]
  3755. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the K orean S arcopenic O besity S tudy
  3756. Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults
  3757. Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM).
  3758. Relationships of Serum Leptin, Tumor Necrosis Factor-? and insulin Resistance in Simple obesity Children
  3759. Relationships of Serum Leptin, Tumor Necrosis Factor-alpha and insulin Resistance in Simple obesity Children
  3760. Relationships of the systolic blood pressure response during exercise with insulin resistance, obesity, and endurance fitness in men with type 2 diabetes mellitus
  3761. Relative adipose tissue failure in Alström syndrome drives obesity-induced insulin resistance
  3762. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women
  3763. Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome
  3764. Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance
  3765. REMOVED: insulin resistance and obesity in childhood and long term consequences during aging
  3766. Renal hemodynamics in Otsuka Long-Evans Tokushima fatty rat, a model rat of spontaneous non-insulin-dependent diabetes mellitus with obesity
  3767. Renal insulin sensitizing effect of exenatide in a high-fat diet obesity rat model
  3768. Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice
  3769. Replication data for: Modest weight loss improves leptin to adiponectin ratio and induces insulin and leptin resensitivization in individuals with obesity.
  3770. Reply to Letter:“Concerning the Article Assessment of Different Bariatric Surgeries in the Treatment of obesity and insulin Resistance in Mice”
  3771. Reproductive tissues maintain insulin sensitivity in diet-induced obesity
  3772. Reprogrammed functional brown adipocytes ameliorate insulin resistance and dyslipidemia in diet-induced obesity and type 2 diabetes
  3773. Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance
  3774. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor
  3775. Rescue of obesity‐induced infertility in female mice due to an ovarian theca cell‐specific knockout of the insulin receptor
  3776. Research data supporting” obesity and insulin Resistance are Associated with Reduced Activity in Core Memory Regions of the Brain”
  3777. Research for the Relationship between obesity, blood sugar, insulin and Type 2 Diabetes in Kunming
  3778. RESEARCH IN EFFECTS OF FAT DISTRIBUTION ON insulin SECRETION AND insulin RESISTANCE IN METABOLIC obesity NORMAL-WEIGHT
  3779. Research Methodology of Aerobic Compared to Resistance Training to Reduce insulin Resistance in obesity
  3780. Research on Character of Glucose and Lipid Metabolism and insulin Sensitivity in Simple obesity Children
  3781. RESEARCH ON THE RELATIONSHIP BETWEEN insulin RESISTANCE AND SUSCEPTIBILITY OF obesity
  3782. RESEARCH ON THE RELATIONSHIP OF SERUM TUMOR NECROTIC FACTOR AND insulin LEVEL IN PATIENTS WITH obesity
  3783. Research progress in aberrant sphingolipid metabolism and obesity and obesity-mediated insulin resistance
  3784. Research progress of Ghrelin and obesity, insulin resistance and type 2 diabetes mellitus
  3785. Research progress of mechanism of vitamin D in regulating obesity and insulin resistance on children
  3786. Research Progress of Relationship between Estrogen Decrease and Abdominal obesity and insulin Resistance [J]
  3787. Research Progress of the Omega-3 Fatty Acids in the Treatment of insulin Resistance, obesity, Diabetes
  3788. Research Progress on Pathogenesis of obesity-Induced insulin Resistance and Its Therapeutic Targets: PPARα/γ
  3789. Resistance of adipose tissue lipoprotein lipase to insulin action in rats fed an obesity-promoting diet
  3790. Resistance to Diet-Induced obesity and Improved insulin Sensitivity in Mice With a Regulator of G Protein Signaling–Insensitive G184S Gnai2 Allele
  3791. Resistance to diet-induced obesity and improved insulin sensitivity in mice with an RGS insensitive G184S Gnai2 allele
  3792. Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin
  3793. Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency
  3794. Resistance to high-fat diet–induced obesity but exacerbated insulin resistance in mice overexpressing Preadipocyte Factor-1 (Pref-1): a new model of partial …
Related Posts

Purgatives

Anti Adipogenic

Piper

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping